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ABSTRACT
Eclampsia is defined as de novo seizure in a woman with the hypertensive complication
of pregnancy known as preeclampsia (PE), and is a leading cause of maternal and fetal
morbidity and mortality worldwide. The pathogenesis of eclamptic seizure remains
unknown, but is considered a form of hypertensive encephalopathy where an acute rise in
blood pressure causes loss of cerebral blood flow (CBF) autoregulation and
hyperperfusion of the brain that results in vasogenic edema formation and subsequent
seizure. However, eclamptic seizure can occur during seemingly uncomplicated
pregnancies, in the absence of hypertension and PE, suggesting that normal pregnancy
may predispose the brain to hypertensive encephalopathy or seizure, independently of
PE. The overall goal of this dissertation was to investigate the effect of pregnancy and PE
on the cerebrovasculature and neurophysiological properties that may promote brain
injury and eclamptic seizure. For this dissertation project, a rat model of PE was
established that combined placental ischemia, induced by restricting blood flow to the
uteroplacental unit, and maternal endothelial dysfunction that was induced by a
prolonged high cholesterol diet. Rats with PE developed several PE-like symptoms,
including elevated blood pressure, fetal growth restriction, placental dysfunction, and
were in a state of oxidative stress and endothelial dysfunction. We found that pregnancy
had an overall protective effect on the maintenance of CBF that was potentially due to a
nitric-oxide dependent enhancement of the vasodilation of cerebral arteries to decreased
intravascular pressure. Further, maintenance of CBF during acute hypertension was
similar in pregnancy and PE. Thus, it does not appear that pregnancy and PE are states
during which CBF autoregulation is compromised in a manner that would promote the
development of hypertensive encephalopathy. However, the brain was found to be in a
hyperexcitable state during normal pregnancy that was augmented in PE, and could
contribute to onset of eclamptic seizure. Under chloral hydrate anesthesia, generalized
seizure was induced by timed infusion of the convulsant pentylenetetrazole (PTZ), with
simultaneous electroencephalography that was stopped at the first onset of spikewave
discharge indicative of electrical seizure. Seizure threshold was determined as the amount
of PTZ required to elicit seizure. Compared to the nonpregnant state, seizure threshold
was ~44% lower in pregnant rats and ~80% lower in rats with PE. Further, pregnant rats
were more susceptible to seizure-induced vasogenic edema formation than the
nonpregnant state. Mechanisms by which pregnancy and PE lowered seizure threshold
appeared to be through pregnancy-associated decreases in cortical γ-aminobutyric acid
type A receptor (GABAAR) subunits and PE-induced disruption of the blood-brain
barrier (BBB) and microglial activation, indicative of neuroinflammation. Magnesium
sulfate (MgSO4), the leading treatment for seizure prophylaxis in women with PE,
restored seizure threshold to control levels by reversing neuroinflammation in PE rats,
without affecting BBB permeability. Overall, this dissertation provides evidence that
pregnancy increases susceptibility of the brain to seizure and vasogenic edema formation
that likely contribute to the onset of eclampsia during seemingly uncomplicated
pregnancies. Further, the pathogenesis of eclampsia during PE likely involves breakdown
of the BBB and subsequent neuroinflammation, resulting in a state of greater seizure
susceptibility that is ameliorated by MgSO4 treatment.
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CHAPTER 1: COMPREHENSIVE LITERATURE REVIEW
1.1 Preeclampsia and Eclampsia
Preeclampsia, defined as the new onset of hypertension with significant
proteinuria after the 20th week of gestation, is a life-threatening complication that afflicts
1-7% of all pregnancies (Roberts and Redman, 1993; Lisonkova and Joseph, 2013;
Abalos et al., 2014; Rich-Edwards et al., 2014). Preeclampsia is a heterogeneous disease
that exists on a spectrum from mild to severe and can affect many organs, including the
kidney, liver, as well as the brain (Duley, 1992; Donaldson, 1994b; Aukes et al., 2007b;
Aukes et al., 2009; Duley, 2009). Neurologic symptoms include severe and persistent
headache, uncontrolled vomiting, visual disturbances, cortical blindness and seizure, or
eclampsia. Eclampsia is the new appearance of unexplained seizure in a woman with
preeclampsia, and is one of the most dangerous complications of pregnancy (Abalos et
al., 2014). Eclampsia is a leading cause of maternal and fetal morbidity and mortality
worldwide that accounts for greater than 50,000 maternal deaths each year with 1 in 50
women dying and 1 in 14 offspring (Donaldson, 1989a; Duley, 1992, 2009). Although by
definition eclampsia is restricted to women with preeclampsia, there does not appear to
be a progression from mild to severe preeclampsia to eclampsia (Sibai, 1990a; Douglas
and Redman, 1994; Katz et al., 2000). In fact, de novo seizure has been reported to occur
in 38-60% of seemingly uncomplicated pregnancies, without hypertension or the
diagnosis of preeclampsia (Douglas and Redman, 1994; Katz et al., 2000). The finding
that de novo seizure occurs in the absence of preeclampsia suggests that pregnancy alone
may be a state of increased seizure susceptibility. In addition, women who develop
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preeclampsia are by definition normotensive and asymptomatic prior to pregnancy, with
no known underlying conditions contributing to seizure onset, supporting the concept that
pregnancy alone may predispose the brain to seizure, independently of preeclampsia.
Thus, a portion of this dissertation investigated the contribution of normal pregnancy to
eclampsia.
A portion of women have de novo seizure during seemingly uncomplicated
pregnancies, however, the majority of eclampsia occurs in the setting of preeclampsia.
Further, by the growing use of magnesium sulfate (MgSO4) for seizure prophylaxis in
women with preeclampsia, the incidence of eclamptic seizure has decreased ~ 50 %
(Duley, 1995). That the incidence of eclampsia has decreased by treating preeclamptic
women with a seizure prophylactic support that preeclampsia, too, contributes to de novo
seizure during pregnancy. Therefore, the research completed for this thesis further
investigated the pathogenesis of preeclampsia as it relates to the involvement of the brain,
the effect of preeclampsia on seizure susceptibility, and mechanisms by which MgSO4
effectively reduces seizure.
1.2 Pathogenesis of Preeclampsia
Currently there is no medical exam or test that can be performed to determine
women that will develop preeclampsia, making this disease unpredictable and
unpreventable. However, general risk factors have been identified including primiparity,
multi-fetal gestations, body mass index > 34 kg/m2, ethnicity, with highest risk for black
women, and underlying medical conditions such as pre-existing hypertension, renal
disease or diabetes mellitus (Steegers et al., 2010; Trogstad et al., 2011; Abalos et al.,
2014). The only known cure for preeclampsia is delivery of the fetus, with preeclamptic
2

women improving nearly immediately upon discharge of the placenta. The finding that
women improve after removal of the placenta has directly implicated the placenta in the
etiology of preeclampsia (Myatt, 2002).
The pathophysiology of preeclampsia was considered as a two-stage model: poor
placental perfusion leads to release of pro-inflammatory cytokines and anti-angiogenic
factors into the maternal circulation and development of maternal endothelial dysfunction
and hypertension, resulting in the hallmark preeclamptic symptoms (Redman, 1991; de
Groot and Taylor, 1993; Brown, 1995). Stage 1 describes placental disease and involves
improper spiral artery adaptation and trophoblast invasion during implantation (Khong et
al., 1986). In the nonpregnant state, spiral arteries are high resistance arteries, however
during normal pregnancy these arteries remodel, with smooth muscle cells and
endothelial cells being replaced by invading trophoblasts (Robertson et al., 1967). This
invasion results in widely dilated, low resistance arteries that allow for increased blood
flow to the placenta necessary for proper growth of the fetus (Brosens et al., 1967;
Pijnenborg et al., 1983; Lyall, 2005). In stage 1 of the two-stage model of preeclampsia,
improper trophoblast invasion leads to spiral arteries remaining in a state of high vascular
resistance, decreasing blood perfusion to the placenta, resulting in placental ischemia and
a state of oxidative stress (Redman, 1991; Roberts and Hubel, 1999). Oxidative stress
causes the placenta to release substances into the maternal circulation that have
deleterious effects. Increases in pro-inflammatory cytokines lead to an increase in the
maternal systemic inflammatory response and increased circulating levels of soluble
receptors for angiogenic factors (Kupferminc et al., 1994; Myatt and Webster, 2009).
Overall, this cascade of events leads to generalized endothelial dysfunction and reversal
3

of cardiovascular adaptations to normal pregnancy (Stage 2). Consequentially,
hypertension develops and glomerular endotheliosis in the kidneys and impaired renal
function results in protein being excreted in the urine (proteinuria) (James et al., 2010).
Significant proteinuria (> 300 mg/24 hours) was, until early 2014, considered a hallmark
preeclamptic symptom necessary for diagnosis. However, due to the variability and
unreliability of proteinuria in women with preeclampsia, the American College of
Obstetricians and Gynecologists (ACOG) has now stressed that the diagnosis of
preeclampsia can be made in the absence of proteinuria if de novo hypertension occurs in
association with thrombocytopenia, renal insufficiency, impaired liver function,
pulmonary edema, or visual disturbances (Lindheimer et al., 2014).
The two-stage theory of preeclampsia has been adapted since first proposed in
1991 as it has become clear that preeclampsia is far more heterogeneous of a disease, and
that all cases do not fit into the two-stage model (Roberts and Hubel, 2009). Some
women are diagnosed with the maternal syndrome of preeclampsia that have a healthy
placenta and no fetal involvement, suggesting that preeclampsia can occur in a setting
absent of placental ischemia (von Dadelszen et al., 2003; Egbor et al., 2006; Szarka et al.,
2010). Further, some women have placental involvement, indicated by fetal growth
restriction that do not develop preeclamptic symptoms (Villar et al., 2006). Thus, the
pathogenesis of preeclampsia does not necessarily appear to be a progression from Stage
1 to Stage 2, and there appear to be subclassifications of preeclampsia, including
separation of maternal and placental disease, making identifying the underlying
mechanism(s) of the pathogenesis of preeclampsia more difficult.
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Classification of preeclampsia is complicated, and how to differentiate mild forms
of the disease from severe is still being debated (Lindheimer et al., 2008; Magee et al.,
2008; Lowe et al., 2009; Steegers et al., 2010). The current ACOG delineation of mild
from severe preeclampsia is based largely upon the level of hypertension. Women with
blood pressures of 140-159 mm Hg systolic and 90-109 mm Hg diastolic are considered
to have a mild form of preeclampsia, where as > 160 mm Hg systolic and > 110 mm Hg
diastolic is considered severe (Lindheimer et al., 2014). The presence of neurologic
symptoms also advances a woman to severe preeclampsia. While the intent of
classification is to separate women at high risk of eclampsia and maternal and fetal
morbidity and mortality from those at low risk, some of the classification systems
exclude, or neglect to include, criteria that appear to be key variables in prediction of
maternal and fetal outcome (von Dadelszen et al., 2003). It is now accepted that the
gestational timing of the onset of symptoms should be considered when assessing the
severity of the disease. Development of hypertension and proteinuria prior to 34 weeks of
gestation is considered early-onset preeclampsia whereas symptoms occurring after 34
weeks of gestation, late-onset preeclampsia (von Dadelszen et al., 2003). The incidence
of neurologic complications, including blurred vision and persistent headache, is greater
in women with early-onset preeclampsia that is more often associated with maternal and
fetal morbidity (Douglas and Redman, 1994; Odegard et al., 2000; Witlin et al., 2000;
von Dadelszen et al., 2003; Lindheimer et al., 2008; Ogge et al., 2011). Further, earlyonset preeclampsia is more often associated with placental disease, with greater incidence
of abnormal vascular morphology and intrauterine growth restriction than in late-onset
preeclampsia (Xiong et al., 2002; Oudejans et al., 2007; Crispi et al., 2008; Raymond and
5

Peterson, 2011). In contrast, late-onset preeclampsia is, for the most part, considered to
be maternal disease, with little involvement of the placenta, and preeclamptic symptoms
arising due to underlying cardiovascular diseases that have been unmasked by the
physiological stress of pregnancy (Ness and Roberts, 1996; Egbor et al., 2006; Raymond
and Peterson, 2011). It has further been proposed that the most severe form of
preeclampsia is early-onset of both placental and maternal disease (Staff et al., 2013).
The combination of the effect of an ischemic placenta in a maternal setting of preexisting inflammation and/or endothelial dysfunction seems to amplify the disease
process. Although eclampsia is most often nonfatal when occurring at term, maternal
mortality due to eclampsia in women with severe early-onset preeclampsia is ~ 50 %,
suggesting the combination of maternal and placental syndromes may adversely affect
the brain to a greater degree than one of the syndromes alone (MacKay et al., 2001).
Overall, there do not appear to be hard and fast rules that exist for the delineation of mild
vs. severe preeclampsia; all women with preeclampsia are at some level of risk of
eclampsia, and therefore increased risk for maternal and fetal morbidity and mortality.
Strict demarcation of any one aspect of preeclampsia, whether it be the level of
hypertension, or gestational age at which symptoms occur, could be misleading. Thus,
seizure prophylaxis in the form of MgSO4 now tends to be administered to most women
with preeclampsia, regardless of “severity”, as eclampsia can occur all along the
spectrum of disease, including during seemingly uncomplicated pregnancies.
1.3 Seizure during Pregnancy
Based upon the timing of eclamptic seizure onset in regards to gestational age,
three types of eclampsia exist. Antepartum eclampsia (occurring prior to labor) most
6

often occurs preterm (before 37 weeks of gestation), whereas intrapartum (during labor)
and postpartum (after delivery of the fetus and placenta) occur more often at term
(Douglas and Redman, 1994). Postpartum eclampsia, however, can occur several weeks
after delivery (Douglas and Redman, 1994). Antepartum eclampsia accounts for 38-45%
of eclampsia and is associated with greater maternal and fetal morbidity and mortality
(Douglas and Redman, 1994; Knight, 2007). Commonly, severe headache and visual
disturbances immediately precede eclamptic seizure onset, followed by confusion, then
progression from focal seizure, frequently over the face, to generalized tonic-clonic
convulsion (Thomas, 1998; Katz et al., 2000; Kaplan, 2001; Shah et al., 2008; Cooray et
al., 2011). Eclamptic seizure seems to be self-limiting, typically lasting no more than 3-4
minutes followed by a post-ictal period of confusion and agitation, and even coma
(Norwitz et al., 2011). Seizure causes hypoxia and lactic acidosis due to cessation of
respiration in the mother, and fetal bradycardia ensues for approximately 20 minutes
(Donaldson, 1994b). Seizures can be recurrent, with the average frequency being three in
12 hours (Thomas et al., 1995). Acute memory deficit is common in women with
eclampsia, with either retrograde or anterograde amnesia lasting hours to days after
seizure manifestation (Shah et al., 2008). Besides hypoxia, eclampsia can lead to
intracerebral hemorrhage, cerebral edema, acute renal failure and pulmonary edema,
which are leading causes of maternal death (Donaldson, 1994b; MacKay et al., 2001).
The most common causes of fetal mortality are prematurity, abrupto placentae, and
severe fetal growth restriction (Sibai, 1990a, 2005). Thus, eclamptic seizure poses an
immediate and serious health risk for both the mother as well as the fetus, although longterm effects remain unclear.
7

Eclampsia does not appear to be linked to the development of epilepsy and is not
thought to have long-term neurological consequences (Zeeman et al., 2009). Thus, it
remains, for the most part, an isolated event. However, it is difficult to assess whether the
eclamptic seizure is simply benign. Studies using magnetic resonance imaging (MRI)
showed that white matter lesions are present more often in women who had eclampsia
than in healthy controls, however whether those white matter lesions were present prior
to eclampsia remains unknown (Zeeman et al., 2004b; Aukes et al., 2009; Wiegman et
al., 2014). A Cognitive Failures questionnaire that was administered to formerly
eclamptic patients to assess the mental difficulty completing daily-life activities indicated
impaired cognitive function later in life (Aukes et al., 2007b). Further, this self-report
study revealed that women who had multiple eclamptic seizures reported greater
cognitive impairment than those women who had a single seizure (Aukes et al., 2007b).
However, neurocognitive function testing revealed no evidence for impaired executive
functioning or sustained attention (Postma et al., 2010). Thus, it remains unclear if there
are long-term neurological complications associated with eclampsia; however, the
immediate risk for the mother and fetus remains high, making seizure prevention during
pregnancy and preeclampsia critical.
The incidence of eclampsia has declined in developed countries with the
advancement of prenatal care, and the use of seizure prophylactics such as MgSO4 reduce
the risk of eclampsia by ~ 50% (Duley et al., 2003). Incidence reports of eclampsia in the
United States decreased by 22 % between 1987 and 2004 (Wallis et al., 2008), and in the
United Kingdom declined from 4.9 cases per 10,000 pregnancies in 1992 to 2.7/10,000
pregnancies in 2005-06 (Douglas and Redman, 1994; Knight, 2007). Similarly, in
8

Scandinavia the incidence was 5.0/10,000 pregnancies between 1998-2000 (Andersgaard
et al., 2006), and in Canada (excluding Quebec) 5.9/10,000 cases between 2009-2010
(Liu et al., 2011). However, in developing countries the incidence of eclampsia is
substantially higher. For example, in 1990 in South Africa the incidence of eclampsia
was 60/10,000 pregnancies (Moodley and Daya, 1994), 144/10,000 in Muheza, Tanga
region, Tanzania in 2007-2008 (Cooray et al., 2011) and 200/10,000 pregnancies at
Muhimbili National Hospital in Dar es Salaam, Tanzania in 1999-2000 (Urassa et al.,
2006). Thus, despite rates of eclampsia declining in the developed world, eclampsia
remains a worldwide problem.
The complexity of the pathogenesis of eclampsia is augmented by the lack of
predictability of women who are most at risk of seizure. In fact, despite the definition of
eclampsia being in the context of a woman with preeclampsia, it does not appear to
always be a progression from preeclampsia to eclamptic seizure. Several studies have
reported a substantial percentage of women with eclamptic seizure did not have the
hallmark preeclamptic symptoms of hypertension and/or proteinuria prior to seizure
(Douglas and Redman, 1994; Katz et al., 2000; Knight, 2007), suggesting that de novo
seizure occurs during seemingly uncomplicated pregnancies. A retrospective study that
sought to investigate the percentage of eclampsia that was preventable, that is with a
diagnosis of preeclampsia before seizure onset so that prophylaxis could be started with
MgSO4, collected records of pregnancies complicated by eclampsia from The University
of North Carolina Medical Center at Chapel Hill between January 1987 – December 1995
and Sacred Heart Medical Center from January 1990 – March 1999 (Katz et al., 2000). In
this study, 53 pregnancies were complicated by eclampsia, and seizure occurred without a
9

prior diagnosis of preeclampsia in 32 of the 53 eclamptic pregnancies (60%) (Katz et al.,
2000). A larger study investigated the incidence of eclampsia at all hospitals in the
United Kingdom in 1992, and then again between February 2005 – February 2006
(Douglas and Redman, 1994; Knight, 2007). Douglas & Redman (1994) reported that
38% of eclampsia occurred prior to hypertension and proteinuria was documented in
1992 (Douglas and Redman, 1994). Interestingly, the 2005-6 study by Knight et al.
(2007) reported that only 38% of women who developed eclampsia had hypertension and
proteinuria the week prior to seizure onset (Knight, 2007). Together these studies suggest
that eclampsia does not only occur in women with pregnancies complicated by
preeclampsia, and that seizure onset is not a progression from preeclampsia to eclampsia.
Instead, these studies suggest that de novo seizure can occur in the absence of
preeclampsia, and that pregnancy alone may predispose the brain to seizure,
independently of preeclampsia. Thus, the term “preeclampsia” seems to be misleading, as
eclampsia can occur in its absence. Further, the progression from normal pregnancy to
preeclampsia to eclampsia should not be considered linear. Overall, understanding the
cerebrovascular and neurophysiological changes associated with normal pregnancy may
shed light into the pathogenesis of eclampsia, as normal pregnancy may contribute to de
novo seizure in the absence of preeclampsia.
1.4 The Cerebral Circulation during Pregnancy and Preeclampsia
1.4.1 Introduction
The brain is an organ of high metabolic demand that consumes ~ 20% of the
body’s oxygen at rest, despite comprising only 2% of body weight (Siegel, 1999).
Importantly, the brain has a relatively narrow capacity to tolerate changes in ion and
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water balance, and blood flow (Siegel, 1999). The brain is also unique in that it is
enclosed in a rigid skull and therefore increased vascular permeability or volume could
result in detrimentally increased intracranial pressure that can cause serious neurological
symptoms, brain herniation, and even death (Rosenberg, 1999; Marmarou, 2007). Thus,
there is a need to maintain tight control of cerebral blood flow (CBF) and water flux in
the face of a 40-50% increase in plasma volume and cardiac output during pregnancy and
a decline in systemic vascular resistance necessary for the maintenance of a healthy blood
pressure (Clapp and Capeless, 1997). In contrast to other organs outside the central
nervous system that undergo substantial increases in both perfusion and transvascular
filtration during pregnancy, including the uterus, kidney and heart, the cerebral
circulation must resist these adaptations to counterbalance global hemodynamic changes
in order to maintain the delicate microenvironment of the brain. Thus, the adaptation of
the brain and cerebral circulation to pregnancy appears to be to maintain normalcy
despite substantial hormonal and cardiovascular changes in almost every other organ.
Pregnancy has the potential to affect several aspects of the cerebral circulation, including
the cerebral endothelium and blood-brain barrier (BBB), the structure and function of the
cerebrovasculature, hemodynamics, and CBF autoregulation. Further, in the context of
these cerebrovascular adaptations, there is risk for neurological complications, such as
eclampsia, when the cerebral circulation is compromised, as all of the parameters listed
above have the potential to lead to seizure onset if disrupted or maladapted. In fact, the
cerebral circulation is thought to have a central role in the pathogenesis of eclampsia.
Further, the cerebrovasculature is directly involved in ~40 % of maternal deaths due to
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eclampsia (MacKay et al., 2001). Thus, understanding how pregnancy and preeclampsia
affect the cerebrovasculature is of interest.
1.4.2 Vasomotor Responses to Circulating Factors
One of the most important adaptations of the cerebral circulation during
pregnancy is to counteract the effects of circulating vasoactive factors. During pregnancy,
large amounts of hormones are secreted from the placenta, ovaries, and brain into the
maternal circulation, including pro- and anti-inflammatory cytokines, chemokines,
steroids and growth factors (Aagaard-Tillery et al., 2006; Szarka et al., 2010). These
factors are critical for the development and survival of the fetus and adaptation of other
organ systems needed for a successful pregnancy. Cerebral arteries uniquely adapt during
pregnancy to oppose an increase in circulating vasoconstrictors present late in gestation.
Exposure of plasma from pregnant women causes vasoconstriction of posterior cerebral
arteries from nonpregnant rats, however, this vasoconstrictive effect is absent in arteries
from pregnant rats (Amburgey et al., 2010a). This lack of effect in arteries from pregnant
rats suggests the cerebral circulation adapts to combat vasoconstrictors present late in
gestation. This adaptation may be due to either development of resistance to
vasoconstrictors circulating during pregnancy, or increased sensitivity to vasodilators also
circulating in pregnancy. Interestingly, this finding was specific to the cerebral
vasculature, as the effect of pregnant plasma was not seen in mesenteric arteries
(Amburgey et al., 2010a). Thus, the adaptation of the cerebral circulation during
pregnancy is unique compared to the adaptation of other organ systems. The exact
mechanism by which the cerebral vasculature resists the vasoconstrictive effect of
circulating factors in pregnancy remains unclear, but may involve receptor
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downregulation or changes in the influence of the endothelium on vascular tone in
response to plasma (Duckles and Krause, 2007; Chan et al., 2010). Regardless, this
adaptation of the cerebral circulation likely occurs to prevent the cerebrovasculature from
constricting in response to circulating factors and may help maintain physiologic levels of
cerebrovascular resistance and blood flow to the brain during pregnancy.
1.4.3 The Cerebral Endothelium and BBB
Vasomotor responses are not the only feature of the cerebral circulation that adapt
to pregnancy. The cerebral endothelium that forms the BBB is a complex interface
between systemically circulating factors and the delicate microenvironment of the brain.
The endothelial cells of the BBB contain specialized high electrical-resistance tight
junctions and lack fenestrations (Ueno, 2007; Zlokovic, 2008). BBB tight junctions limit
the passage of blood constituents into the brain parenchyma by preventing paracellular
transport and are highly protective of the brain milieu (Wahl et al., 1988; Rubin and
Staddon, 1999). Cerebral endothelial cells also have a low rate of pinocytosis, which
limits the amount of transcellular transport, reinforcing the overall function of the BBB
(Reese and Karnovsky, 1967; Brightman and Reese, 1969; Fenstermacher et al., 1988).
Pregnancy does not affect mRNA expression of the primary tight junction proteins of the
BBB, including claudin-1, claudin-5, occludin and zona occludens-1, as these are similar
to the nonpregnant state (Cipolla et al., 2011). In addition, paracellular and transcellular
transport at the BBB remain unchanged during normal pregnancy, as BBB permeability
to solutes does not increase (Cipolla et al., 2011). In addition, hydraulic conductivity, an
important parameter that relates water movement through the vessel wall in response to
hydrostatic pressure, is normally very low in cerebral endothelial cells due to the high
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electrical resistance tight junctions and low pinocytotic activity (Rubin and Staddon,
1999). Similar to paracellular and transcellular permeability, hydraulic conductivity is not
changed during pregnancy (Cipolla et al., 2012b), but is increased in response to
preeclamptic plasma (Amburgey et al., 2010b). Increased hydraulic conductivity during
preeclampsia could promote neurologic symptoms as increased BBB permeability has
been linked to several pathologic states including preeclampsia and eclampsia as well as
epilepsy (Oby and Janigro, 2006; Marchi et al., 2007; Marchi et al., 2011).
Pregnancy is a state marked by increased circulating permeability factors,
including several that are known to promote BBB permeability (Brown et al., 1997;
Evans et al., 1997), yet it is remarkable that no such changes in permeability have been
measured (Cipolla et al., 2012b). For example, vascular endothelial growth factor
(VEGF), a cytokine originally named vascular permeability factor, is secreted by the
placenta and elevated during pregnancy in the uteroplacental unit and the maternal
circulation (Brown et al., 1997; Evans et al., 1997; Charnock-Jones et al., 2004;
Amburgey et al., 2010b). VEGF interacts with its receptors VEGFR1 (or FMS-like
tyrosine kinase receptor 1, Flt-1) and VEGFR2 (or fetal liver kinase 1, Flk-1) located on
vascular endothelium to initiate several critical physiological processes involved in
angiogenesis, vascular growth, and endothelial cell survival (Dvorak, 2002; Shibuya,
2013). In addition to VEGF, placental growth factor (PlGF), a member of the VEGF
family, is also elevated during pregnancy and contributes to angiogenesis in the uterus
and placenta (Krauss et al., 2004). Most notably, VEGF and PlGF are potent vasodilators
and increase peripheral microvascular permeability to serum proteins and
macromolecules, considered a primary step in preparation for angiogenesis (Feng et al.,
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1996; Dobrogowska et al., 1998; Dvorak, 2002; Oura et al., 2003), and increase BBB
permeability (Schreurs et al., 2012). Interestingly, despite elevated circulating VEGF and
PlGF during pregnancy, exposure of cerebral vessels to pregnant plasma or serum does
not increase BBB permeability (Cipolla et al., 2012b; Schreurs et al., 2012). Further,
VEGF receptor expression in cerebral arteries does not appear to change during
pregnancy, suggesting the lack of effect of VEGF and PlGF is not due to downregulation
of VEGFRI/II or neuropilin (Schreurs et al., 2012). In fact, plasma from late-pregnant
rats prevents VEGF-induced increases in BBB permeability (Schreurs et al., 2012), likely
due to increased levels of soluble Flt-1 (sFlt-1). The selective binding of VEGF and PlGF
to sFlt-1 is important for regulating their bioavailability, thus limiting the permeabilitypromoting effects at the BBB during pregnancy (Schreurs et al., 2012). The prevention of
circulating permeability factors from increasing BBB permeability is an important
adaptation during pregnancy to help maintain brain homeostasis.
Although paracellular and transcellular permeability of the BBB appear to remain
intact during pregnancy, efflux transporters present at the BBB are an important
regulatory mechanism controlling passage of serum factors into the brain that appear to
be gestationally regulated (Coles et al., 2009b; Chung et al., 2010). Specifically, pglycoprotein (Pgp) is a main efflux transporter at the BBB that extricates steroids,
cytokines and chemokines as well as many pharmacologic agents that can pass through
the BBB, essentially acting a gatekeeper to the central nervous system (Begley, 2004;
Ueno, 2007). Pgp is an obstacle in administration of therapeutics to the brain, making it
difficult for pharmacological interventions to be delivered in patients with epilepsy, brain
tumors, HIV, etc. (Begley, 2004). The role of Pgp in restricting drug delivery to the brain
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during pregnancy has been investigated in pregnant mice and nonhuman primates. Pgp
protein expression is elevated at the BBB mid-gestation, but returns to pre-pregnancy
levels by late-gestation in mice (Coles et al., 2009b). In the same study, the protein
expression of another efflux transporter, multi-drug resistance-associated protein 1
(Mrp1), was also elevated at the BBB mid-pregnancy that remained higher late in
gestation (Coles et al., 2009b). A study using positron emission tomography scanning to
investigate Pgp activity at the BBB across gestation in nonhuman primates reported that
Pgp activity increases with gestational age (Chung et al., 2010). Thus, it appears that
efflux transporters are gestationally regulated, potentially in response to the increase in
circulating factors occurring during pregnancy (Bauer et al., 2007; Coles et al., 2009a).
While it appears that Pgp expression increases at the BBB only in mid-gestation, its
activity may increase late in pregnancy. This potential adaptation may play a key role in
maintaining barrier function despite increases in circulating factors, some of which are
hormones and steroids that can pass through the BBB due to their lipophilic nature. In
fact, it is possible that during preeclampsia this adaptation fails or is overcome, resulting
in eclamptic seizure (see below). Overall, increases in efflux transporter expression
and/or activity across gestation are likely a critical adaptation of the BBB to prevent
passage of circulating factors into the brain during pregnancy.
Preservation of BBB properties and adaptation of efflux transporters in the face of
elevated circulating permeability factors during pregnancy appears to be highly
protective, and may be central to seizure prevention. Seizure-provoking serum
constituents are also present late in gestation. Serum from late-pregnant, but not
nonpregnant rats causes hyperexcitability of hippocampal neuronal networks in cultured
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slices, measured by evoked field potentials (Cipolla et al., 2012b). The increase in
excitability is due to serum factors causing neuroinflammation via activation of microglia
and secretion of tumor necrosis factor α (TNFα) (Riazi et al., 2008; Cipolla et al., 2012b).
However, under normal conditions the brain is not likely to come into contact with
circulating serum factors due to the protective nature of the BBB, highlighting the
importance of the BBB in seizure prevention during pregnancy (Ueno, 2007; Johnson et
al., 2014).
The adaptation of the BBB to normal pregnancy may play a critical role in seizure
prevention, by protecting the brain from exposure to seizure-provoking constituents
circulating late in gestation. However, during preeclampsia, maternal endothelial
dysfunction appears to lead to BBB disruption and result in an increase in BBB
permeability and edema formation (Kaplan, 2001; Demirtas et al., 2005). Under such
conditions, seizure-provoking factors, or other deleterious proteins or pro-inflammatory
cytokines that are increased in preeclampsia may cross into the brain and lead to seizure
onset. In fact, plasma from women with preeclampsia caused increased BBB
permeability when exposed to cerebral arteries of rats (Amburgey et al., 2010b). Further,
when the effect of plasma from women with early-onset preeclampsia on BBB
permeability was compared to that of late-onset preeclampsia, only plasma from earlyonset preeclamptic patients increased BBB permeability (Schreurs et al., 2013). This was
due to a > 200% increase in circulating oxidized low-density lipoprotein (oxLDL) present
in early-onset preeclampsia (Schreurs et al., 2013). Through interaction of oxLDL with
its receptor, lectin-like oxLDL receptor 1 (LOX1), subsequent peroxynitrite formation
leads to BBB disruption and an increase in BBB permeability (Schreurs et al., 2013).
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This differential effect of plasma supports that early-onset preeclampsia is more severe
than late-onset, and may explain the greater propensity of neurologic involvement during
early-onset preeclampsia. Overall, increased BBB permeability during preeclampsia
likely contributes to edema formation and/or passage of seizure-provoking factors into
the brain, and may represent one mechanism by which eclamptic seizure occurs
(Donaldson, 1994b; Cipolla, 2007).
Cerebral edema formation is considered a leading cause of the neurological
symptoms that occur in preeclampsia, including eclamptic seizure (Donaldson, 1994a;
Hinchey et al., 1996; Zeeman et al., 2009). In fact, approximately 90 % of women with
eclampsia have vasogenic cerebral edema formation, as indicated by diffusion-weighted
MRI (Zeeman et al., 2004b; Brewer et al., 2013). Further, preeclampsia and eclampsia
are commonly associated with hypertensive encephalopathy, and more specifically,
posterior reversible encephalopathy syndrome (PRES) (Schwartz et al., 1992; Hinchey et
al., 1996; Schwartz et al., 2000; Bartynski and Boardman, 2007). However, seizure itself
leads to BBB disruption, making it difficult to determine if edema is the cause of or a
consequence of eclamptic seizures (Oby and Janigro, 2006; Marchi et al., 2010).
Regardless, the presence of vasogenic edema formation in women with preeclampsia that
have not had seizures is definitive evidence of increased vascular permeability that leads
to an accumulation of edematous fluid in the extracellular space within the brain (Klatzo,
1987b, a). However, having the outcome of vasogenic edema in women with
preeclampsia does not contribute to the understanding of what may be occurring at the
cellular level at the BBB during preeclampsia in order to allow passage of solutes and
water into the brain. Studies investigating changes in BBB permeability in the placental
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ischemia rat model of preeclampsia have reported increased permeability of the BBB to
albumin-bound Evans Blue (Porcello Marrone et al., 2014; Warrington et al., 2014).
However, serum albumin levels change during pregnancy and preeclampsia (Honger,
1968b, a; McCartney et al., 1971; Gojnic et al., 2004), suggesting conclusions from these
studies about the integrity of the BBB should be made cautiously. Additionally, these
studies using Evans Blue highlight the necessity for future studies using animal models of
preeclampsia to investigate BBB permeability to other fluorescently tagged solutes.
Overall, there is evidence that the BBB is compromised in both women with
preeclampsia as well as in animal models of preeclampsia that likely plays a role in the
pathogenesis of eclampsia. Further, it has been suggested that such BBB disruption and
subsequent vasogenic edema formation may be a consequence of impaired CBF
autoregulation.
1.4.4 CBF Autoregulation and Hemodynamics
The cerebral circulation ultimately functions to deliver oxygen, glucose and
nutrient rich blood to, and remove metabolic waste from the central nervous system that
is crucial to ensure proper brain function. It is therefore not surprising that blood flow
autoregulation is well developed in the brain. CBF autoregulation is the intrinsic property
of the brain to maintain relatively constant blood flow in the face of changes in blood
pressure (Harper, 1966; Hayman et al., 1981). In normal healthy adults, CBF
autoregulation operates between ~ 60 – 160 mmHg (Lassen, 1959; McHenry et al.,
1974). Although the effect of pregnancy on the lower limit of CBF autoregulation has yet
to be investigated, pregnancy appears to shift the upper limit of the CBF autoregulatory
curve. In normal pregnant rats, the upper limit of the CBF autoregulatory curve was
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investigated by using a phenylephrine infusion to acutely raise blood pressure together
with continuous CBF measurements using laser Doppler flowmetry (Cipolla et al.,
2012a). This study found that compared to the nonpregnant state, the upper limit of CBF
autoregulation was shifted rightward to higher pressure (Cipolla et al., 2012a). Thus, the
effect of pregnancy on CBF autoregulation appears to be protective, making the maternal
brain better prepared to maintain blood flow in the face of acute hypertension. However,
this study used an animal model of pregnancy, as such measurements in pregnant women
are challenging and potentially dangerous. Studies in humans using non-invasive
techniques to measure dynamic autoregulation during normal pregnancy have found
improved or no change in CBF autoregulation in pregnant compared to nonpregnant
women (Bergersen et al., 2006; Janzarik et al., 2014). To our knowledge, no study has
determined the limits of CBF autoregulation during pregnancy but is important to
understand because of the potential for acute hypotensive and hypertensive episodes that
exist, especially during parturition. For example, hemorrhage can occur during parturition
causing hypotension, or parturition can also lead to increased sympathetic discharge
resulting in an acute elevation in blood pressure (Pickering, 2003).
The cerebral circulation has a central role in neurologic complications associated
with preeclampsia (MacKay et al., 2001). In fact, cerebrovascular events such as edema
and hemorrhage account for ~ 40 % of maternal deaths (MacKay et al., 2001). An
underlying feature of neurological complications, including seizure, in women with
preeclampsia is the impairment of CBF autoregulation and subsequent edema formation
(Engelter et al., 2000; Kaplan, 2001; Janzarik et al., 2014). Impaired CBF autoregulation
is associated with decreased cerebrovascular resistance, hyperperfusion of the brain, BBB
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disruption, and vasogenic edema formation (Schwartz et al., 2000; Janzarik et al., 2014).
Studies that have assessed dynamic CBF autoregulation in women with preeclampsia
using transcranial Doppler (TCD) to measure changes in CBF velocity in the middle
cerebral artery (MCA) in response to hemodynamic fluctuations have found that CBF
autoregulation appears to be intact in preeclampsia (Sherman et al., 2002; van Veen et al.,
2013; Janzarik et al., 2014). However, these studies did not delineate disease severity. A
case report assessing cerebral autoregulation in women with severe preeclampsia
experiencing neurologic symptoms reported impaired CBF autoregulation (Oehm et al.,
2006). Although small numbers of patients were assessed, this finding suggests that CBF
autoregulation may be differentially affected in severe versus mild preeclampsia. Further,
CBF autoregulation has been shown to be impaired in women with eclampsia (Oehm et
al., 2003), however, whether loss of autoregulation is due to the convulsions themselves
or whether it truly is an underlying mechanisms leading to seizure onset remains unclear,
and difficult to determine. The use of animal models of preeclampsia has been employed
to investigate the effect of preeclampsia on CBF autoregulation. A recent study
investigating CBF autoregulation in the placental ischemia rat model of preeclampsia
reported that autoregulation was impaired in the anterior brain region during stepwise
increases in arterial blood pressure (Warrington et al., 2014). Interestingly, it is thought
that CBF autoregulation in the posterior cerebral cortex is predominantly affected during
preeclampsia, as the posterior cortex is a primary location of vasogenic edema formation
(Schwartz et al., 2000). Further, most neurologic symptoms that occur in women with
preeclampsia arise specifically from the posterior cerebral cortex, such as blurred vision
and cortical blindness (Cunningham et al., 1995). Thus, while the effectiveness of CBF
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autoregulation in preeclampsia has begun to be investigated using animal models, the
need for more elaborate studies remains before a clear understanding of the role of
impaired autoregulation in preeclampsia and eclampsia can be elucidated.
Numerous recent studies have also investigated potential changes in basal CBF
during pregnancy and preeclampsia, employing several techniques including
ultrasonography and magnetic resonance (MR) studies. Early human studies using
inhalation of a gaseous mixture of nitrous oxide, oxygen and nitrogen and the Fick
principle to assess CBF, oxygen delivery and metabolism in the brain reported no
differences in CBF between the nonpregnant, pregnant and preeclamptic states (McCall,
1949, 1953). TCD studies have measured CBF velocity in cerebral arteries in pregnant
women across gestation that revealed CBF velocity decreases during normal gestation
(Williams and Wilson, 1994; Serra-Serra et al., 1997; Belfort et al., 2001), where as CBF
velocity has been reported to be higher in preeclamptic than normotensive pregnant
women (Williams and McLean, 1993; Williams and MacLean, 1994; Ohno et al., 1997).
However, changes in vascular resistance and blood flow calculated from these
measurements may not accurately reflect CBF due to the lack of information about vessel
diameter (Kontos, 1989). In fact, despite reported increases in CBF velocity in women
with preeclampsia, the majority of women with preeclampsia, regardless of severity, have
normal CBF (Belfort et al., 2002; Belfort et al., 2006). Further, using dual-beam angleindependent digital Doppler ultrasonography, diameter and blood flow volume of the
internal carotid artery were measured during pregnancy. This study found that CBF
increased ~ 20% across gestation based on these measurements (Nevo et al., 2010). In
contrast, a study using MR reported ~ 20% decrease in CBF during pregnancy, however,
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this was in comparison to post-partum and not pre-pregnancy values (Zeeman et al.,
2003). MR studies also report contradictory findings regarding CBF in women with
severe preeclampsia. One study reported a significant increase in CBF in the MCAs and
the posterior cerebral arteries (PCAs) of women with preeclampsia (Zeeman et al.,
2004a), while another study conducted similarly reported no difference in MCA or PCA
blood flow between severe preeclamptic and normal pregnancies (Morriss et al., 1997). A
possible explanation for this particular discrepancy could be the administration of
medications. Zeeman et al. (2004), who reported an increase in CBF, excluded women
with severe preeclampsia (blood pressure > 160 mm Hg systolic or with the presence of
neurologic symptoms) and only took measurements in preeclamptic women not being
treated with an antihypertensive medication and/or MgSO4 (Zeeman et al., 2004a). The
study by Morriss et al. (1997) that reported no change in CBF was conducted in women
with severe preeclampsia, many of which were being treated with either antihypertensive
medications, MgSO4 or both (Morriss et al., 1997). Studies have used microspheres to
measure absolute CBF in late-pregnant rats and found a nonsignificant 5-10% increase in
CBF compared to the nonpregnant state (Buelke-Sam et al., 1982; Cipolla et al., 2011).
Regardless, there appears to be conflicting evidence regarding the effect of both normal
pregnancy, as well as preeclampsia on CBF, potentially due to variability in methodology
and study populations. Overall, while studies reporting the effect of pregnancy and
preeclampsia on CBF in women are contradictory, the use of animals that allowed
invasive measurements suggest CBF remains similar in pregnancy to the nonpregnant
state. However, animal models of preeclampsia have yet to be used to investigate the
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effect of preeclampsia on absolute CBF, making it difficult to interpret the incongruous
results that are currently reported from women with preeclampsia.
1.4.5 Function and Structure of the Cerebrovasculature
Understanding changes occurring in the structure and function of cerebral arteries
and arterioles during pregnancy may shed some light on potential changes in vascular
resistance that may drive changes in CBF and autoregulation. Cerebral arteries and
arterioles exist in a state of partial constriction and thus have basal tone. A major
contributor to basal tone in the cerebral circulation is the myogenic response of vascular
smooth muscle cells (Bayliss, 1902; MacKenzie et al., 1979). Pregnancy does not appear
to affect myogenic tone in cerebral pial arteries or penetrating brain arterioles (Chan et
al., 2010; Cipolla et al., 2011). While myogenic tone refers to the degree of basal
constriction of a vessel relative to its passive diameter at a constant pressure, the
myogenic response refers to the dynamic response of cerebral arteries and arterioles to
changes in intravascular pressure (Kontos et al., 1978). The myogenic response is a main
contributor to CBF autoregulation through increasing and decreasing cerebrovascular
resistance in response to changes in intravascular pressure and appears to be different in
the pregnant versus nonpregnant state (Kontos et al., 1978; Faraci et al., 1987a; Faraci
and Heistad, 1990; Cipolla et al., 2004; Chapman et al., 2013). In isolated cerebral
arteries from pregnant rats, increased intravascular pressure caused forced dilatation at
lower pressures than arteries from nonpregnant rats, suggesting a lower capacity to
maintain cerebrovascular resistance in the face of increased pressure during pregnancy
(Cipolla et al., 2004). However, the CBF autoregulatory curve is shifted to higher, not
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lower pressures during pregnancy, suggesting other contributors to CBF autoregulation
may act in a compensatory way during pregnancy.
The vasculature of many organ systems, particularly within the uteroplacental
circulation, changes structurally to accommodate the physiological adaptation of normal
pregnancy (Osol and Mandala, 2009). There is evidence that the cerebrovasculature also
structurally remodels during pregnancy in a selective manner. Structural remodeling
describes changes in luminal diameter and vascular wall thickness in response to
physiological or pathological stimuli (Martinez-Lemus et al., 2009). Remodeling can be
directed outward or inward, depending upon whether the luminal diameter increases or
decreases (Mulvany, 1999). Further, remodeling can be hypo-, hyper- or eutrophic,
depending upon whether the vessel wall thickness decreases, increases or stays the same,
respectively (Mulvany, 1999). During rat pregnancy, no changes in luminal diameter or
wall thickness have been measured in cerebral pial arteries, suggesting pregnancyinduced remodeling does not occur in the pial vasculature (Chan et al., 2010). However,
brain parenchymal arterioles, precapillary resistance vessels that branch off pial vessels
and perfuse the brain tissue, undergo outward hypotrophic remodeling during pregnancy,
resulting in larger vascular lumens and thinner vessel walls than in the nonpregnant state
(Cipolla et al., 2011). Although there is no change in myogenic tone in these vessels
during pregnancy, the intravascular pressure vs. luminal diameter curve is shifted upward
due to the structural changes (Cipolla et al., 2011). This selective remodeling of
parenchymal arterioles during pregnancy is through arteriogenesis and driven by
peroxisome proliferator-activated receptor gamma (PPARγ) activation by the hormone
(ser)relaxin (Chan and Cipolla, 2011). Interestingly, the primary relaxin receptor is not
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expressed in parenchymal arterioles (Chan and Cipolla, 2011). However, circulating
relaxin appears to cross the BBB and is thought to activate PPARγ on astrocytes and
neurons that in turn exert a paracrine effect on parenchymal arterioles to drive outward
remodeling (Chan and Cipolla, 2011). In contrast to parenchymal arterioles, pial arteries
are not intimately associated with brain parenchymal cell types such as astrocytes and
neurons, and this may explain the selective effect of pregnancy-induced remodeling on
parenchymal arterioles. This process of arteriogenesis is unique compared to
angiogenesis, however, angiogenesis also occurs in the brain during pregnancy. In fact,
capillary density increases during pregnancy in the posterior cerebral cortex, a finding
that has also been linked to increased activation of PPARγ by relaxin (Chan and Cipolla,
2011; Cipolla et al., 2011). Thus, while pregnancy does not affect the structure of the pial
vasculature, it seems to have an outward hypotrophic remodeling effect on parenchymal
arterioles that may contribute to the extension of the CBF autoregulatory curve.
During pregnancy, outward remodeling of parenchymal arterioles and increased
capillary density coupled with the approximate 10% hemodilution that occurs could
decrease cerebrovascular resistance and increase CBF (Gordon, 2007). Despite these
vascular and hemodynamic changes, pregnancy has little effect on cerebrovascular
resistance when measured under normotensive conditions in the rat (Cipolla et al., 2011).
The substantial contribution of large cerebral arteries to vascular resistance is unique to
the cerebral circulation (Faraci and Heistad, 1990). In fact, large extracranial and
intracranial cerebral arteries contribute ~50% of cerebrovascular resistance (Faraci et al.,
1987b; Faraci and Heistad, 1990). Although downstream arterioles undergo structural
changes that may decrease small vessel resistance, the pial vasculature does not change
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structurally during pregnancy and may compensate to maintain normal vascular
resistance. The structural remodeling of the cerebral circulation may be important when
considering hypertensive pathologies of pregnancy such as preeclampsia. Under
experimental conditions of acute hypertension, cerebrovascular resistance of cerebral
arteries was decreased in pregnant rats, leading to autoregulatory breakthrough and ~40%
increase in CBF (Cipolla et al., 2011). The decrease in cerebrovascular resistance with
autoregulatory breakthrough was further associated with increased BBB permeability due
to greater hydrostatic pressure on the microcirculation (Cipolla et al., 2011). Thus, while
the BBB seems to remain intact during normal pregnancy under physiological conditions,
it also appears to be at greater risk of injury during pathologic states such as acute
hypertension. Under conditions of elevated intravascular pressure when large arteries
become ineffective in regulating CBF due to forced dilatation of myogenic tone, outward
hypotrophic remodeling of parenchymal arterioles may predispose the microcirculation to
injury by transmitting high hydrostatic pressure downstream. Outward hypotrophic
remodeling of brain arterioles could also contribute to the maternal brain being more
sensitive to vasogenic edema formation after acute hypertension (Euser and Cipolla,
2007; Cipolla et al., 2012a). The increase in capillary density may further contribute to
the susceptibility of the brain to hypertension-induced vasogenic edema during pregnancy
by increasing the potential sites of BBB disruption. In addition, pregnancy both prevents
and reverses remodeling of cerebral arteries that occurs in response to chronic
hypertension (Cipolla et al., 2006; Aukes et al., 2007a; Cipolla et al., 2008). Chronic
hypertension in the nonpregnant state leads to inward hypertrophic remodeling of
cerebral arteries, resulting in smaller lumen diameters and thicker vascular walls
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(Baumbach and Heistad, 1989; Cipolla et al., 2006). This is considered a protective
adaptation by which cerebrovascular resistance is increased, thus protecting the
microcirculation from elevated arterial blood pressure (Cipolla et al., 2006; Chan et al.,
2010). The prevention and/or reversal of this remodeling during pregnancy may be
related to the downregulation of angiotensin type 1 receptor (AT1R) expression in the
cerebral circulation that also occurs during pregnancy (Chan et al., 2010). While the
reduction in AT1R expression may be a physiological adaptation to normal pregnancy,
reversal and/or prevention of hypertensive remodeling may make the cerebral
microcirculation even more susceptible to injury during states associated with
hypertension. Again, this may be important during preeclampsia, where acute elevations
in blood pressure are thought to lead to cerebral vasogenic edema formation and
subsequent neurologic complications including eclamptic seizure (Cipolla, 2007).
The adaptation of parenchymal arterioles during pregnancy may be further
implicated in neurologic complications associated with preeclampsia and eclampsia.
Parenchymal arterioles are the primary vessels involved in small vessel disease in the
brain (Rincon and Wright, 2014). Women with eclampsia seem to be prone to white
matter lesions later in life that may indicate the presence of small vessel disease in the
brain (Aukes et al., 2009). It is possible albeit speculative at this time, that failure of
parenchymal arterioles to outward remodel during preeclampsia underlies the potential
for white matter lesions later in life. Lack of spiral artery remodeling during pregnancy is
a feature of some women with preeclampsia that may indicate a type of small vessel
disease (Egbor et al., 2006). We further speculate that the lack of adaptation of small
vessels in the uterine circulation may be similar to the lack of adaptation of the small
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vessels in the brain, both of which may be occurring in women with severe preeclampsia
and eclampsia. Further, if the lack of remodeling occurs in parenchymal arterioles in the
brain, as it does in the uterine circulation in some eclamptic women, this may suggest a
common pathology that leads to white matter lesions and cognitive impairment
associated with eclampsia (Aukes et al., 2007b; Aukes et al., 2009). However, the
association of small vessel disease of the brain later in life in formerly eclamptic women
with impaired spiral artery remodeling during pregnancy is speculative and further
studies are needed to understand these processes.
In summary, pregnancy is associated with many adaptations of the cerebral
circulation including changes in receptor and transporter activity, keeping increased
permeability factors in balance in order to maintain brain homeostasis and protect against
increases in BBB permeability. Further, structural and functional changes occur in certain
segments of the cerebral vasculature; however, CBF and cerebrovascular resistance
appear unchanged under normotensive conditions. The CBF autoregulation curve appears
to extend to the right in the pregnant state, protecting the maternal brain against acute and
drastic increases in blood pressure. It is remarkable that BBB permeability and CBF are
affected so minimally during pregnancy, especially in the face of substantially increased
factors that have direct effects on vascular filtration and flow in many other organ
systems. However, this supports the principle that the adaptation of the cerebral
circulation to normal pregnancy functions to maintain essential oxygen and nutrient
delivery and waste removal similar to the nonpregnant state, especially in the face of
tremendous systemic hemodynamic changes associated with pregnancy. There is
evidence that the cerebral circulation may be compromised during preeclampsia, through
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disruption of the BBB and/or effects on CBF autoregulation that may contribute to the
onset of eclamptic seizure. However, a complete understanding of how preeclampsia
affects the cerebrovasculature has yet to become clear and continued research efforts in
this area would likely be fruitful.
1.5 Changes in Neuronal Excitability during Normal Pregnancy
1.5.1 Introduction
The majority of women do not seize during pregnancy; however, if there is
greater susceptibility to seizure in the maternal brain, then under conditions where other
protective mechanisms fail, such as at the BBB, seizure could ensue. Susceptibility to
seizure during pregnancy has previously been investigated in the context of
understanding epilepsy in pregnancy. However, the effect of pregnancy on seizure
frequency in women with epilepsy is difficult to discern and appears variable (Pennell,
2002; Battino and Tomson, 2007; Meador, 2014). A review of over 2000 pregnancies in
epileptic patients found that ~ 25% of patients experienced an increase, ~25% a decrease,
and ~50% experienced no change in the frequency of epileptic seizures (Schmidt, 1982).
This variability in seizure frequency noted may be complicated by the absence or
presence of anti-epileptic medications during pregnancy. One study investigating the
effect of antiepileptic drugs on seizure in pregnant mice found that electroconvulsive
seizure threshold was increased on day 18 of pregnancy compared to nonpregnant mice
(Nau et al., 1984). Another study using amygdaloid kindled rats also reported increased
threshold to electroconvulsive seizure in pregnant compared to nonpregnant animals (Kan
et al., 1985). However, the latency to seizure onset using the chemoconvulsant
pentylenentetrazole revealed no change in seizure threshold between nonpregnant and
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pregnant rats in a study investigating seizure threshold in the lipopolysaccharide (LPS)
model of preeclampsia (Huang et al., 2014). Thus, there are discrepancies in the effect of
pregnancy on seizure threshold depending upon which seizure-induction method is used.
Further, these few studies that have investigated seizure threshold in pregnancy used
latency to physical convulsion as the threshold; however, the use of
electroencephalography (EEG) may allow for a more sensitive means to detect seizure
threshold differences. Despite these incongruities, there is evidence of central changes
that occur during pregnancy that may increase the potential for seizure. If the brain
during pregnancy is more susceptible to seizure, that could account for the 38-60% of
women that experience de novo seizure during seemingly uncomplicated pregnancies.
Understanding the neurophysiological changes occurring during normal pregnancy may
lead to a greater understanding of the pathogenesis of de novo seizure in the absence of
preeclampsia.
1.5.2 Neuroactive Steroids
Pregnancy is a state during which there are tremendous elevations in estrogen and
progesterone produced from several areas including the placenta. Estrogen and
progesterone are precursors for neuroactive steroids that have been shown to affect
neuronal excitability (Reddy, 2003). Neuroactive steroids, or neurosteroids, are
synthesized from their precursor steroids de novo by neurons and glia throughout the
brain and are capable of rapidly (within seconds) affecting neuronal excitability through
non-genomic mechanisms (Baulieu and Robel, 1990; Mensah-Nyagan et al., 1999; AgisBalboa et al., 2006). Neurosteroids affect neuronal excitability by interacting with ion
channels and neurotransmitter receptors at the neuronal cell membrane (Reddy, 2003).
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Specifically, estradiol exerts pro-convulsive effects by increasing neuronal excitability
through increasing dendritic spine density and synapses on CA1 pyramidal cells of the
hippocampus and facilitating N-methyl-D-aspartate (NMDA) receptor binding (Woolley
et al., 1997; Pozzo-Miller et al., 1999). Further, estradiol increases excitatory responses
of neurons by both enhancing inward sodium currents and attenuating outward potassium
currents, independently of one another (Kow et al., 2006; Druzin et al., 2011). In contrast,
many progesterone-derived neurosteroids have anti-convulsive effects through
modulatory actions at gamma-aminobutyric acid type A receptors (GABAARs), the main
inhibitory neurotransmitter receptors in the brain (Macdonald and Olsen, 1994; Herd et
al., 2007). Specifically, the neurosteroid allopregnanolone has binding sites on the δsubunit of GABAARs, at which it acts as a positive allosteric modulator, exerting an
overall sedative effect (Stell et al., 2003). GABAARs that contain the δ-subunit
(GABAAR- δ) are located extrasynaptically and are involved in tonic inhibition
throughout the brain (Stell et al., 2003). Studies investigating changes in GABAAR-δ
expression during conditions of increased progesterone such as pregnancy have shown
downregulation of GABAAR-δ (Maguire et al., 2009; Maguire and Mody, 2009). This
downregulation has been associated with increased neuronal excitability of brain slices
from pregnant mice that was normalized by the presence of allopregnanolone (Maguire et
al., 2009). It is likely that the downregulation of GABAAR-δ is an adaptation that
functions to maintain the steady state of excitability and avoid overinhibition in the face
of increased neurosteroids present during pregnancy. Although these in vitro studies
suggest that the brain may be hyperexcitable during pregnancy, it remains unclear as to
whether pregnancy is a state of increased seizure susceptibility under physiological
32

conditions when neurosteroids are naturally circulating. Understanding the overall status
of brain excitability during pregnancy, and whether pregnancy is a state of increased
seizure susceptibility seems important as that could contribute to the potential for
eclampsia.
1.5.3 Neuroinflammation
Neuronal excitability may also be affected during pregnancy by inflammation.
Pregnancy is considered a state of mild peripheral inflammation, and peripheral
inflammation has been shown to cause neuroinflammation through the activation of
microglia, the resident immune cells in the brain (Sacks et al., 1998; Riazi et al., 2008).
Active microglia may be in a reparative state that clean up cellular debris and promote
restoration of the injury or insult that lead to their activation (Hu et al., 2014). These
productive activated microglia are classified as M2 microglia (Hu et al., 2014). However,
another role of active microglia has emerged. For unknown reasons, M2 microglia can
transform to M1 microglia that have a cytotoxic effect on brain repair (Hu et al., 2014).
Instead of promoting and facilitating healing, M1 microglia secrete pro-inflammatory
cytokines and reactive oxygen species that act in a feed-forward system to promote
detrimental neuroinflammation (Hu et al., 2014). Further, the secretion of proinflammatory cytokines such as TNFα increase neuronal excitability through promoting
the endocytosis of GABAARs and trafficking of α-amino-3-hydroxy-5-methyl-4isoxazolepropionic acid (AMPA) receptors to the neuronal cell surface (Stellwagen et al.,
2005; Riazi et al., 2008). By shifting the excitatory/inhibitory balance, M1 microglia
increase neuronal excitability that may potentiate seizure (Rodgers et al., 2009). Whether
neuroinflammation is present during normal pregnancy is currently unknown, but is
33

possible as pregnancy is considered a state of mild peripheral inflammation that has been
shown to cause microglial activation and may increase seizure susceptibility during
normal pregnancy.

Blood-Brain Barrier Disruption

Change in Neurosteroids
-

Decreased GABAAR subunits
Pro-convulsive effects of estradiol
Imbalance of progesterone and estrogen
Others

-

Increased permeability factors
Failure of efflux transporters
Endothelial dysfunction
Autoregulatory breakthrough
Edema formation
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-
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Local cytokine production
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Figure 1: Summary of potential mechanisms that may contribute to eclamptic seizure onset
during normal pregnancy and preeclampsia. The pathogenesis of eclampsia remains unclear
and the initiation of seizure onset may differ between preeclamptic patients. Further, eclampsia
can occur during seemingly uncomplicated pregnancies, suggesting that the brain during normal
pregnancy may be at greater risk of seizure that is augmented during preeclampsia. However, the
majority of pregnant women do not seize, and not all women with preeclampsia become
eclamptic, making it likely that additional insults are required to initiate seizure onset that are
multifactoral and may exist in combination:
1) BBB disruption. Seizure-provoking factors are circulating late in gestation that do not
gain access to the brain under healthy conditions due to the BBB (Cipolla et al., 2012b).
However, under conditions of BBB disruption, increased BBB permeability could allow such
hyperexcitable factors into the brain, potentially leading to seizure onset. Disruption of the BBB
during normal pregnancy that could lead to seizure onset may be due to increased permeability
factors such as VEGF, PlGF, vasopressin or histamine, or failure of efflux transporters located on
the luminal surface of endothelial cells to extricate serum constituents back into the vascular
lumen. During preeclampsia, maternal endothelial dysfunction is present that likely affects the
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cerebral endothelium and may lead to increased BBB permeability and edema formation. Further,
an acute rise in blood pressure during pregnancy or preeclampsia that leads to loss of
cerebrovascular resistance and CBF autoregulatory breakthrough causes BBB disruption and
cerebral vasogenic edema formation. Vasogenic edema formation may be another contributor to
seizure onset during pregnancy and preeclampsia.
2) Changes in neurosteroids. Neurosteroids, specifically progesterone metabolites such as
allopreganolone are positive allosteric modulators of GABAARs that exert an overall sedative
effect (Stell et al., 2003). For this reason, it is thought that GABAARs downregulate in response
to elevated concentrations of neurosteroids to maintain a normal level of inhibition (Maguire et
al., 2009). In fact, hyperexcitability of brain slices from pregnant mice is thought to be kept in
balance by progesterone and progesterone metabolites; however, seizure can occur in response to
changes in neurosteroids concentrations (Maguire et al., 2009). Thus, it is possible that an
imbalance in neurosteroid levels that may be driven by rapid fluctuations of estrogen and
progesterone concentrations could contribute to seizure onset during pregnancy and preeclampsia.
It is further possible that the simultaneous and rapid decrease in progesterone and increase in
GABAARs that occurs at parturition is out of balance, resulting in decreased inhibition and
seizure onset (Maguire et al., 2009).
3) Inflammation and infection. Peripheral inflammation and infection lead to
neuroinflammation through activation of microglia. Microglia, the resident immune cells in the
brain, secrete pro-inflammatory cytokines that increase neuronal excitability and potentiate
seizure (Riazi et al., 2008). Pregnancy is considered a mild form of peripheral inflammation that
is thought to be exaggerated during preeclampsia. Thus, activated microglia and
neuroinflammation could contribute to seizure onset during pregnancy and preeclampsia through
the secretion of pro-inflammatory cytokines and subsequent neuronal hyperexcitability.
Overall, the particular insult(s) that initiate seizure in women during seemingly healthy
pregnancies or women with pregnancies complicated by preeclampsia remain ambiguous. It is
possible that physiological adaptations to normal pregnancy increase the potential for seizure that
are exacerbated in the pathologic state of preeclampsia. This figure proposes several potential
mechanisms of eclamptic seizure onset, yet seizure onset may involve a myriad of such
contributors where several events such as those listed in this figure occur simultaneously.
Additionally, the exact cause of seizure onset may be unique to each eclamptic patient, as
convulsion can occur as a result of numerous pathologic processes, further complicating the
determination of the pathogenesis of eclampsia.

1.6 Magnesium Sulfate
Eclampsia poses an immediate threat to both the mother and fetus and has been
associated with white matter lesions in the brain and cognitive impairment later in life
(Aukes et al., 2007b; Aukes et al., 2009; Duley, 2009). Together the immediate and
potential long-term risk of morbidity highlights the importance of seizure prevention
during pregnancy and preeclampsia. MgSO4 is the leading therapeutic for seizure
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prophylaxis in women with preeclampsia (Sibai, 1990b; Witlin and Sibai, 1998). MgSO4
has a controversial history and its use as a seizure prophylactic has been scrutinized for
decades (Kaplan et al., 1988). However, extensive studies have shown that MgSO4
reduces the risk of eclampsia by > 50 %, and that it is more effective in prevention of
recurrent eclamptic seizure than placebo and accepted anticonvulsant medications,
including phenytoin and diazepam (Duley, 1995; Lucas et al., 1995; Altman et al., 2002;
Duley et al., 2003; Duley and Henderson-Smart, 2003a, b). In fact, the incidence of
recurrent eclamptic seizure in women treated with phenytoin or diazepam was 23.1%
compared to 9.4% in women that received MgSO4 (Witlin and Sibai, 1998). Further, it
was suggested that MgSO4 acted as a seizure prophylactic by lowering blood pressure
through its vasodilatory properties; however, this blood pressure effect is transient, and
MgSO4 is neither considered nor administered as an antihypertensive agent (Cotton et al.,
1984; Kaplan et al., 1988; Belfort et al., 2003; Lindheimer et al., 2008). Interestingly, the
incidence of recurrent seizure in eclamptic women that received only antihypertensive
agents was 2.8% and 0.9% in patients that received MgSO4 (Witlin and Sibai, 1998).
Similarly, in a study comparing the effectiveness of nimodipine, a calcium-channel
antagonist that has antihypertensive effects and inhibits cerebral vasospasm, to the
effectiveness of MgSO4 in seizure prevention in women with severe preeclampsia
reported that women who received nimodipine were more likely to become eclamptic
(2.6% of patients) than those treated with MgSO4 (0.8% of patients) (Belfort et al., 2003).
Together, these studies support that simply controlling hypertension during preeclampsia
does not prevent development of eclamptic seizure, and that the actions specifically of
MgSO4 are effective at preventing eclamptic seizure (Witlin and Sibai, 1998).
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Eclampsia can occur antepartum, intrapartum or postpartum, with antepartum
eclampsia occurring more often preterm and being associated with recurrent seizures and
greater maternal and fetal morbidity and mortality (Douglas and Redman, 1994; Knight,
2007). The largest and most recent study conducted by Knight et al. in 2005 investigated
the incidence of eclampsia in the United Kingdom after the introduction of MgSO4 as a
seizure prophylactic. This study reported that 45% of eclampsia occurred antepartum,
19% intrapartum, and 36% postpartum (Knight, 2007). This was in agreement with a
similar study conducted by Douglas & Redman in 1992, prior to MgSO4 being widely
administered as an eclamptic seizure prophylactic (Douglas and Redman, 1994). Overall,
it does not appear that the introduction of MgSO4 as a seizure prophylactic, at least in the
United Kingdom, affected the distribution of eclamptic onset in regards to the timing of
labor or the type (antepartum, etc.). This suggests that while MgSO4 effectively reduces
the incidence of eclampsia, it does not suggest that one type of eclampsia is preferentially
affected by MgSO4 treatment. However, it should be noted that eclamptic seizure still
occurs in some preeclamptic patients, regardless of receiving appropriate MgSO4
treatment (Katz et al., 2000). Overall, despite being widely administered to women with
preeclampsia and eclampsia, and being remarkably effective in eclamptic seizure
prophylaxis and cessation, the mechanism by which MgSO4 prevents seizure remains
largely unknown, and may be multifaceted.
The normal serum concentration of Mg2+ in humans is 1.8-3.0 mg/dL and the
target therapeutic range of treatment of women with preeclampsia is to raise serum Mg2+
levels to 4.2-8.4 mg/dL (Pritchard, 1979; Sibai et al., 1984a). MgSO4 is typically
dispensed intramuscularly, intravenously or a combination of the two. Despite being the
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most widely administered drug for seizure prophylaxis in women with preeclampsia, its
use is associated with potentially serious side effects including respiratory paralysis,
cardiac arrest and death (Kelly et al., 1960; McCubbin et al., 1981; Donaldson, 1989b).
Hypermagnesemia first leads to weakness of muscles, but can progress to full paralysis if
severe enough (Donaldson, 1986; Fisher et al., 1988; Ramanathan et al., 1988). The
effect of hypermagnesemia is due to the calcium antagonistic effects of Mg2+ blocking
acetylcholine release at the neuromuscular junction (Ramanathan et al., 1988).
Hyporeflexia begins to occur at serum Mg2+ levels greater than 5 mg/dL and areflexia at
approximately 10 mg/dL making constant monitoring of serum concentrations of Mg2+
and deep patellar reflexes critical in preeclamptic and eclamptic patients receiving
MgSO4 treatment (Donaldson, 1986). Due to MgSO4 impairing neuromuscular
transmission, it was proposed in the argument against the use of MgSO4 treatment in the
1980s that MgSO4 did not prevent seizure, but rather prevented the physical
manifestation of convulsion due to its paralytic-like effects at high serum concentrations,
and that MgSO4 simply masked the presence of the dangerous seizure activity that was
still occurring in the brain (Donaldson, 1986; Fisher et al., 1988; Kaplan et al., 1988). In
support of this theory, it was further argued that Mg2+ could not have central
anticonvulsant effects because it could not cross the BBB, making its administration to
preeclamptic women ineffective, dangerous and unnecessary (Kaplan et al., 1988).
However, a study in the early 1990s investigating this controversy provided direct
evidence that, not only does systemically administered MgSO4 correlate with increased
Mg2+ concentrations throughout the brain, but also that it had direct anti-convulsant
effects at NMDA receptors, likely due to the Mg2+-gated properties of these receptors
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(Hallak et al., 1994). Since these early studies, substantial investigation has been done
seeking to elucidate the mechanism by which MgSO4 acts as an eclamptic seizure
prophylactic in women with preeclampsia.
BBB disruption is a consequence of multiple pathologies and disease processes
that may be central to eclamptic seizure onset, and is a potential therapeutic target of
MgSO4. Studies have shown that MgSO4 treatment reduces BBB permeability under
conditions of BBB disruption, including during dehydration of endothelial cells with
hyperosmolar mannitol (Kaya et al., 2004), acute hypertension (Euser et al., 2008),
hypoglycemia (Kaya et al., 2001), traumatic brain injury (Esen et al., 2003), and septic
encephalopathy (Esen et al., 2005). This protective effect under pathologic conditions
that increase permeability is likely due to the calcium antagonistic actions of Mg2+. The
studies listed above measured BBB permeability to Evans Blue, a common tracer that
binds to serum albumin. Serum albumin is a large protein (~ 70 kDa) and the use of
Evans Blue specifically measures paracellular permeability due to disruption of tight
junctions at the BBB. Tight junction proteins, including zona occludin-1, claudin-5 and
occludin, are attached to the endothelial cell actin cytoskeleton. Through phosphorylation
of myosin light chains by calcium-dependent myosin light chain kinase, endothelial cell
contraction increases paracellular permeability, resulting in decreased barrier function
(Bogatcheva and Verin, 2008). By inhibiting this calcium-dependent process, MgSO4
seems to exert a “tightening” effect at the BBB that may be one mechanism by which
MgSO4 treatment prevents seizure onset during preeclampsia.
Treatment with MgSO4 has been shown to decrease the activity of NMDA
receptors, likely through prolongation of the presence of the Mg2+ gate (Hallak et al.,
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1994). Removal of Mg2+ is necessary for the passage of cations to occur through the pore
of these receptors to contribute to the depolarization of neurons, and propagation of
action potentials. Thus, there seems to be a role for MgSO4 as a direct anti-convulsant.
Treatment with MgSO4 increases Mg2+ concentrations within the central nervous system,
having an antagonistic effect on NMDA receptor activity (Hallak et al., 1994). NMDA
receptors are widely expressed in the hippocampus, a location considered central to
seizure onset and propagation, as well as throughout the cerebral cortex. Interestingly,
MgSO4 treatment does not appear to affect EEG patterns of women with preeclampsia,
which one may suspect would occur with the reduction in NMDA receptor activity
shown with MgSO4 treatment (Sibai et al., 1984b). The effect of MgSO4 on seizure
threshold has been investigated in studies seeking to understand its role as a central
anticonvulsant agent. MgSO4 treatment has been shown to increase the threshold for
electrically-induced seizure in the hippocampus of awake rats (Cotton et al., 1992; Hallak
et al., 1992), bupivicaine-induced seizure in awake pregnant rats (Okutomi et al., 2005),
but shown to have no effect on lidocaine-induced seizures in rats anesthetized with
nitrous oxide (Choi et al., 1991; Kim et al., 1996). It should be noted that the lack of
effect of MgSO4 on lidocaine-induced seizures was attributed to the MgSO4 treatment
regiment not increasing Mg2+ concentrations in the brain. More recently, MgSO4 was
shown to increase the latency to seizure onset induced by pentylenetetrazol (PTZ) in a
LPS model of preeclampsia (Huang et al., 2014), however the mechanisms by which
MgSO4 affected seizure threshold in models of preeclampsia remain unclear. The
pathogenesis of preeclampsia and eclampsia are likely heterogeneous and, like the actions
of MgSO4, likely multifaceted. Thus, the multiple sites of action of MgSO4 may be why it
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is more effective than a medication that functions solely as an anticonvulsant at
preventing seizure during preeclampsia. Overall, understanding the mechanism(s) by
which MgSO4 acts as a seizure prophylactic in preeclampsia may allow for more targeted
therapies to be developed. Further, screening processes may be established to identify
women who would most readily benefit from MgSO4 therapy, thereby targeting its use
and avoiding unnecessary risk.
1.7 Methodology
1.7.1 Rat Model of Pregnancy
The rat is a useful and appropriate model of pregnancy because it has similar
hemochorial implantation (Pijnenborg et al., 1981), undergoes similar cardiovascular
changes (e.g. plasma volume increase) (Barron, 1987; Gilson et al., 1992), and has
similar architecture of the cerebrovasculature (Edvinsson and MacKenzie, 2002) as
humans. Further, the rat has a short gestation of approximately 22 days. All experiments
were conducted using 12-14 week old female Sprague Dawley rats that were either
virgin, nonpregnant animals or primiparous late-pregnant animals on day 20 of
pregnancy, as late in pregnancy is when eclampsia occurs most often (Douglas and
Redman, 1994).
1.7.2 Rat Models of Preeclampsia
In order to investigate changes in cerebrovascular and neurophysiological
properties during preeclampsia, an animal model of preeclampsia was used. Preeclampsia
is a disease unique to humans, with only very few incidences being reported in primates
(Stout and Lemmon, 1969; Van Wagenen, 1972). Many animal models of preeclampsia
exist and have been used to investigate the pathogenesis of preeclampsia, and potential
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treatment options; however, there is not a single model that is able to capture the full
spectrum of symptoms of the human-specific disorder. Many models target a single
pathway or organ system that is afflicted in preeclampsia to mimic hypertension,
proteinuria, oxidative stress and endothelial dysfunction. For example, endothelial
dysfunction and vasoconstriction that is associated with preeclampsia has been
investigated by inhibiting production of nitric oxide synthase (Yallampalli and Garfield,
1993; Molnar et al., 1994; Cadnapaphornchai et al., 2001). Further, the role of renal
pathology associated with preeclampsia has been investigated by using the rat model of
adriamycin nephropathy to induce hypertension and proteinuria in pregnant rats
(Podjarny et al., 1992; Podjarny et al., 1995; Rathaus et al., 1995). Other models
capitalize on the imbalance of angiogenic factors that is associated with preeclampsia by
infusion of soluble receptors of the pro-angiogenic factors VEGF and PlGF, including
infusion of or adenoviral administration of sFlt-1, soluble endoglin (sEng), or a
combination of both (Venkatesha et al., 2006; Bridges et al., 2009; Murphy et al., 2010).
There are inflammatory models of preeclampsia induced by infusion of TNFα (LaMarca
et al., 2005a; LaMarca et al., 2005b), interleukin-6 (IL-6) (Gadonski et al., 2006;
Lamarca et al., 2011), AT1R autoantibodies (LaMarca et al., 2009; Parrish et al., 2010),
or a low-dose endotoxin such as LPS (Faas et al., 1994), as well as metabolic models of
preeclampsia induced by nutritional selenium deficiency (Vanderlelie et al., 2004) and
chronic insulin resistance (Podjarny et al., 2001).
One of the most common models of preeclampsia is the Reduced Uteroplacental
Perfusion Pressure (RUPP) rat model of preeclampsia. Adapted from original studies in
pregnant dogs in the 1940s, placental ischemia is induced by limiting blood flow to the
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uteroplacental unit by placing silver clips of specific diameters on the distal abdominal
aorta and uterine arcades on day 14 of pregnancy, as seen in Figure 1. This method
reduces uterine perfusion pressure by ~ 40 % and raises blood pressure by ~ 25 mm Hg
(Crews et al., 2000; Alexander et al., 2001). Further, rats with RUPP have proteinuria,
placental ischemia and fetal growth restriction, and are in a state of oxidative stress and
endothelial dysfunction similar to that of women with preeclampsia (Alexander et al.,
2001; Granger et al., 2001; Sedeek et al., 2008; LaMarca et al., 2009). Rats that
have RUPP have elevated circulating pro-inflammatory cytokines including TNFα and
IL-6, as well as increased serum and placental concentrations of anti-angiogenic factors,
including sFlt-1 (LaMarca et al., 2005a; Gadonski et al., 2006; Gilbert et al., 2007). Thus,
the RUPP model of preeclampsia portrays many preeclamptic-like symptoms, as shown
in Table 1. However, as with any animal model, there are limitations. The primary
limitation of the RUPP model is that placental ischemia is induced. Therefore, this model
does not incorporate the original disease process that causes lack of spiral artery
remodeling, or any other small vessel disease pathology. Despite this, there is a broad
spectrum of symptoms mimicked by this model, and the experimental model used in this
dissertation was adapted from the RUPP model of preeclampsia. In addition to RUPP
inducing placental disease, rats were also maintained on a high cholesterol diet (HC) days
7-20 of gestation to further induce maternal disease. This diet regimen has been
previously shown to cause hypercholesterolemia as well as endothelial and
cerebrovascular dysfunction during pregnancy, indicative of maternal endothelial
dysfunction (Schreurs and Cipolla, 2013). As mentioned previously, although the
majority of eclampsia is nonfatal and occurs at term, when eclampsia occurs in women
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with severe disease, maternal mortality is high (MacKay et al., 2001). Thus, RUPP+HC
rats were used to focus on a more severe model of preeclampsia that incorporated both
placental and maternal disease.

Figure 2: Illustration of the induction of placental ischemia. A silver clip
0.203 mm in diameter is placed on the abdominal aorta, distal to the renal and
superior mesenteric arteries, just proximal to the iliac bifurcation, and clips 0.10 mm
in diameter placed on the uterine arcade, proximal to the first segmental branches to
the fetal-placental unit. Adapted from Li et al., Am J Physiol Heart Circ Physiol
303:H1-H8, 2012.
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Table 1: Comparison of characteristics of women with preeclampsia and
preeclamptic-like symptoms in the RUPP rat model. IUGR, intrauterine growth
restriction; TNFα, tumor necrosis factor alpha; IL-6, interleukin-6; sFlt-1, soluble FMSlike tyrosine kinase receptor 1; sEng, soluble endoglin; VEGF, vascular endothelial
growth factor; PlGF, placental growth factor; HIF-1α, hypoxia-inducible factor 1alpha.
Adapted from Li et al., Am J Physiol Heart CircPhysiol 303:H1-H8, 2012.

Characteristic
New-onset hypertension
Proteinuria
Abnormal placentation
Fetal IUGR
Inflammation (TNFα, IL-6)
Oxidative stress
Endothelin-1
sFlt-1 and sEng
VEGF and PlGF
Placental HIF-1α
AT1 autoantibodies
Glomerular endotheliosis
Glomerular filtration rate

Women with Preeclampsia
Yes
Yes
Yes
Yes
Increased
Increased
Increased
Increased
Decreased
Increased
Increased
Yes
Decreased

Rats with RUPP
Yes
Yes
No
Yes
Increased
Increased
Increased
Increased
Decreased
Increased
Increased
No
Decreased

1.7.3 Measurement of Seizure Threshold
To investigate the effect of normal pregnancy and preeclampsia on seizure
susceptibility in vivo, seizure threshold was measured in virgin, nonpregnant and normal
pregnant rats, and rats with experimental preeclampsia. Under chloral hydrate anesthesia,
seizure was induced by a timed intravenous infusion of pentylenetetrazole (PTZ) while
recording electroencephalography (EEG) simultaneously. EEG measures the summated
activity of many neurons by detecting the extracellular current flow that occurs during
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synaptic excitation of cortical neurons. PTZ infusion was stopped at the first onset of
spikewave discharges, defined as a change in waveform when small amplitude, high
frequency spikes that slowed and synchronized to large amplitude, rhythmic spikes, as
detected by EEG (Sakamoto et al., 2008). Seizure threshold was then calculated as the
amount of PTZ (mg/kg) required to elicit electrical seizure: Tinfusion * Rinfusion * [PTZ] /
bw where Tinfusion is the time of infusion in min, Rinfusion is the rate of infusion in mL/min,
[PTZ] is the concentration of PTZ in mg/mL, and bw is the body weight in kg (Riazi et
al., 2008). Seizure susceptibility scores were also calculated: bw * 10/v where bw is body
weight in grams and v is volume of PTZ infused in µL (Riazi et al., 2008). PTZ is a
chemoconvulsant that quickly and reliably elicits seizure through antagonistic actions at
GABAA receptors (Squires et al., 1984; Bough and Eagles, 2001). The use of this specific
convulsant was chosen to directly investigate the role of pregnancy-induced changes in
GABAA receptor subunit expression in whole-brain excitability during pregnancy and
preeclampsia. EEG was recorded unipolarly using silver subdermal corkscrew electrodes
placed over the parieto-occipital cortex to monitor generalized seizure. It has previously
been determined that subcutaneous electrodes are a suitable alternative for cortical
electrodes for less invasive EEG recordings (Ke-jian et al., 2001). Although some studies
use a single intraperitoneal injection of PTZ and measure the latency to physical
manifestation of seizure to avoid the use of an anesthetic, chloral hydrate was used
because it is thought to not depress neural function, and is the preferred anesthetic for
studies measuring EEG (Thoresen et al., 1997; Olson et al., 2001). Further, the use of
EEG allowed for a more sensitive measure of electrical seizure activity that may be more
precise than monitoring for physical convulsions only.
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1.7.4 Blood-brain Barrier Permeability
In order to investigate the effect of experimental preeclampsia on basal BBB
permeability in vivo, the integrity of the BBB was assessed in normal pregnant and
preeclamptic rats using two different sized fluorescent tracers. Under chloral hydrate
anesthesia, tracers were infused intravenously into the femoral vein and allowed to
circulate for ten minutes, a sufficient amount of time to detect changes in BBB
permeability (Euser et al., 2008; Cipolla et al., 2011). After ten minutes, a cardiac
perfusion of lactated Ringer’s solution was performed through a thoracotomy to flush the
circulation of all tracers and blood. Allowing the beating heart to flush the circulation
avoided any pressure-induced artifact that can occur when the pressure at which the
circulation is flushed exceeds the physiological pressure range, disrupting the BBB and
pushing tracer into the brain. After the circulation was properly flushed, the brain was
immediately removed, homogenized and centrifuged, and the amount of tracer that
passed from the lumen of the cerebrovasculature into the brain parenchyma quantified
using fluorescent spectroscopy.
Fluorescent tracers have been used to investigate the BBB for over a century, and
are a common method of quantifying changes in BBB permeability (Belayev et al., 1996;
Oztas et al., 2003; Esen et al., 2005; Euser et al., 2008; Cipolla et al., 2011). In fact, the
presence of the BBB was originally discovered by the lack of passage of systemically
administered water soluble dyes into the brain (Ehrlich, 1885; Goldmann, 1913). The
smaller 470 Da sodium fluorescein is thought to pass both paracellularly and
transcellulary, whereas the larger 70 kDa Texas Red dextran moves only via paracellular
transport. Thus, the use of two fluorescent tracers of differing sizes allowed the
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investigation of potential changes in size-selectivity of the BBB, as well as differential
effects on the type of permeability (paracellular vs. transcellular) under basal conditions
during experimental preeclampsia.
1.7.5 Quantification of Cerebral Vasogenic Edema
Cerebral edema has been defined as “an abnormal accumulation of fluid within
the brain parenchyma, producing a volumetric enlargement of the tissue” (Klatzo,
1987b). Specifically, vasogenic edema is a type of cerebral edema that occurs in response
to increased cerebrovascular permeability to proteins and solutes that disrupts the osmotic
gradient and leads to passage and retention of water in the extracellular space in the brain
(Klatzo, 1987b, a). Vasogenic edema is a consequence of many pathological states,
including seizure, traumatic brain injury and stroke and has been shown to contribute to
poor neurological outcome (Terry et al., 1990; Lin et al., 1993; Yang et al., 1994;
Feldman et al., 1996; Unterberg et al., 2004). In fact, if extensive enough, vasogenic
edema formation can lead to a drastic increase in intracranial pressure that exceeds the
compensatory venous and cerebrospinal fluid space, and result in brain or brainstem
herniation that can be fatal (Rosenberg, 1999; Marmarou, 2007).
A common and accepted measure of vasogenic edema formation is through
comparison of the wet and dry brain weights (Schwab et al., 1997). Studies in this
dissertation investigated the susceptibility of the posterior cerebral cortex to seizureinduced vasogenic edema during normal pregnancy and in experimental preeclampsia. To
do so, after seizure threshold was measured, brains were removed and the posterior
cerebral cortex isolated and immediately weighed (weightwet). The cortices were then
dried for 24 hours in a laboratory oven at 90 oC then re-weighed (weightdry) and percent
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water content calculated by the following formula: (weightwet - weightdry/weightwet) * 100.
The posterior brain region was chosen as it is a primary location of edema in women with
eclampsia (Sanders et al., 1991).
1.7.6 MgSO4 Treatment
To investigate potential mechanisms by which MgSO4 acts as a seizure
prophylactic during preeclampsia, including effects on seizure threshold and
susceptibility, BBB permeability and neuroinflammation, RUPP+HC rats were treated for
24 hours with MgSO4 prior to experimentation. A previous study from our laboratory
investigated the effect of MgSO4 on BBB permeability during acute hypertension in
pregnant rats using a dosing regimen of MgSO4 shown to raise serum Mg2+
concentrations into the therapeutic range given to preeclamptic women for seizure
prophylaxis (e.g. 4.2 – 8.4 mg/dL) (Pritchard, 1979; Hallak et al., 1994; Euser et al.,
2008). This dosing regimen consisted of an intraperitoneal injection of 270 mg/kg
MgSO4 every four hours for 24 hours (day 19 – 20 of pregnancy) (Euser et al., 2008).
However, rats with experimental preeclampsia (RUPP+HC) had recently undergone an
invasive abdominal surgery for induction of placental ischemia on day 14 of pregnancy,
making repeated intraperitoneal injections unfavorable for this dissertation project.
Another study used a subcutaneous osmotic minipump for continuous delivery of 60
mg/kg/day of MgSO4, based on the solubility of MgSO4, however, this dose was not
sufficient to raise serum Mg2+ above ~ 2 mg/dL (Standley et al., 2006). Thus, the dosing
regimen of MgSO4 employed in this dissertation consisted of a combination of these
methodologies to effectively raise serum Mg2+ into the therapeutic range in a less
invasive manner to avoid additional stress on the animals. RUPP+HC rats received a
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loading dose of 270 mg/kg of MgSO4 subcutaneously on the morning of the 19th day of
gestation. Four hours later, under isoflurane anesthesia, three osmotic minipumps were
implanted subcutaneously between the scapulae to continuously deliver ~ 180 mg/kg/day
of MgSO4. Prior to implantation, minipumps were primed overnight at 37 oC in sterile
saline to allow for immediate drug delivery once placed. On day 20 of pregnancy,
RUPP+HC rats received a second bolus of 270 mg/kg MgSO4 subcutaneously
approximately 1 hour prior to beginning experimentation. This course of treatment
assured RUPP+HC rats received MgSO4 continuously for approximately 24 hours.
Further, after experimentation, serum was collected and Mg2+ concentrations determined
using a colorimetric assay that uses the magnesium-dependent enzyme glycerol kinase to
generate a kinetic red reaction that is proportional to the concentration of Mg2+ in serum
(Wimmer et al., 1986). The dosing regimen of MgSO4 used in this dissertation was
clinically relevant, raising serum Mg2+ concentrations to ~ 5.2 mg/dL that is within the
target therapeutic range administered to women with preeclampsia for eclamptic seizure
prophylaxis.
1.7.7 Assessment of Microglial Activation
To investigate the potential role of neuroinflammation in pregnancy- and
preeclampsia-induced changes in seizure susceptibility, a method of quantifying the
activation state of microglia was used. There are many established methods to quantify
the activation state of microglia, the resident immune cells in the brain indicative of
neuroinflammation, nearly all of which use the morphological changes associated
microglial cell activation. Discovered and characterized by Pio del Rio-Hortega in the
early 1900s, inactive microglia are highly ramified cells that typically have two to six
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branches radiating from the soma, often with thin, finger-like protrusions extending from
primary branches (Del Rio-Hortega, 1919). These inactive, or resting microglia are
continuously surveying the brain parenchyma, monitoring for any pathological stimuli
(Kreutzberg, 1996). As microglia respond to injury or disruption of the brain milieu, they
transform morphologically as they activate and migrate to the site of injury, as illustrated
in Figure 2. The primary branches retract, shortening and becoming thicker, and the cell
bodies enlarge in preparation to phagocytose damaged cells, becoming amoeboid-like
(Del Rio-Hortega, 1919; Kettenmann et al., 2011). Microglia are from
mesodermal/mesenchymal origin and originate from bone marrow. In rodents, monocyte
progenitor cells of future microglia migrate through the vasculature and immigrate into
the brain during postnatal development, specifically until postnatal day 10 (Chan et al.,
2007). Once these cells have migrated into the brain parenchyma, they mature and
transform into the ramified phenotype.
There are several
antibodies that can be used to
visualize microglial cells in the
brain. One of the most
commonly used antibodies to
specifically visualize microglia
with particular detail of their
Figure 3: Illustration of the progression from left to
right of inactive, resting microglia to active,
phagocytotic microglia. Adapted from Kreutzberg,
Trends Neurosci 19:312-318, 1996.
51

processes is ionized calciumbinding adaptor molecule 1

(Iba1), a protein involved in calcium homeostasis (Imai et al., 1996; Imai and Kohsaka,
2002). The morphological changes that occur when microglia become activated are well
established and stereotypical, and commonly used to accurately determine the activation
state of microglia (Kreutzberg, 1996; Stence et al., 2001). Thus, in this dissertation
immunostaining with an antibody against Iba1 was used to assess the morphology of
microglia in the cerebral cortex. A graded scale was established from 1 (relatively
inactive) to 4 (relatively active) to allow each Iba1+ microglial cell to be ranked upon its
morphology, similar to Figure 2 (Kreutzberg, 1996). Cells with highly ramified, long
processes with a scattered, irregularly shaped cell body were ranked in state 1. Cells with
an asymmetrical cell body and many long, defined processes were ranked in state 2. Cell
bodies that were more rounded with several shorter, thicker processes were ranked 3, and
large, round amoeboid-like cell bodies with few to no processes were ranked in state 4.
By quantifying the activation state of microglia, the level of neuroinflammation present
in the cerebral cortex during normal pregnancy and experimental preeclampsia was
assessed as an underlying mechanism by which seizure susceptibility may be affected.
1.7.8 CBF Measurement
To investigate the effect of pregnancy on the lower limit of CBF autoregulation,
as well as the effect of experimental preeclampsia on CBF autoregulation, laser Doppler
flowmetry was used to measure changes in relative CBF in response to manipulation of
arterial pressure. Laser Doppler flowmetry measures CBF by detecting the disruption of
light by moving red blood cells, producing a relative measurement of cerebral perfusion
in arbitrary units (Stern, 1975). The use of laser Doppler is advantageous over more
invasive and absolute measures such as with the use of radio-labeled microspheres, due to
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the ability of laser Doppler to provide continuous and instantaneous measurements,
allowing autoregulatory curves to be obtained (Tonnesen et al., 2005). Methods
measuring absolute CBF typically require immediate euthanization of the animal, and are
therefore limited in use when investigating CBF autoregulation across a wide pressure
range. Further, laser Doppler flowmetry has been shown to accurately detect the lower
limit of CBF autoregulation in rats when compared to absolute CBF measurements via
the 133xenon injection technique (Tonnesen et al., 2005). As portions of this dissertation
were focused on assessing CBF autoregulation across the physiological pressure range
during normal pregnancy and experimental preeclampsia, laser Doppler flowmetry was
an appropriate and ideal method.
1.7.9 Isolated Vessel & Arteriograph Studies
A major contributor to CBF autoregulation is the myogenic function of cerebral
arteries. In order to investigate the effect of pregnancy on the myogenic vasodilation of
cerebral arteries in response to decreased intravascular pressure, pial arteries were
isolated and studied using arteriograph. Arteries were dissected out of the brain, cleared
of connective tissue and mounted and secured onto glass cannulas in an arteriograph
chamber, shown in Figure 3. The proximal cannula is connected to an in-line pressure
transducer and a servo-null pressure control system that allows for the controlled
manipulation of intraluminal pressure. The distal cannula remained closed throughout the
experiment to avoid flow-mediated responses. Luminal diameters and wall thicknesses
were measured via video microscopy: the optical window in the bottom of the
arteriograph allows for visualization of vessels mounted within the arteriograph chamber
by an inverted microscope. The inverted microscope is attached to a video camera and
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monitor that is connected to a video dimension analyzer. The pressure transducer and
video dimension analyzer signals are recorded with a data acquisition system on a
computer that allows for continuous recordings to be made of the pressure-diameter
relationship of cerebral vessels. By using this arteriograph system to study isolated
cerebral vessels in vitro, it was possible to investigate the myogenic response to
fluctuations in intraluminal pressure independently of other factors that contribute to CBF
autoregulation that are present in vivo, such as neuronal or metabolic influences.

Figure 4: A cerebral artery secured on glass cannulas in an arteriograph chamber.
Image courtesy of Dr. Marilyn J. Cipolla

1.8 Project Goals and Hypotheses
The pathogenesis of the eclamptic seizure remains unclear, but is considered a
form of hypertensive encephalopathy where an acute rise in blood pressure causes loss of
cerebral blood flow autoregulation and hyperperfusion of the brain that result in
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vasogenic edema formation and subsequent seizure (Schwartz et al., 2000). However,
eclamptic seizure can occur during seemingly uncomplicated pregnancies in the absence
of hypertension and preeclampsia (Douglas and Redman, 1994; Katz et al., 2000),
suggesting that normal pregnancy may predispose the brain to hypertensive
encephalopathy or seizure, independently of preeclampsia. The overarching goal of this
dissertation was to investigate the effect of normal pregnancy and preeclampsia on the
cerebrovasculature and neuronal excitability that may promote brain injury and eclamptic
seizure. In addition, the pathologic processes by which preeclampsia may potentiate
seizure onset that may be ameliorated by MgSO4 treatment were investigated. We
hypothesized that normal pregnancy affects the function of the cerebrovasculature and
CBF autoregulation by shifting the limits of CBF autoregulation, making the brain more
susceptible to injury. In Chapter 2 of this dissertation the effect of pregnancy on the lower
limit of CBF autoregulation and the vasodilatory response of cerebral arteries to
decreased intravascular pressure was investigated. We further hypothesized that normal
pregnancy increases seizure susceptibility that may potentiate eclamptic seizure, and this
was investigated in Chapter 3 of this dissertation. Additionally, we hypothesized that
preeclampsia is a state of greater seizure susceptibility due to compromised integrity of
the BBB and neuroinflammation, and that MgSO4 treatment restores seizure susceptibility
by protecting the BBB and reducing neuroinflammation. These hypotheses were
investigated in Chapter 4 of this dissertation.
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Abstract
Hemorrhage during parturition can lower blood pressure beyond the lower limit
of cerebral blood flow (CBF) autoregulation that can cause ischemic brain injury.
However, the impact of pregnancy on the lower limit of CBF autoregulation is unknown.
We measured myogenic vasodilation, a major contributor of CBF autoregulation, in
isolated posterior cerebral arteries (PCA) from nonpregnant and late-pregnant rats
(n=10/group) while the effect of pregnancy on the lower limit of CBF autoregulation was
studied in the posterior cerebral cortex during controlled hemorrhage (n=8). Pregnancy
enhanced myogenic vasodilation in PCA and shifted the lower limit of CBF
autoregulation to lower pressures. Inhibition of nitric oxide synthase (NOS) prevented the
enhanced myogenic vasodilation during pregnancy but did not affect the lower limit of
CBF autoregulation. The shift in the autoregulatory curve to lower pressures during
pregnancy is likely protective of ischemic injury during hemorrhage and appears to be
independent of NOS.

Key words: CBF autoregulation, hypotension, myogenic vasodilation, nitric oxide,
pregnancy
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Introduction
Cerebral blood flow (CBF) autoregulation is an intrinsic property of the brain that
maintains relatively constant blood flow despite fluctuations in blood pressure (BP).1, 2 In
normotensive adults, CBF autoregulation operates within the arterial pressure range of ~
60 to 160 mmHg, outside of which autoregulation is lost and CBF becomes dependent on
pressure in a linear fashion.2-5 A drop in BP within this autoregulatory range results in
insignificant clinical symptoms as brain perfusion is maintained by autoregulatory
mechanisms.2 However, when BP falls below the lower limit of CBF autoregulation,
CBF decreases with pressure, potentially causing loss of consciousness and hypoxicischemic brain injury.6-8 During pregnancy, hemorrhage occurs with parturition. In some
pregnancies, hemorrhage may be severe (> 1500 mL blood loss) and cause an acute drop
in maternal BP potentially below the lower limit of CBF autoregulation.9-11 However,
whether pregnancy alters the lower limit of CBF autoregulation is not known, but is
important to understand. For example, a shift in CBF autoregulation to lower pressures
during pregnancy may be protective of the brain, allowing maintenance of blood flow in
the face of acute hypotension. Alternatively, a shift of the lower limit of CBF
autoregulation to higher pressures could increase the susceptibility of the brain to injury
during parturition.
The myogenic response of cerebral arteries and arterioles is a major contributor to
CBF autoregulation.12 Myogenic vasodilation occurs as BP decreases, contributing to the
maintenance of blood flow to the brain.5 If BP decreases below the lower limit of CBF
autoregulation, maximal dilation of cerebral vessels occurs and this vascular contributor
to CBF autoregulation becomes insufficient to maintain brain perfusion.8 Several
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mechanisms may be involved in the relaxation of vascular smooth muscle (VSM) to
decreased intravascular pressure, including endothelial vasodilators such as nitric oxide
(NO).13, 14 Pregnancy has been shown to increase expression of endothelial-NO synthase
(eNOS) in several vascular beds.15, 16 However, the involvement of NO in the myogenic
vasodilatory response of cerebral arteries and CBF autoregulation during pregnancy has
yet to be investigated.
In the present study, in-vitro methodology was used to investigate the myogenic
vasodilatory response to decreased intravascular pressure of posterior cerebral arteries
(PCA) from nonpregnant (NP) and late-pregnant (LP) rats. The contribution of NO to
myogenic vasodilation during pregnancy was also assessed. We found that pregnancy
enhanced myogenic vasodilation in response to decreased pressure that was NOdependent. To test if this enhanced myogenic vasodilation translates to a shift of CBF
autoregulation, the effect of pregnancy on the lower limit of CBF autoregulation was
measured using an in-vivo model of hemorrhagic hypotension and measuring changes of
CBF in the posterior cerebral cortex. We further investigated the role of NO on CBF
autoregulation during acute hypotension by infusing a NOS inhibitor.

Materials and Methods
Animal model. All experiments were conducted using virgin NP female (14-16
weeks) or timed-pregnant Sprague Dawley rats (Charles River, Canada). Rats were
housed individually in the University of Vermont Animal Care Facility. NP females were
chosen randomly and timed-pregnant rats were studied during LP on days 19 - 21 of a 22
day gestation. All procedures were approved by the Institutional Animal Care and Use
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Committee and conducted in accordance with the National Institute of Health Guide for
the Care and Use of Laboratory Animals.
Isolated Vessel Preparation and Pressurized Arteriograph System. NP and LP
animals were anesthetized with isoflurane (3 % in oxygen) and decapitated. Brains were
promptly removed and placed in cold, oxygenated physiological saline solution (PSS).
PCA were carefully dissected and cleared of connective tissue. Third-order PCA were
mounted and secured onto glass cannulas in an arteriograph chamber as previously
described.17 Briefly, the proximal cannula was connected to an in-line pressure transducer
and a servo-null pressure control system (Living Systems Instrumentation, Inc.,
Burlington, VT). The distal cannula remained closed throughout the experiment to avoid
flow-mediated responses. Vessel diameters were measured via video microscopy. PSS
was aerated with 5 % CO2, 10 % O2, and 85 % N2 to maintain pH at 7.40 ± 0.05.
Temperature within the arteriograph chamber was maintained at 37.0 ± 0.1 o C
throughout the experiments.
Determination of myogenic vasodilation in isolated PCA. Vessels were
equilibrated at 50 mmHg for 1 hour, after which pressure was increased to 125 mmHg in
25 mmHg increments to allow for tone development. Myogenic vasodilation was
measured by decreasing pressure from 125 to 5 mmHg in a step-wise manner and
recording active luminal diameter at each pressure once stable. Myogenic vasodilation
was measured in PCA from NP and LP rats in PSS alone (n=10/group) and in the
presence of the NOS inhibitor Nω –nitro-L-arginine (L-NNA, 0.1 mM, n=7/group).
Pressure steps were then repeated in zero calcium PSS to obtain passive diameter
measurements.
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In-vivo measurement of CBF during hemorrhagic hypotension in the posterior
cerebral cortex. A separate set of NP and LP rats (n=8/group) were anesthetized initially
with isoflurane (3% in O2), which was then lowered to 1.5 – 2.0 % in O2 for
instrumentation and tracheostomy. Anesthesia was then shifted to intravenous injections
of chloral hydrate (200 mg/kg, left femoral vein). Animals were mechanically ventilated
to maintain blood gases and pH within normal physiological ranges (Table 1). Body
temperature was monitored and maintained with a heating pad at 37 o C throughout the
experiment. CBF was measured and recorded transcranially using laser Doppler
flowmetry as previously described.18 The left side of the medioposterior skull was
exposed and a laser Doppler probe was affixed over a thinned area 2 mm lateral to the
sagittal suture and 1 mm anterior to the lambdoid suture to measure CBF in the PCA
territory. Both femoral arteries were cannulated to measure arterial blood pressure via a
pressure transducer (Living Systems Instrumentation, Inc., Burlington, VT), and to obtain
blood samples for blood gas measurements and controlled blood withdrawal. Blood was
slowly withdrawn through the femoral catheter at a steady rate (0.67 - 0.69 ml/min) to
gradually decrease arterial blood pressure from 100 mmHg to 30 mmHg. The lower limit
of CBF autoregulation was defined as the arterial pressure at which CBF decreased by 20
% from baseline.19, 20
A separate set of LP animals (n=7) underwent the same instrumentation as
described above, with the addition of cannulation of the right femoral vein for the
infusion of the NOS inhibitor Nω –nitro-L-arginine methyl ester hydrochloride (LNAME, 10 mg/kg/min, 3 min). After drug infusion, controlled blood withdrawal was
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performed in the same manner as described above and the lower limit of CBF
autoregulation was determined as stated above.
Real-time quantitative PCR of eNOS in pial arteries. A separate group of NP
(n=5) and LP (n=4) rats were used for the isolation of arteries for real-time qPCR for
eNOS. PCA segments from both right and left sides of the brain were pooled from each
animal. RNA was extracted using Trizol reagent (Life Technologies) followed by
purification using an RNeasy Micro Kit (Qiagen) per manufacturers’ protocols. RNA
concentrations and quality were determined using an Agilent Bioanalyzer (Agilent). Real
time qPCR was performed in a two step process. Total RNA was reverse transcribed
using a mix of oligo dTs and random primers using the iScript cDNA Synthesis Kit
(Biorad). For each sample, cDNA was used to amplify the target gene eNOS and two
housekeeping genes: Hprt1 and Ywhaz. One microliter of cDNA was used per reaction
with 150 nM of the forward and reverse primers (eNOS: forward
CCTGAGCAGCACAAGAGTTACAA, reverse GGAGCCCAGCCCAAACACA; Hprt1:
forward CTCATGGACTGATTATGGACAGGAC, reverse
GCAGGTCAGCAAAGAACTTATAGCC; and ywhaz: forward
GATGAAGCCATTGCTGAACTTG, reverse GTCTCCTTGGGTATCCGATGTC) and
12.5 µl of Power Sybrgreen Master mix (Life Technologies) in a 25 µl reaction. Primers
were designed by the Obstetrics and Gynecology Departmental Molecular Core Facility
at the University of Vermont using PrimerSelect (DNASTAR). The reactions were
performed using an initial denaturation of 3 minutes at 95 ° C, 40 cycles of 15 seconds at
95 ° C and 60 seconds at 60 ° C followed by a melt curve analysis to ensure only the
correct product was amplified. One set of PCR products for each gene were checked for
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correct size on a 2 % agarose gel. Each sample was run in triplicate on the ABI 7000
Sequence Detection System (ABI). Negative water controls were run for each primer set
in the real time PCR reaction to ensure no contamination in the reagents as well as no
secondary primer structures were amplified. Primers were designed over an exon-exon
junction or the amplicon was designed to span an exon-exon junction to ensure genomic
DNAwas not amplified. Relative expression was calculated using the 2 -ΔΔCT method.21
Drugs and Solutions. All experiments were conducted using a bicarbonate-based
PSS containing (mmol/L): NaCl 119.0, NaHCO3 24.0, KCl 4.7, KH2PO4 1.18, MgSO4 ·
7H2O 1.17, CaCl2 1.6, and EDTA 0.026. PSS was made and stored without glucose at 4 o
C; glucose (5.5 mmol/L) was added to the PSS prior to each experiment. Zero calcium
PSS was made similarly, omitting the addition of CaCl2. L-NNA and L-NAME were
purchased from Sigma-Aldrich (St. Louis, MO). L-NNA was made weekly in a 0.01 mM
stock solution and stored at 4 o C. L-NAME was made fresh daily at 40 mg/ml in sterile
lactated ringers solution.
Data Calculations and Statistical Analysis. Results are presented as mean ± SEM.
Percent tone of isolated arteries was calculated at 100 mmHg and after addition of LNNA as the percent decrease in active luminal diameter from the passive diameter by the
equation: [ 1 – (diameteractive / diameterpassive)] x 100 %, where diameteractive is luminal
diameter in PSS with or without L-NNA and diameterpassive is maximum luminal diameter
in zero calcium PSS. To determine the pressure at which diameters of PCA from NP and
LP rats differed from baseline of 125 mmHg, repeated measures ANOVA with a post-hoc
Bonferroni test was used. Differences in diameters between the presence and absence of
L-NNA were determined using Student’s unpaired t-test. The lower limit of CBF
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autoregulation, defined as when CBF decreased 20 % from baseline, was determined
from the laser Doppler traces for each animal. Differences in the percent change in CBF
during hemorrhagic hypotension and between the pressure at which the lower limit of
CBF autoregulation was reached between NP and LP, and LP and LP+L-NAME animals
were determined using Student’s unpaired t-test. Differences were considered significant
at p < 0.05.

Results
Myogenic vasodilation in response to decreased intravascular pressure in PCA
from NP and LP rats. We sought to determine the effect of pregnancy on the myogenic
vasodilatory response of PCA to decreased intraluminal pressure. We used PCA because
they are the main blood supply to the posterior cortex.22 PCA from NP and LP animals
developed similar myogenic tone at 100 mmHg (33.8 ± 2.3 % and 33.7 ± 1.5 %; ns).
When intravascular pressure was decreased, luminal diameter of PCA from NP and LP
rats remained relatively unchanged until ~ 60 mmHg (Figure 1A). As intravascular
pressure was lowered below 60 mmHg, myogenic vasodilation occurred in PCA from
both NP and LP animals. However, PCA from LP rats had significantly greater dilation
compared to NP rats when pressure was lowered between 50 – 30 mmHg. The diameter
of PCA from LP rats was significantly greater than baseline diameter (183 ± 8 µm at 50
mmHg vs. 147 ± 5 µm at 125 mmHg; p < 0.05). In contrast, arteries from NP rats dilated
less in response to decreased intravascular pressure, with luminal diameter never
becoming statistically significantly different compared to baseline at any pressure (Figure
1A). Below 30 mmHg, the diameter of PCA from both NP and LP animals passively
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decreased with pressure. Figure 1B shows that there was no difference in passive
diameters of PCA from either group at any pressure studied, suggesting the difference in
the magnitude of myogenic vasodilation between the groups was due to a difference in
active vasodilation and not structural remodeling. Thus, the magnitude of the myogenic
vasodilation in response to decreased pressure was greater in PCA from LP compared to
NP rats.
Effect of NOS inhibition on myogenic vasodilation to decreased pressure. As
greater myogenic vasodilation occurred in PCA from LP compared to NP rats, we
investigated NO as an underlying mechanism by which pregnancy increases myogenic
vasodilation in PCA by inhibiting NOS with L-NNA and measuring myogenic
vasodilation. Addition of L-NNA caused similar constriction of PCA from both groups of
animals and the percent tone with NOS inhibition at 100 mmHg was similar between
PCA from NP and LP animals (52.1 ± 3.4 % and 51.8 ± 3.2 %; ns). In PCA from NP rats
treated with L-NNA, vasodilation occurred and diameters were similar to PCA in PSS
alone when pressure was decreased, becoming significantly greater than baseline at 60
mmHg (176 ± 20 µm at 60 mmHg vs. 105 ± 7 µm at 125 mmHg; p < 0.05; Figure 2A). In
contrast, vasodilation of PCA from LP rats was markedly reduced with NOS inhibition
(Figure 2B). The diameters of L-NNA treated vessels from LP animals were smaller than
those in PSS alone (p < 0.01; Figure 2B). Despite this, luminal diameter of L-NNA
treated PCA from LP rats still became significantly greater than baseline at 50 mmHg
(140 ± 20 µm at 50 mmHg vs. 93 ± 8 µm at 125 mmHg; p < 0.05; Figure 2B).
Figure 2C compares vasodilation of PCA with L-NNA treatment from NP and LP
rats. Vessels from both groups of animals underwent similar vasodilation with NOS
100

inhibition as pressure was decreased. However, the dilation was shifted to lower pressure
in PCA from LP compared to NP rats. When pressure was lowered to 70 mmHg the
diameter of PCA from LP rats was significantly smaller than the diameter of PCA from
NP rats (88 ± 8 µm vs. 148 ± 22 µm, respectively; p < 0.05; Figure 2C). Thus, NOS
inhibition prevented the greater myogenic vasodilation of PCA from LP compared to NP
rats from occurring without eliminating myogenic vasodilation all together, and it shifted
the dilation of PCA from LP rats leftward compared to PCA from NP rats.
The results above suggest that enhanced vasodilation of PCA from LP rats was
NO-dependent. To determine if this was due to an affect of pregnancy on eNOS
expression, real time qPCR was performed on PCA from both groups of animals. There
were no differences in relative quantity (RQ) of mRNA expression of eNOS between
PCA from NP and LP rats (0.86 ± 0.25 vs. 1.02 ± 0.27; ns; Figure 2D). These results
suggest that greater vasodilation of PCA from LP compared to NP rats via NO was not
due to changes in mRNA expression of eNOS during pregnancy.
CBF autoregulation during acute hypotension in NP and LP rats. The myogenic
response of cerebral arteries is a main contributor to CBF autoregulation.12 Since we
found that enhanced myogenic vasodilation in response to decreased pressure during
pregnancy was NO-dependent, we sought to determine the effect of pregnancy on the
lower limit of CBF autoregulation and investigate the role of NOS in CBF autoregulation
during acute hypotension. Table 1 shows the physiological parameters of all groups of
animals used. Importantly, arterial pH and arterial gasses that can affect CBF were within
physiological ranges and were not different between groups.
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Figures 3A & B show the effect of pregnancy on CBF autoregulation during
hemorrhagic hypotension in the posterior cortex. Baseline BPs were similar between LP
and NP rats (100.1 ± 0.2 mmHg vs. 100.0 ± 0.3 mmHg; ns) prior to controlled blood
withdrawal. The autoregulatory curve was shifted leftward to lower pressures in LP
compared to NP animals during hemorrhagic hypotension (Figure 3A). The lower limit of
CBF autoregulation was significantly lower in LP vs. NP rats (Figure 3B). To determine
the role of NO in the pregnancy-specific leftward shift in CBF autoregulation, L-NAME
was infused into LP rats and the autoregulatory curve determined. Figures 3C & D show
the effect of acute NOS inhibition during pregnancy on CBF autoregulation and its lower
limit during hemorrhagic hypotension, respectively. NOS inhibition caused a rise in BP,
which has been previously shown,23, 24 with the BP of LP rats infused with L-NAME
being 115.1 ± 2.0 mmHg prior to blood withdrawal. Despite this baseline increase in BP
with L-NAME infusion, CBF was maintained similarly between LP rats with and without
NOS inhibition during hemorrhagic hypotension (Figure 3C). The lower limit of CBF
autoregulation was also unaffected by acute NOS inhibition during pregnancy (Figure
3D). Thus, it appears that pregnancy shifts the autoregulatory curve leftward to lower
pressures, and that this is unaffected by acute NOS inhibition.

Discussion
In the present study, we investigated the effect of pregnancy and NOS inhibition
on the myogenic vasodilatory response of PCA to decreased intravascular pressure and
the lower limit of CBF autoregulation. PCA from LP rats dilated to a greater extent in
response to decreased pressure compared to PCA from NP rats that was NO-dependent.
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However, L-NNA did not prevent myogenic vasodilation from occurring in PCA from
either NP or LP rats, but it eliminated the pregnancy-specific enhancement of
vasodilation, causing the magnitude of dilation of PCA from NP and LP rats to be
similar. Using an animal model of controlled hemorrhage, we found that pregnancy
caused a leftward shift in the CBF autoregulatory curve during acute hypotension, with
the lower limit being reached at significantly lower pressures compared to the NP state.
We hypothesized this was due to the enhanced vasodilatory response to decreased
pressure seen in PCA of LP rats, however, acute NOS inhibition in pregnancy did not
affect the lower limit of CBF autoregulation. These results suggest that CBF
autoregulation is more effective in pregnancy during hemorrhagic hypotension, but that
this shift in the lower limit of the CBF autoregulatory curve to lower pressure is not due
to NO.
NO appears to be responsible for the enhanced vasodilation of PCA from LP
compared to NP rats. There are at least three possibilities by which NO may be affecting
vasodilation during pregnancy. First, expression of eNOS could be increased in PCA
during pregnancy, although this is unlikely as no difference in mRNA expression was
seen in PCA from NP and LP rats. Second, pregnancy could enhance the sensitivity of
VSM to NO. However, a previous study showed no differences in VSM sensitivity to the
NO donor sodium nitroprusside between PCA from NP and LP rats.17 Finally, the activity
of eNOS could be increased in endothelium from pregnant animals as intravascular
pressure was lowered. Changes in phosphorylation of eNOS during pregnancy could
change the activity of NO and increase NO production.25 In addition, the role of NO in
myogenic vasodilation appeared to be pressure-dependent because there was no
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difference in the magnitude of constriction of PCA with NOS inhibition between NP and
LP rats at a constant pressure, as has also been shown previously.26 Pregnancy increases
flow-mediated vasodilation in an NO-dependent manner in mesenteric arteries from rats
27, 28

and subcutaneous arteries from humans.29 Thus, it is possible that changes in

response to shear stress during decreased intravascular pressure are responsible for
increasing NO in PCA from LP rats.
To our knowledge, this is the first study investigating the effect of pregnancy on
CBF autoregulation during acute hypotension and the involvement of NOS in the
pregnant state. NOS inhibition did not alter the lower limit of CBF autoregulation
although it inhibited pregnancy-specific enhancement of myogenic vasodilation in
response to decreased pressure. Thus, the response of an isolated cerebral artery may not
be indicative of what is occurring during hemorrhagic hypotension that encompasses the
entire brain. Our previous study showed that, in pregnancy, brain parenchymal arterioles
are significantly larger than in the NP state, an effect that may also contribute to more
effective CBF autoregulation when upstream pial vessels are dilated.44 Thus, it is possible
that even when the NO-dependent enhancement of myogenic vasodilation of PCA in
pregnancy was inhibited, CBF was better maintained in pregnancy during acute
hypotension due to the vasodilation that was occurring in upstream vessels, coupled with
structurally larger downstream arterioles.
Our findings of NOS inhibition having no effect on the lower limit of the
autoregulatory curve are in accordance with other studies utilizing systemic NOS
inhibition in the investigation of the role of NO in the lower limit of CBF
autoregulation.30-33 In fact, the involvement of NO in CBF autoregulation is controversial,
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with several studies showing contrasting findings.23, 24, 30-36 It is possible that differences
in methodology, such as the method that hypotension is induced, may play a role in the
outcome of a study. Our result agrees with others when hypotension was induced by
hemorrhage, but not by ganglionic blockade or administration of a potassium channel
activator.24 Another previous study used similar methodology as the present study and
found intravenous infusion of a NOS inhibitor shifted the lower limit of CBF
autoregulation to higher pressure.23 However, NOS inhibition raised BP in the present
study to 115 mmHg, compared to over 150 mmHg in the previous study.23 Therefore, it is
possible that the difference between the two findings is due to the greater acute increase
in BP upon NOS inhibition. It should be noted that the rise in BP in our study confirmed
that eNOS was indeed inhibited by L-NAME infusion. However, it is possible that a
greater degree of inhibition would have produced a shift in the autoregulatory curve seen
in other studies.
Despite evidence for NO having no role in the low end of CBF autoregulation
with i.v. infusion of a NOS inhibitor,24, 30-33 including our findings in the present study,
other studies have identified a role of NO in the lower limit of CBF autoregulation when
the NOS inhibitor was suffused over the cortex.35, 36 L-NAME suffusion over a cranial
window both raised the lower limit of CBF autoregulation and depressed the height of the
CBF autoregulatory curve.35, 36 In addition to eNOS, neuronal NOS (nNOS) contributes
to CBF autoregulation and increases NO production during hypotension-induced
hypoxia, effectively dilating cerebral vessels.37, 38 nNOS mRNA and protein levels are
increased in the hypothalamus of pregnant rats15 suggesting that pregnancy increases
nNOS in some brain regions. Although our recent study determined there were no
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changes in nNOS mRNA expression in the posterior cortex between NP and LP rats,
activity of nNOS was not measured and may be increased during pregnancy.39 These data
support the idea that changes in NO production by increased activation of nNOS during
acute hypotension in pregnancy could contribute to the leftward shift of the CBF
autoregulatory curve seen in LP rats. As inhibition of nNOS appears to take substantially
longer time to achieve than that of eNOS,35 it is possible that nNOS was not inhibited in
the present study due to the acute nature of the L-NAME infusion. Therefore, it is
possible that NO derived from nNOS was still maintaining CBF in the face of acute
hypotension.
In this study, we investigated the myogenic component of CBF autoregulation.
However, there are other contributors to CBF autoregulation, including metabolic and
neuronal influences in addition to myogenic responses of VSM of cerebral arteries and
arterioles.2, 8 Oxygen metabolism of the pregnant brain has been found to be similar to
that of NP brain, thus this is unlikely to be contributing to the shift in the autoregulatory
curve.40 Pregnancy-induced changes in neuronal contributors, such as nNOS as
previously discussed, may be contributing to the leftward shift of the autoregulatory
curve. The baroreceptor reflex also influences CBF autoregulation during increases in
BP, with its disruption extending the autoregulatory curve surpassing the pressure at
which autoregulatory breakthrough would normally occur.41 The baroreflex stimulates
sympathetic fibers which have been shown to affect CBF autoregulation during acute
hypotension as well.42 Both alpha-adrenergic blockade as well as sympathectomy shifts
the lower limit of CBF autoregulation leftward to lower pressures.6, 42, 43 A recent study
by our group measured perivascular sympathetic fiber density of PCA of NP and LP rats
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and found that pregnancy did not affect innervation of PCA; however, nerve activity was
not measured.39 Thus, pregnancy-induced attenuation of the baroreflex44, 45 may be partly
responsible for the left-ward shift of the lower limit of CBF autoregulation seen in LP
rats by decreasing activity of sympathetic nerves that innervate PCA.
In summary, investigation of the myogenic vasodilation to decreased intravascular
pressure of PCA revealed greater dilation in vessels from pregnant rats that was NOdependent. Pregnancy improved CBF autoregulation during hemorrhagic hypotension by
shifting the lower limit of CBF autoregulation leftward in the posterior cortex, which
remained unaffected by acute NOS inhibition. This leftward shift in CBF autoregulation
in the posterior cortex during pregnancy may be a protective mechanism by which the
maternal brain is better prepared to maintain CBF in the face of acute hypotension that
can occur during parturition.
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Table 1: Physiological parameters of nonpregnant (NP), late-pregnant (LP) and LP
rats infused with L-NAME during hemorrhagic hypotension to assess the lower
limit of CBF autoregulation.

NP (n=8)

LP (n=8)

Weight (g)

342 ± 6

442 ± 11

389 ± 12

Arterial pH

7.40 ± 0.01

7.33 ± 0.01

7.42 ± 0.01

Arterial pCO2

40.1 ± 1.6

40.3 ± 1.5

40.2 ± 1.4

Arterial pO2

128 ± 8

139 ± 14

121 ± 6
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LP+L-NAME (n=7)

Figure 1. Impact of pregnancy on myogenic vasodilation to decreased pressure in
posterior cerebral arteries (PCA). (A) Graph showing active pressure-diameter
relationship in PCA from nonpregnant (NP) and late-pregnant (LP) rats. Note that
greater myogenic vasodilation was seen in PCA from LP animals, with diameters
becoming statistically greater than baseline at 50, 40 and 30 mmHg. (B) Graph showing
passive pressure-diameter relationship in PCA from NP and LP rats. There was no
difference in passive diameters between PCA from NP and LP rats at any pressure
studied. * p < 0.05 vs. LP at 125 mmHg by repeated measures ANOVA.
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Figure 2. Role of nitric oxide synthase (NOS) inhibition on myogenic vasodilation of
posterior cerebral arteries (PCA) during pregnancy. Graphs showing active pressurediameter relationships of PCA from (A) nonpregnant (NP) and (B) late-pregnant (LP)
animals in the presence or absence of the NOS inhibitor L-NNA. (C) Graph comparing
the effect of NOS inhibition on myogenic vasodilation in PCA from NP and LP rats.
Despite NOS inhibition, PCA from NP and LP rats had substantial myogenic vasodilation
in response to decreased pressure. (D) Relative eNOS mRNA expression in PCA from
NP and LP rats. There was no difference between eNOS expression in cerebral arteries
from NP and LP rats. * p < 0.05 vs. baseline by repeated measures ANOVA; HH p <
0.01 vs. PSS and H p < 0.05 vs. NP L-NNA by t-test.
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Figure 3. Effect of pregnancy on the lower limit of cerebral blood flow
autoregulation. (A) Graph showing changes of CBF during hemorrhagic hypotension in
the posterior cerebral cortex of nonpregnant (NP) and late-pregnant (LP) rats, and (B) the
lower limit of CBF autoregulation in NP and LP rats during hypotension. (C) Graph
showing the effect of acute NOS inhibition on changes in CBF during hemorrhagic
hypotension in the posterior cerebral cortex in LP rats only, and (D) the lower limit of
CBF autoregulation in LP rats with and without NOS inhibition. The lower limit is
indicated by the dotted line and defined as the pressure at which CBF decreased to 20%
of baseline. * p < 0.05 vs. NP by t-test.
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Abstract
Eclampsia, clinically defined as unexplained seizure in a woman with preeclampsia, is a
life threatening complication unique to the pregnant state. However, a subpopulation of
women with seemingly uncomplicated pregnancies experience de novo seizure without
preeclamptic signs or symptoms, suggesting pregnancy alone may predispose the brain to
seizure. Here, we hypothesized that normal pregnancy lowers seizure threshold and
investigated mechanisms by which pregnancy may affect seizure susceptibility, including
neuroinflammation and plasticity of gamma-aminobutyric acid type A receptor
(GABAAR) subunit expression. Seizure threshold was determined by quantifying the
amount of pentylenetetrazole (PTZ) required to elicit electrical seizure in Sprague
Dawley rats that were either nonpregnant (Nonpreg, n=7) or pregnant (Preg; d20, n=6).
Seizure-induced vasogenic edema was also measured. Further, the basal activation state
of microglia, a measure of neuroinflammation (n=6-8/group), and GABAAR δ-subunit
(GABAAR-δ) protein expression (n=3/group) in the cerebral cortex were determined as
underlying contributors to changes in seizure threshold. Seizure threshold was lower in
Preg compared to Nonpreg rats (36.7±9.6 vs. 65.0±14.5 mg/kg PTZ; p<0.01) that was
associated with greater vasogenic edema formation (78.55±0.11 vs. 78.04±0.19 % water;
p<0.05). The % of active microglia was similar between groups; however, pregnancy was
associated with downregulation of GABAAR-δ in the cerebral cortex. Overall, pregnancy
appears to be a state of increased seizure susceptibility that is not due to
neuroinflammation, but rather is associated with reduced expression of GABAAR-δ and
greater edema. Understanding neurophysiological changes occurring in normal
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pregnancy could allow for better prevention and management of de novo seizure,
including pathologic states such as eclampsia.

Introduction
Preeclampsia, defined as the new onset of hypertension and proteinuria after the
20th week of gestation, is a life-threatening complication of pregnancy that afflicts 1-7%
of all pregnancies [1-4]. Numerous organs are affected by preeclampsia, including the
brain in the form of eclampsia [5-9]. Eclampsia is the appearance of unexplained seizure
in a woman with preeclampsia and is one of the most dangerous complications of
pregnancy [4]. Eclampsia is a leading cause of maternal and fetal morbidity and mortality
worldwide that accounts for greater than 50,000 maternal deaths each year [6,7,10].
While eclampsia by definition is restricted to women with preeclampsia, seizure during
pregnancy does not appear to be a progression from severe preeclampsia to eclampsia
[11-13]. In fact, de novo seizure has been reported to occur in 38-60% of seemingly
uncomplicated pregnancies, without hypertension and proteinuria, or the diagnosis of
preeclampsia [11]. The finding that de novo seizure occurs in the absence of
preeclampsia suggests that pregnancy alone may be a state of increased seizure
susceptibility. In addition, women who develop eclampsia are by definition normotensive
and asymptomatic prior to pregnancy, with no known underlying conditions contributing
to seizure onset, supporting the concept that pregnancy alone may predispose the brain to
seizure independently of preeclampsia.
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It is well-established that fluctuations in neurosteroids occur during the menstrual
cycle, and to a greater extent during pregnancy, that can affect neuronal excitability [1416]. Specifically, increases in progesterone metabolites, including allopregnanolone, act
as positive allosteric modulators of gamma-aminobutyric acid type A receptors
(GABAARs), the main inhibitory neurotransmitter receptors in the brain, and decrease
neuronal excitability [16]. GABAARs consist of several subunits, however, the main
binding site and therefore site of action of allopregnanolone is on the δ-subunit [17]. δsubunit-containing GABAARs (GABAAR-δ) are located extrasynaptically and are
involved in tonic inhibition throughout the brain [16]. A delicate balance of excitatory
and inhibitory inputs maintains neuronal excitability of the brain, and alterations in
excitatory/inhibitory receptor expression can result in a hyperexcitable or hyperinhibited
state. Neuroactive steroids such as allopregnanolone reduce neuronal excitability
selectively through actions at GABAAR-δ and cause their downregulation [16,17].
Plasticity of the δ-subunit of GABAARs occurs in the brain during pregnancy, and is an
adaptation that likely functions to maintain a steady state of excitability in the face of
increased neurosteroids [17,18]. In fact, brain slices from pregnant mice were found to be
hyperexcitable due to the downregulation of the δ-subunit that was normalized by the
presence of allopregnanolone [18]. While these in-vitro studies suggest that the brain is
hyperexcitable during pregnancy, it is less clear if the brain is more susceptible to seizure
under normal physiological conditions of pregnancy where naturally circulating
neurosteroids are present.
One mechanism by which brain excitability may be affected during pregnancy is
through peripheral inflammation. Pregnancy is considered a state of mild peripheral
121

inflammation and peripheral inflammation has been shown to cause neuroinflammation
through the activation of microglia, the resident immune cells in the brain [19,20]. When
microglia become active, they aid in clearance of debris and play a reparative role in the
brain (M2); however, for unknown reasons they can become cytotoxic (M1) [21]. M1
microglia secrete proinflammatory cytokines such as tumor necrosis factor alpha (TNFα)
and increase local neuronal excitability by simultaneously promoting the endocytosis of
GABAARs and exocytosis of excitatory α-amino-3-hydroxy-5-methyl-4isoxazolepropionic acid (AMPA) receptors [20,22]. In fact, neuroinflammation has
recently been shown to be present in a rat model of preeclampsia that was associated with
decreased seizure threshold [23]. Whether neuroinflammation is present during normal
pregnancy is unknown, however, it may be one mechanism by which the pregnant state is
more susceptible to seizure. We hypothesized that pregnancy is a state of increased
seizure susceptibility due to decreased expression of GABAAR-δ and/or
neuroinflammation that acts to lower seizure threshold.
Onset of eclampsia may also be related to loss of cerebral blood flow
autoregulation and decreased cerebrovascular resistance that increases pressure on the
microcirculation and subsequent vasogenic edema formation [24]. In fact, vasogenic
edema is present in ~ 90 % of women with eclampsia, as assessed by diffusion weighted
MRI [25,26]. However, it is difficult to determine if edema is present prior to seizure and
contributes to the occurrence of eclampsia because seizure itself causes blood-brain
barrier (BBB) disruption and edema formation [27-30]. Further, vasogenic edema
formation occurs to a greater extent during pregnancy under pathologic conditions such
as acute hypertension, suggesting pregnancy predisposes the brain to edema [31,32].
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Thus, we hypothesized that the maternal brain is more susceptible to seizure-induced
vasogenic edema formation than in the nonpregnant state. Understanding if the maternal
brain is more susceptible to seizure-induced edema may lead to a greater understanding
of the pathophysiological process of de novo seizure during pregnancy. Further,
investigating seizure susceptibility during normal pregnancy and underlying mechanisms
by which pregnancy may affect seizure threshold may shed light on the contribution of
pregnancy-induced neurophysiological changes to de novo seizure in the absence of
preeclampsia.

Methods
Animals and ethics statement
All experiments were conducted using virgin, nonpregnant (Nonpreg) or timed-pregnant
(Preg) Sprague Dawley rats that were 14-16 weeks old (Charles River, Canada). Pregnant
rats were used experimentally late in gestation (day 20 of a 22 day gestation), a time
point when eclampsia occurs most often [12]. All rats were housed singly in the
University of Vermont Animal Care Facility, an Association for Assessment and
Accreditation of Laboratory Animal Care International accredited facility. All procedures
were approved by the Institutional Animal Care and Use Committee and conducted in
accordance with the National Institute of Health Guide for the Care and Use of
Laboratory Animals.
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Measurement of seizure threshold, susceptibility and severity, and brain water content
Rats that were Nonpreg (n = 9) or Preg (n = 9) were anesthetized initially with isoflurane
(1 – 3 % in oxygen) for intubation, electrode placement and instrumentation. Animals
were mechanically ventilated to maintain blood gases and pH within normal
physiological ranges. Body temperature was monitored with a rectal thermometer and
maintained with a heating pad at 37 oC throughout the experiment. The dorsal surface of
the head was shaved to expose the scalp and silver subdermal corkscrew electrodes
(Ambu, Glen Burnie, MD) were implanted under the scalp and secured in place with
collodion glue. Electroencephalography (EEG) was recorded unipolarly using a MP150
acquisition system (BIOPAC System Inc., Goleta, CA) to monitor generalized seizure, as
previously described [23]. After placement of electrodes, animals were placed in supine
position for placement of venous and arterial catheters. Femoral arteries were cannulated
to obtain blood samples for blood gas measurements and continuous measurement of
arterial blood pressure via a pressure transducer (BIOPAC Systems Inc., Goleta, CA).
Femoral veins were cannulated for administration of the anesthetic chloral hydrate and
infusion of the chemoconvulsant pentylenetetrazole (PTZ). PTZ was used because it
reliably elicits seizure through antagonistic actions at GABAARs. After instrumentation,
animals were tapered off isoflurane and anesthesia maintained by continuous intravenous
infusion of chloral hydrate (41.5 mg / mL in Nonpreg, 50 mg / mL in Preg; 30 µL / min)
and seizure threshold measured as previously described [23]. Chloral hydrate was used
because it is thought to not depress neural function, and is the preferred anesthetic for
studies measuring EEG [33,34]. Seizure threshold was calculated as the amount of PTZ
(mg/kg) required to elicit electrical seizure: Tinfusion * Rinfusion * [PTZ] / bw where Tinfusion
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is the time of infusion in min, Rinfusion is the rate of infusion in mL/min, [PTZ] is the
concentration of PTZ in mg/mL, and bw is the body weight in kg. Seizure susceptibility
scores were also calculated: bw * 10/v, where bw is body weight in grams and v is
volume of PTZ infused in µL [20]. Baseline blood pressures were taken 30 seconds prior
to PTZ infusion and at seizure onset. EEG was recorded for 30 minutes post-PTZ
infusion and seizure severity assessed by counting the number of recurring seizures and
calculating the percent of the post-infusion period spent in seizure. Two Nonpreg and
three Preg rats were excluded because blood gases were outside of the physiological
range. Seizure severity was not assessed in one Preg rat because EEG recordings were
not available for the entire 30 minutes due to a technical issue with the ground electrode.
After 30 minutes animals were euthanized under chloral hydrate anesthesia by
decapitation and brains immediately removed. The posterior cerebral cortex was isolated
and weighed wet (weightwet), then dried in a laboratory oven at 90 o C for 24 hours and
re-weighed dry (weightdry). The posterior brain region was chosen as it is a primary
location of edema in women with eclampsia [35]. Percent water content was determined
by wet:dry weights using the following formula: (weightwet - weightdry/weightwet) * 100.
Brain water content of one Nonpreg rat was not measured because the 24-hour drying
time point was unable to be completed.

Quantification and morphological assessment of microglia
Separate groups of Nonpreg (n = 6) and Preg (n = 8) rats were euthanized under
isoflurane anesthesia and brains immediately removed. A 3 mm section (4 – 7 mm
posterior to bregma) was taken of the posterior cerebral cortex and fixed in 10 % buffered
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formalin at 4 o C overnight, then transferred to 0.1 M PBS and slices paraffin embedded.
Immunohistochemical staining for ionized calcium binding adapter molecule 1 (Iba 1;
Wako, Richmond, VA), a marker for microglia was done using standard procedure as
described previously [23]. For each brain section, four micrographs of cerebral cortex
were captured using an Olympus BX50 microscope at 20X magnification. Each Iba1+ cell
was assessed by its morphology and activation state ranked using a graded scale from 1
(relatively inactive) to 4 (relatively active) as previously described [23]. To assess
microglia, two analyses were performed. First, the percentage of cells in each activation
state was calculated for each micrograph and averaged per group. Second, total number
of Iba1+ cells were counted per mm2 and averaged for each group. Two evaluators that
were blinded to group performed all morphological assessments.

GABAAR δ-subunit expression by Western blot
Separate groups of Nonpreg and Preg animals (n = 3 / group) were euthanized under
isoflurane anesthesia and brains immediately removed. Cerebral cortex was isolated and
snap frozen in liquid nitrogen and stored at – 80 o C. Cerebral cortex from either Nonpreg
or Preg rats were homogenized in COMP1 buffer and centrifuged at 16,000 g at 4 o C for
20 min. Protein concentration was determined using the bicinchoninic acid, or BCA,
protein Assay Kit (Pierce Biotechnology, Rockford, IL) with bovine serum albumin as a
standard. Bromophenol blue and dithiothreitol were added to the supernatant to give a
final concentration of 0.01 % and 50 mM, respectively, and heated at 95 o C for 10 min.
40 μg was loaded on a 4 – 20 % Mini-PROTEAN TGX Precast Gel (BioRad, Hercules,
CA) and ran at 35 mA. The gel was then wet transferred to a polyvinyl difluoride
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membrane at 90 V for 45 min. The membrane was Ponceau-S stained to ensure that
protein was properly transferred. The membrane was blocked with 5 % non-fat dried
milk in TBS-T for 1.5 hrs at room temperature. The membrane was then rinsed with
TBS-T and the primary antibody was applied, anti-GABAAR-δ (1:200; Santa Cruz
Biotechnology, Dallas, TX) overnight at 4 ° C with rocking. The antibody was removed
and the membrane rinsed with TBS-T and secondary antibody was applied, anti-Goat
(1:100,000) (Southern Biotech, Birmingham, AL) for 1 hr at room temperature. The
secondary antibody was removed and subsequent TBS-T washes were done. West Pico
chemiluminescent substrate (ThermoScientific, Rockford, IL) was applied to the
membrane and then exposed to film. β-actin served as a loading control (1:5000, Abcam,
Cambridge, MA) and all samples were normalized to a Nonpreg control.

Drugs and solutions
Chloral hydrate and PTZ were purchased from Sigma Aldrich (St Louis, MO) and made
daily in sterile lactated Ringer’s solution. Western blot solutions were prepared as
follows: COMP1 buffer contained 60 mM TrisCl, 2 % Sodium Dodecyl Sulfate, 10 %
Glycerol, pH 6.8; and TBS-T containing 15.4 mM Tris-HCl, pH 7.4, 137.0 mM NaCl, 0.1
% Tween-20.

Statistical Analysis
Data are presented as mean ± standard error of mean. All comparisons were made
between groups one-way using analysis of variance (ANOVA).
127

Results
The effect of pregnancy on seizure threshold, susceptibility and severity
Figure 1A shows representative EEG tracings during seizure threshold
measurements from Nonpreg (top tracing) and Preg rats (bottom tracing). The black
arrowheads indicate when PTZ infusion started and the time of seizure onset. The time to
seizure onset was longer in Nonpreg rats compared to Preg rats. When seizure threshold
was calculated, the amount of PTZ (mg/kg) required to elicit electrical seizure was
significantly lower in Preg compared to Nonpreg rats (Figure 1B). Further, Preg rats had
significantly higher seizure susceptibility scores compared to Nonpreg rats (Figure 1C).
There were no differences in physiological parameters during seizure threshold
measurements between groups, except that, as expected, body weights were significantly
higher in Preg compared to Nonpreg rats (Table 1).
To determine if there were changes in seizure severity during pregnancy, the total
number of recurrent seizures was counted in the 30 minutes post-infusion time period,
and the percent of time spent in seizure calculated. Figure 2A shows a representative
EEG tracing within the 30 minutes post-PTZ infusion recording time period. Indicated on
the tracing is the rapid onset of a recurrent seizure, followed by the rapid cessation of the
recurring seizure. There was no change in the number of recurrent seizures in the 30
minutes post-PTZ infusion between groups (Figure 2B). There were also no differences
in the percent of time spent in seizure between Nonpreg and Preg rats (Figure 2C).
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The effect of pregnancy on microglial activation and GABAAR δ-subunit expression
To determine if normal pregnancy was a state of basal neuroinflammation, we
used the microglia-specific marker Iba 1 to morphologically assess the activation state of
microglia in the posterior cerebral cortex from Nonpreg and Preg rats. Figure 3A shows
representative photomicrographs of Iba 1+ microglia in the posterior cerebral cortices of
Nonpreg and Preg rats. There was no difference in the total number of microglial cells in
the posterior cerebral cortex between groups (Figure 3B). Further, there were no changes
in basal microglial activation during pregnancy with no differences in the percent of cells
in any activation state between groups (Figure 3C).
To determine if pregnancy induced changes in protein expression of GABAAR-δ
in the cerebral cortex of Nonpreg and Preg rats, GABAAR-δ expression was measured
using Western blot and shown in Figure 4A. GABAAR-δ expression was significantly
reduced in the cerebral cortex of Preg compared to Nonpreg rats (Figure 4B).

The effect of pregnancy on seizure-induced vasogenic brain edema formation
Percent water content of the brain was calculated post-seizure in Nonpreg and
Preg rats to determine if there were differences in seizure-induced vasogenic edema
formation. Percent water content was significantly higher after seizure in the brains of
Preg rats compared to Nonpreg rats (Figure 5).
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Discussion
The major finding of this study was that normal pregnancy was a state of
increased seizure susceptibility, indicated by seizure threshold being significantly lower
during pregnancy compared to the nonpregnant state. This increase in seizure
susceptibility did not appear to be due to basal neuroinflammation, as the percent of
microglia in each activation state was similar between Preg and Nonpreg animals.
However, there was decreased GABAAR δ-subunit expression in the cerebral cortex of
Preg compared to Nonpreg rats. The GABAAR-δ are extrasynaptic neurotransmitter
receptors and involved in tonic inhibition throughout the brain [17]. Thus, it is not
surprising that a decrease in inhibitory input was associated with increased excitability
and seizure susceptibility. However, the δ-subunit is considered the main site of action of
neurosteroids elevated during pregnancy that act as positive allosteric modulators of
GABAARs [16,17]. Thus, plasticity of the GABAAR-δ is likely a normal adaptation to an
increase in neuroactive steroids during pregnancy, necessary to maintain the steady state
of excitability and avoid overinhibition of neuronal networks. Interestingly, despite the
presence of naturally circulating neurosteroids, pregnant animals remained in a state of
increased seizure susceptibility, suggesting this downregulation of GABAAR-δ resulted
in increased cortical excitability. Increased neuronal excitability in response to
neurosteroids may contribute to the subpopulation of women who experience de novo
seizure during pregnancies uncomplicated by preeclampsia. Further, the rapid and
dramatic drop in progesterone and its metabolites that occur immediately after parturition
may also represent one mechanism by which postpartum eclampsia occurs [36].
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Susceptibility to seizure during pregnancy has previously been investigated in the
context of understanding epilepsy in pregnancy. The finding of a lower seizure threshold
during pregnancy in the current study would suggest that there would be an increase in
seizure frequency in pregnant women with epilepsy. However, the effect of pregnancy on
frequency of seizures in women with epilepsy is difficult to discern and appears variable.
A review of over 2000 pregnancies in epileptic patients found that ~ 25 % of patients
experienced a decrease, ~ 25 % an increase, and ~ 50 % experienced no change in seizure
frequency during pregnancy [37]. This variability in seizure frequency noted may be
complicated by the absence or presence of anti-epileptic medications during pregnancy.
One study investigating the effect of antiepileptic drugs on seizure in pregnant mice
found that electroconvulsive seizure threshold was increased on day 18 of pregnancy
compared to nonpregnant mice [38]. Another study using amygdaloid kindled rats also
reported increased threshold to electroconvulsive seizure in pregnant compared to
nonpregnant animals [39]. The finding that pregnancy increases seizure threshold in these
previous studies is in contrast to the current study in which seizure threshold was
significantly lower in Preg compared to Nonpreg rats. One significant difference in the
present study is that seizure threshold was defined as the onset of electrographic seizure
and not based on physical manifestations as in the previous studies. Therefore, the
method of measuring seizure threshold could contribute to these disparate findings. In
addition, the chemoconvulsant used to induce seizure was also different. In the current
study, the decrease in seizure threshold in response to PTZ is in accordance with the
decrease in GABAAR δ-subunit expression, since the mechanism by which PTZ acts as a
convulsant is through antagonistic actions at GABAARs. Thus, the use of PTZ-induced
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seizure in the current study allowed investigation into the direct involvement of
GABAAR plasticity in whole brain excitability during pregnancy. However, whether
there is plasticity in excitatory receptors in the brain, such as AMPA receptors, during
pregnancy is currently unknown. To our knowledge this is the first in vivo study
reporting that normal pregnancy is associated with lowered seizure threshold and
increased seizure susceptibility using non-kindled rats and EEG to determine seizure
susceptibility during pregnancy.
The cause of spontaneous, unexplained seizure in a woman with a seemingly
normal pregnancy is unknown; however, pregnancy-induced increased seizure
susceptibility could be a contributing factor. It is also possible that de novo seizure in a
seemingly healthy pregnant woman represents a form of status epilepticus (SE) of
idiopathic nature and that eclampsia is idiopathic SE that happens to occur in a woman
while she is pregnant. In addition, the incidence of eclampsia has declined in developed
countries with the advancement of prenatal care and the use of seizure prophylactic
agents such as magnesium sulfate that have reduced the risk of eclampsia by ~ 50% [40].
Incidence reports of eclampsia for the United Kingdom found a decrease from 4.9 cases
of eclampsia per 10,000 pregnancies in 1992 to 2.7/10,000 pregnancies in 2005-06
[12,41]. Similarly, in Scandinavia the incidence of eclampsia was 5.0/10,000 pregnancies
between 1998-2000 [42], and in Canada (excluding Quebec) 5.9/10,000 cases between
2009-2010 [43]. However, in developing countries the incidence of eclampsia is
considerably higher. For example, in 1990 in South Africa the incidence of eclampsia
was 60/10,000 pregnancies [44], and 200/10,000 pregnancies at Muhimbili National
Hospital in Dar es Salaam, Tanzania in 1999-2000 [45]. Population-based epidemiologic
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studies of SE report incidences of 18.3/100,000 population in Rochester, Minnesota
between 1965-1984 [46], 13.1/100,000 in Bologna, Italy between 1999-2000 [47],
15.8/100,000 in Hessen, Germany between 1997-1999 [48], and 10.3/100,000 in Frenchspeaking Switzerland between 1997-1998 [49]. Interestingly, studies reporting the
incidence of SE often report that the majority of patients have no history of epilepsy
[47,48]. Thus, the incidence of eclampsia seems to be magnitudes higher than SE,
especially in undeveloped countries, and therefore is likely not simply an idiopathic form
of SE. In fact, these comparisons likely dampen the differences in incidence since
eclampsia is limited only to women who are of childbearing age. Overall, unexplained de
novo seizure seems to be more prevalent during pregnancy than in the rest of the
population, and supports the theory that normal pregnancy increases seizure
susceptibility.
Previously we have shown that there are seizure-provoking factors present in
serum that circulate late in gestation that are not present in the nonpregnant state [43].
Using a hippocampal slice culture model to measure excitability using evoked field
potentials after exposure to serum from pregnant and nonpregnant rats revealed that
serum from pregnant, but not nonpregnant rats increased slice excitability [50]. This was
due to serum factors activating microglia and subsequent TNFα secretion increasing
neuronal excitability [50]. However, under normal conditions, serum constituents do not
readily gain access to the brain due to the protective nature of the BBB. In addition, the
pregnant rats from which the hyperexcitable serum was taken did not appear to have
spontaneous convulsions, suggesting the BBB may be central to seizure prevention
during normal pregnancy. Together with the findings of the current study that the brain is
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in a hyperexcitable state during pregnancy, further points to the BBB as a critical factor
in preventing seizure during pregnancy. We speculate that it is the failure of this crucial
function of the BBB that underlies de novo seizure during seemingly uncomplicated
pregnancies, as well as during preeclampsia, by allowing the passage of circulating
seizure-provoking factors into the hyperexcitable maternal brain.
The brain has been shown to be more susceptible to vasogenic edema formation
under certain pathologic conditions during pregnancy, such as acute hypertension
[31,32]. The current study shows that the maternal brain is also more sensitive to seizureinduced brain injury, with seizure causing greater vasogenic edema formation than in the
nonpregnant state. It is important to note that previous studies have revealed no
differences in brain water content basally between pregnant and nonpregnant rats [31],
demonstrating that the increase in brain water content found in the present study was an
effect of seizure. Although edema formation is considered a leading cause of eclampsia
and is present in ~ 90 % of women with eclampsia [25,26], seizure itself can cause edema
formation through disruption of the BBB [27-29]. The finding in the current study that
the brain is more susceptible to seizure-induced vasogenic edema formation during
pregnancy supports the concept that the brain is more susceptible to injury-induced
edema formation during pregnancy. Further, this sensitivity to seizure-induced edema
may help explain vasogenic edema formation that may be present in eclamptic women
who experienced de novo seizure without an acute elevation in blood pressure.
There are several potential contributors to pregnancy-induced increase in
susceptibility to cerebral vasogenic edema formation. Firstly, if pregnancy were
associated with more severe seizure, there may be greater brain injury and edema
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formation. However, there were no differences in seizure severity between Preg and
Nonpreg rats, with the percent of time spent in seizure and number of recurrent seizures
being similar, making this possibility unlikely. Secondly, seizure-induced acute
hypertension could account for the increase in vasogenic edema formation during
pregnancy. However, seizure did not cause a significant change in blood pressure in
either Preg or Nonpreg rats (data not shown). The lack of effect of seizure onset on blood
pressure is likely due to the sensitive measure of seizure threshold used in the current
study that allowed for detection of electrical seizure, as opposed to measuring latency to
tonic clonic seizure that has been associated with a rapid rise in blood pressure [51]. As
there was no significant change in blood pressure with the onset of electrical seizure in
either group, an acute elevation in blood pressure likely did not contribute to the
increased formation of vasogenic edema in Preg rats. Thirdly, capillary density increases
in the posterior cerebral cortex during pregnancy [52] that may increase the number of
sites of BBB disruption during seizure. Further, plasma volume increases ~ 50 % during
pregnancy resulting in a hemodiluted state that under conditions of BBB disruption such
as seizure may drive water into the brain due to decreased osmolality [53]. Overall, it
appears that the maternal brain is more susceptible to vasogenic edema formation during
conditions that cause BBB disruption, highlighting the importance of seizure prevention
during pregnancy.
In summary, this is the first study we are aware of to report that pregnancy is a
state of increased susceptibility to seizure and seizure-induced cerebral vasogenic edema.
While the brain appears to be hyperexcitable during pregnancy, this did not appear to be
due to low-level neuroinflammation, but rather a reduction in GABAAR-δ expression in
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the cerebral cortex. Understanding pregnancy-related neurophysiological changes may
clarify mechanisms by which eclamptic seizure occurs during seemingly uncomplicated
pregnancies when there are failures of other protective mechanisms, such as at the BBB
or neurosteroid concentrations involved in maintaining steady state excitability, as
illustrated in Figure 6. Further, elucidating the contribution of normal pregnancy to
seizure onset could lead to a greater understanding of pregnancy-specific pathologies
such as preeclampsia and eclampsia. Our understanding of these conditions may result in
development of specific screenings to identify pregnant women who are at risk of de
novo seizure, aiding in seizure prevention and specific treatment during pregnancy.
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Table 1. Physiological parameters of nonpregnant (Nonpreg) and late-pregnant
(Preg) rats under chloral hydrate anesthesia for seizure threshold measurements.
Nonpreg

Preg

(n = 7)

(n = 6)

Body Weight (grams)

287 ± 7

377 ± 10 **

Body Temp (o C)

36.3 ± 0.2

36.8 ± 0.2

Arterial PO2 (mm Hg)

114 ± 8

111 ± 7

Arterial PCO2 (mm Hg)

42.1 ± 1.9

42.8 ± 1.7

** p < 0.01 vs. Nonpreg
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Figure 1. The effect of normal pregnancy on seizure threshold and susceptibility. (A)
Representative EEG tracings from nonpregnant (Nonpreg) and late-pregnant (Preg) rats
during timed-infusion of pentylenetetrazol (PTZ). Black arrows indicate when PTZ
infusion started and the onset of spike-wave discharge indicative of electrical seizure. (B)
Seizure threshold was significantly lower in Preg rats compared to Nonpreg rats. (C) Preg
rats scored higher on the seizure susceptibility scale compared to Nonpreg rats. ** p <
0.01 vs. Nonpreg by one-way ANOVA.
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Figure 2. The effect of pregnancy on seizure severity. (A) Representative EEG tracing
of a recurrent seizure during the 30-minute post-pentylenetetrazol (PTZ) infusion time
period. Left black arrow indicates seizure onset and right black arrow seizure cessation.
(B) Number of recurrent seizures in the 30-minute post-PTZ infusion period was similar
between nonpregnant (Nonpreg) and late-pregnant (Preg) rats. (C) The percent of time
spent in seizure during the 30-minute post-PTZ time period was similar between Nonpreg
and Preg rats.
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Figure 3. Basal activation state of microglia in cerebral cortex of nonpregnant
(Nonpreg) and pregnant (Preg) rats. (A) Representative photomicrographs of Iba 1+
microglia in the cerebral cortices of Nonpreg and Preg rats. (B) There was no difference
in the number of microglia in the cerebral cortices of Nonpreg and Preg rats. (C) The
percent of Iba 1+ microglial cells in each activation state was similar in the cortices of
Nonpreg and Preg rats.
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Figure 4. The effect of pregnancy on GABAAR δ-subunit protein expression in the
cerebral cortex. (A) Representative Western blot showing protein expression of the
GABAAR δ-subunit in the cerebral cortices of nonpregnant (Nonpreg) and pregnant
(Preg) rats. (B) δ-subunit protein expression was significantly lower in the cerebral cortex
from Preg compared to Nonpreg rats. ** p < 0.05 vs. Nonpreg using one-way ANOVA.
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Figure 5. The effect of seizure on vasogenic edema formation in nonpregnant
(Nonpreg) and late-pregnant (Preg) rats. Percent water content of the posterior
cerebral cortex was significantly higher after seizure in Preg compared to Nonpreg rats. *
p < 0.05 vs. Nonpreg using one-way ANOVA.
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Figure 6. Schematic of the potential contribution of normal pregnancy to eclampsia.
The maternal brain appears hyperexcitable due to decreased protein expression of the
GABAAR δ-subunit that increases the potential for spontaneous seizure. However,
because the majority of women do not have seizure during pregnancy, additional insults
are required to cause seizure onset that are multifactorial: 1) Imbalanced neurosteroids.
Hyperexcitability due to downregulation of cortical GABAAR subunits is thought to be
kept in balance by progesterone and progesterone metabolites; however, seizure can
occur in response to changes in neurosteroid concentrations, such as postpartum when
progesterone levels decrease to pre-pregnancy levels. Further, estradiol exerts proconvulsive effects by increasing neuronal excitability through activity at excitatory
ionotropic neurotransmitter receptors and neuronal sodium and potassium channels [5456]. Thus, the switch from a progesterone- to an estrogen-dominated state at parturition
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could facilitate seizure onset during pregnancy. 2) Increased inflammation and/or
infection. During pregnancy, neuroinflammation and activation of microglia can occur to
increase neuronal excitability through local production of inflammatory cytokines (e.g.,
TNFα). 3) Failure or dysregulation of the BBB. Increased permeability of the BBB can
occur through elevated mediators such as vasopressin and histamine that are elevated
during pregnancy and preeclampsia [57,58]. An increase in BBB permeability has several
effects including passage of circulating seizure-provoking factors into an already
hyperexcitable maternal brain and movement of water or solutes from blood to brain that
can disrupt the delicate microenvironment of the brain and cause a charge screening
effect that depolarizes neurons. Decreased osmolality during pregnancy may result in
greater vasogenic edema formation under conditions of disrupted BBB. In addition,
failure of efflux transporters to regulate the entry of steroids, cytokines and chemokines
into the brain may also lead to de novo seizure during pregnancy.
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CHAPTER 4: MAGNESIUM SULFATE TREATMENT REVERSES
SEIZURE SUSCEPTIBILITY AND DECREASES
NEUROINFLAMMATION IN A RAT MODEL OF SEVERE
PREECLAMPSIA

Abbie Chapman Johnson, Sarah M. Tremble, Siu-Lung Chan, Janae Moseley,
Babette LaMarca, Keith J. Nagle, and Marilyn Cipolla
PLoS One. 2014 Nov 19;9(11):e113670.doi: 10.1371/journal.pone.0113670.
152

Abstract
Eclampsia, defined as unexplained seizure in a woman with preeclampsia, is a lifethreatening complication of pregnancy with unclear etiology. Magnesium sulfate
(MgSO4) is the leading eclamptic seizure prophylactic, yet its mechanism of action
remains unclear. Here, we hypothesized severe preeclampsia is a state of increased
seizure susceptibility due to blood-brain barrier (BBB) disruption and neuroinflammation
that lowers seizure threshold. Further, MgSO4 decreases seizure susceptibility by
protecting the BBB and preventing neuroinflammation. To model severe preeclampsia,
placental ischemia (reduced uteroplacental perfusion pressure; RUPP) was combined
with a high cholesterol diet (HC) to cause maternal endothelial dysfunction. RUPP+HC
rats developed symptoms associated with severe preeclampsia, including hypertension,
oxidative stress, endothelial dysfunction and fetal and placental growth restriction.
Seizure threshold was determined by quantifying the amount of pentylenetetrazole (PTZ;
mg/kg) required to elicit seizure in RUPP+HC±MgSO4 and compared to normal pregnant
controls (n=6/group; gestational day 20). RUPP+HC rats were more sensitive to PTZ
with seizure threshold being ~65% lower vs. control (12.4±1.7 vs. 36.7±3.9 mg/kg PTZ;
p<0.05) that was reversed by MgSO4 (45.7±8.7 mg/kg PTZ; p<0.05 vs. RUPP+HC).
BBB permeability to sodium fluorescein, measured in-vivo (n=5-7/group), was increased
in RUPP+HC vs. control rats, with more tracer passing into the brain (15.9±1.0 vs.
12.2±0.3 counts/gram x1000; p<0.05) and was unaffected by MgSO4 (15.6±1.0
counts/gram x1000; p<0.05 vs. controls). In addition, RUPP+HC rats were in a state of
neuroinflammation, indicated by 35±2% of microglia being active compared to 9±2% in
normal pregnancy (p<0.01; n=3-8/group). MgSO4 treatment reversed neuroinflammation,
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reducing microglial activation to 6±2% (p<0.01 vs. RUPP+HC). Overall, RUPP+HC rats
were in a state of augmented seizure susceptibility potentially due to increased BBB
permeability and neuroinflammation. MgSO4 treatment reversed this, increasing seizure
threshold and decreasing neuroinflammation, without affecting BBB permeability. Thus,
reducing neuroinflammation may be one mechanism by which MgSO4 prevents
eclampsia during severe preeclampsia.
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Introduction
Preeclampsia (PE) is a hypertensive complication of pregnancy that involves
many organ systems, including the kidney, liver and brain [1]. Some of the most serious
complications of PE involve neurologic symptoms and include uncontrolled vomiting,
severe and persistent headache, visual disturbances, unexplained seizure (eclampsia),
coma and death [1]. Eclampsia is a life-threatening condition with high maternal and fetal
morbidity and mortality [2,3]. The mechanism by which de novo seizure occurs in
women with PE is not known, however, studies have shown that the brain is more
excitable during pregnancy and PE, suggesting a lower seizure threshold that may
contribute to de novo seizure. For example, network excitability in brain slices of
pregnant mice was increased compared to virgin animals [4]. Further, a lower seizure
threshold was reported in a lipopolysaccharide (LPS)-induced rat model of PE compared
to normal pregnancy [5], suggesting pregnancy and PE may predispose the brain to
seizure through increased neuronal excitability. However, the mechanism by which
neuronal excitability is augmented in PE is unknown.
One of the primary mechanisms by which neuronal excitability can increase is
through activation of microglia and neuroinflammation [6,7]. Microglial activation under
conditions of peripheral inflammation has been shown to decrease seizure threshold via a
promotional effect on neuronal excitability [8]. In addition, increased blood-brain barrier
(BBB) permeability can result in neuroinflammation by allowing passage of serum
constituents into the brain that activate microglia [9-12]. A previous study showed that
circulating factors present during normal pregnancy are hyperexcitable to the brain
through activation of microglia, and increase network excitability in a hippocampal slice
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culture model [13]. In addition, circulating factors during PE have been shown to
increase BBB permeability that could potentially pass into the maternal brain to promote
neuroinflammation and decrease seizure threshold [14,15]. In the present study, we
hypothesized that PE produces a state of neuroinflammation that lowers seizure
threshold. We further hypothesized that BBB disruption during PE leads to microglia
activation and is a mechanism by which seizure threshold is lowered during PE.
Magnesium sulfate (MgSO4) is currently the most effective and commonly
administered drug for eclamptic seizure prophylaxis and reduces the incidence of
eclampsia by ~ 50 % [16-20]. MgSO4 is administered to women at relatively high doses
to raise serum levels to between 4.2 – 8.4 mg/dL over 12 - 24 hours [16]. However,
despite its apparent effectiveness, dangerous side effects are associated with MgSO4 use,
including the potential for areflexia, respiratory paralysis and cardiac arrest [16]. Further,
although it is the preferred treatment strategy in women with PE, the exact mechanism by
which MgSO4 prevents eclampsia is not clear and may be multifaceted. Animal studies
have provided evidence that MgSO4 has protective actions at the BBB, lowering
permeability during acute hypertension, and reducing hyperosmolar-induced disruption
of the BBB [21,22]. We hypothesized that MgSO4 treatment during PE increases seizure
threshold by preserving the integrity of the BBB and preventing microglial activation,
thereby decreasing neuroinflammation.
In the present study, we developed a rat model of severe PE that incorporated
placental ischemia and maternal endothelial dysfunction that are thought to contribute to
the pathogenesis of PE [23]. In particular, we sought to model severe PE that
encompasses both fetal and maternal symptoms and has the greatest risk of life156

threatening complications [23,24]. This model used the reduced uteroplacental perfusion
pressure (RUPP) model of placental ischemia [25] combined with a high cholesterol diet
previously shown to cause maternal endothelial dysfunction [15,26]. Using this model,
we investigated the effect of severe PE on seizure threshold, BBB permeability in vivo
and neuroinflammation. Further, rats with severe PE were treated with a clinically
relevant dose of MgSO4 for 24 hours, and the effect of MgSO4 on these parameters was
also determined.

Methods
Animals and ethics statement
All experiments were conducted using timed-pregnant Sprague Dawley rats that were 1416 weeks old (Charles River, Canada). All rats were used experimentally and euthanized
late in gestation (day 20 of a 22 day gestation), as this is when eclampsia occurs most
often [1]. Rats of the same gestational age were housed in pairs in the University of
Vermont Animal Care Facility, an Association for Assessment and Accreditation of
Laboratory Animal Care International accredited facility. All procedures were approved
by the Institutional Animal Care and Use Committee at the University of Vermont and
conducted in accordance with the National Institute of Health Guide for the Care and Use
of Laboratory Animals.
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Rat model of severe PE and assessment of pregnancy outcome
To model severe PE, we combined the RUPP model of placental ischemia with a high
cholesterol diet (RUPP+HC) previously shown to cause hyperlipidemia by increasing
total plasma cholesterol, maternal endothelial dysfunction and increased blood pressure
[15,26]. Forty-eight pregnant rats were fed a high cholesterol diet (Prolab 3000 rat chow
with 2 % cholesterol and 0.5 % sodium cholate; Scotts Distributing Inc., Hudson, NH) on
days 7-20 of gestation. To induce placental ischemia, on day 14 of pregnancy while
maintained on a high cholesterol diet, a midline abdominal incision was made under
isoflurane anesthesia and a silver clip (diameter 0.203 mm) placed on the distal aorta, just
proximal to the iliac bifurcation and distal to the renal and mesenteric arteries. Silver
clips (diameter 0.10 mm) were placed on the arteries of the uterine arcade before the first
segmental branch to the uteroplacental unit. This is an established method of reducing
uteroplacental perfusion pressure by ~ 40 % [25]. Pregnant rats that had a sham surgery
(n = 4) underwent the same surgical procedure, excluding the placement of silver clips.
Animals were weighed prior to use and euthanized by decapitation after experimentation
under anesthesia. Trunk blood was collected and serum stored at – 80 oC until use.
Uterine horns were examined for total number of pups and any reabsorbed fetuses. To
assess growth restriction and placental disease, pups and placenta from some RUPP+HC
rats (n = 5) were removed, weighed individually and compared to control rats (n = 3).

Measurement of conscious, unrestrained arterial blood pressure
Separate groups of normal late-pregnant (Late-Preg; n = 6) and RUPP+HC rats (n = 6)
were implanted with indwelling carotid catheters on day 18 of gestation. Under isoflurane
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anesthesia, the left common carotid artery was exposed and cannulated with saline filled
V-3 tubing (SCI) which was tunneled to the back of the neck and externalized. On day 19
of pregnancy, rats were lightly anesthetized with isoflurane (1 - 2 % for 3 - 4 minutes)
and a pressure transducer (BIOPAC, Inc., Goleta, CA, USA) connected to the indwelling
carotid catheter. Rats were placed in a rectangular, clear plastic modular chamber (10” x
7” x 5”) with a metal grid floor, large enough to move freely. Average conscious,
unrestrained systolic blood pressures were recorded using AcqKnowledge software
(BIOPAC, Inc., Goleta, CA, USA). One RUPP+HC rat died due to surgical
complications during catheter implantation and was excluded.

Measurement of circulating markers of endothelial dysfunction and oxidative stress
Commercially available rat ELISA kits for endothelin-1 (ET-1; R&D Systems,
Minneapolis, MN, USA) and free 8-isoprostane (Caymen Chemicals, Ann Arbor, MI,
USA) were used to measure circulating factors in the serum of Late-Preg (n = 6) and
RUPP+HC (n = 6 – 8) rats. Serum samples were diluted 1:3 for measurements of free 8isoprostane otherwise samples were measured undiluted. All samples were measured in
duplicate.

MgSO4 treatment in RUPP+HC rats
Eighteen RUPP+HC rats were injected s.c. the morning of day 19 of pregnancy with 270
mg/kg 1.0 M MgSO4 (RUPP+HC+MgSO4). Four hours later, rats were briefly
anesthetized with 2 % isoflurane and three 2 mL osmotic minipumps (Alzet, Cupertino,
CA, USA) primed with 1.0 M MgSO4 were implanted s.c. between the shoulder blades.
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On day 20 of pregnancy, 1.5 hours prior to surgery and experimentation rats were
injected with a second bolus of 270 mg/kg 1.0 M MgSO4 s.c. After experimentation, rats
were euthanized by decapitation under anesthesia and serum collected and stored at – 80
o

C until use. Serum [Mg2+] was measured using a colorimetric assay (BioVision Inc., San

Francisco, CA, USA) according to the manufactures’ instructions and compared to
RUPP+HC rats that did not receive treatment with MgSO4 (n = 4 / group).

Measurement of seizure threshold, susceptibility and severity, and brain water content
Separate groups of Late-Preg (n = 10), RUPP+HC (n = 6) and RUPP+HC+MgSO4 (n =
6) were anesthetized initially with isoflurane (1 – 3 % in oxygen) for intubation, electrode
placement and instrumentation. Animals were mechanically ventilated to maintain blood
gases and pH within normal physiological ranges. Body temperature was monitored with
a rectal thermometer and maintained with a heating pad at 37 oC throughout the
experiment. The dorsal surface of the head was shaved to expose the scalp and silver
subdermal corkscrew electrodes (Ambu, Glen Burnie, MD, USA) were implanted under
the scalp and secured in place with collodion glue. Electroencephalography (EEG) was
recorded unipolarly using a MP150 acquisition system (BIOPAC System Inc., Goleta,
CA, USA) to monitor generalized seizure. The recording electrode was placed over the
right parieto-occipital cortex (5 ± 0.16 mm lateral and 7 ± 0.16 mm posterior to bregma)
[27], a reference electrode was placed in the soft tissue of the snout and a ground
electrode placed posterior to the right ear. Signals were amplified and filtered (low
frequency filter, 0.1 Hz; high frequency filter 35.0 Hz) and sampled at 1.0 kHz. After
placement of electrodes, the animal was placed in supine position for placement of
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venous and arterial catheters. Femoral arteries were cannulated to obtain blood samples
for blood gas measurements and continuous measurement of arterial blood pressure via a
pressure transducer (BIOPAC Systems Inc., Goleta, CA, USA). As placement of a silver
clip on the distal aorta in rats with RUPP made monitoring blood pressure in the femoral
artery inaccurate, blood pressures were measured in the axillary artery, as done
previously [28]. Femoral veins were cannulated for administration of the anesthetic
chloral hydrate and infusion of the chemoconvulsant pentylenetetrazole (PTZ). PTZ was
chosen because it reliably elicits seizure by its antagonistic action at the main inhibitory
receptors in the brain, gamma-aminobutyric acid (GABA) type A receptors [29]. After
instrumentation, animals were tapered off isoflurane and anesthesia maintained by
continuous intravenous infusion of chloral hydrate (50 mg/mL; 30 µL/min). Chloral
hydrate was used because it is thought to not depress neural function, and is the preferred
anesthetic for studies measuring EEG [30,31]. Seizure was induced by a timed infusion
of PTZ (10 mg/mL; 1 mL / min) that was stopped at the first onset of spikewave
discharges. Seizure threshold was calculated as the amount of PTZ (mg/kg) required to
elicit electrical seizure: Tinfusion * Rinfusion * [PTZ] / BW where Tinfusion is the time of
infusion in min, Rinfusion is the rate of infusion in mL/min, [PTZ] is the concentration of
PTZ in mg/mL, and BW is the body weight in kg. Seizure susceptibility scores were also
calculated: bw * 10/v where bw is body weight in grams and v is volume of PTZ infused
in µL.[8] Baseline blood pressures were taken 30 seconds prior to PTZ infusion and at
seizure onset. EEG was recorded for 30 minutes post-PTZ infusion and seizure severity
assessed by counting the number of recurring seizures and calculating the percent of the
post-infusion period spent in seizure. After 30 minutes animals were euthanized under
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chloral hydrate anesthesia by decapitation and brains immediately removed. The
posterior cerebral cortex was isolated and weighed wet (weightwet), then dried in a
laboratory oven at 90 oC for 24 hours and re-weighed dry (weightdry). Percent water
content was determined by wet:dry weights using the following formula: (weightwet weightdry/weightwet) * 100. The posterior cortex was chosen for measurements as this is a
primary brain region affected in women with PE and eclampsia [32]. Four Late-Preg rats
were excluded because blood gases were outside of the physiological range.

Measurement of in vivo BBB permeability
Permeability of the BBB was measured in Late-Preg (n = 6), RUPP+HC (n = 5) and
RUPP+HC+MgSO4 (n = 8) using previously described methods with modifications [33].
Briefly, animals were anesthetized and instrumented similarly as during seizure threshold
measurements, excluding EEG electrode placement and substituting the catheter for PTZ
with fluorescent tracers. While under chloral hydrate anesthesia, fluorescent tracers were
infused into the femoral vein (0.5 mL/min for 2.25 min) and allowed to circulate for 10
minutes. Sodium fluorescein (0.1 %; mol wt 476 Da; Stokes-Einstein radius ~ 0.45 nm)
and 70-kDa Texas red dextran (0.5 mg/mL; Stokes-Einstein radius ~ 7.0 nm) in lactated
Ringer’s solution and heparin were used to distinguish size selectivity to small and large
solutes, respectively. A thoracotomy was performed, a needle inserted into the left
ventricle of the heart and the right atrium cut to allow for drainage of blood and tracers.
Using an infusion pump, the circulation was flushed with 60 mL lactated Ringer’s
solution (5.0 mL/min) until the circulation was clear of blood. Animals were decapitated,
the brain removed and the posterior cerebral cortex isolated and weighed. Each brain
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section was homogenized in 5.0 mL 0.1 M PBS, 5.0 mL 50 % trichloroacetic acid (TCA)
added, vortexed for 1 min, and centrifuged at 4 o C for 10 min at 4500 rpm (Sorvall
Legend X1R, Thermo Scientific, Waltham, MA, USA. The supernatant was removed and
re-centrifuged. The fluorescence of the supernatant was determined at excitation and
emission wavelengths of 460 and 515 nm for sodium fluorescein and 595 and 615 nm for
Texas red dextran. Background emissions of 50:50 lactated Ringer’s and 50 % TCA were
subtracted and samples normalized to brain weight to compare fluorescence as
counts/gram of brain tissue. One Late-Preg rat and one RUPP+HC+MgSO4 rat were
excluded due to surgical complications.

Quantification and morphological assessment of microglia
Separate groups of Late-Preg (n = 8), RUPP+HC (n = 3) and RUPP+HC+MgSO4 (n = 4)
rats were euthanized under isoflurane anesthesia and brains immediately removed. A 3
mm coronal section (4 – 7 mm posterior to bregma) of the posterior cerebral cortex was
taken and fixed in 10 % buffered formalin at 4 o C overnight, then transferred to 0.1 M
PBS and paraffin embedded. Immunohistochemical staining for ionized calcium-binding
adapter molecule 1 (Iba1; Wako, Richmond, VA), a marker for microglia, was done
using standard procedures. Briefly, tissue was sectioned at 4 μm on a Leica 2030 paraffin
microtome. Slides were allowed to air dry overnight at room temperature and then baked
for one hour at 60 o C. Following deparaffinization and rehydration, the sections
underwent antigen retrieval with DAKO Target Retrieval Solution, pH 6.0 in 50 %
glycerol at 95 o C for 20 min. Sections were treated with 1 % bovine serum albumin, 10
% normal goat serum and 0.1 % Triton X-100. The tissue was incubated overnight at
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room temperature with Iba1 antibody (1 μg/mL) and one hour in Cyanine 3 dye (1:100).
For each brain section, four micrographs of cerebral cortex were captured using an
Olympus BX50 microscope at 20X magnification. Each Iba1+ cell was assessed by its
morphology and activation state ranked using a graded scale from 1 (relatively inactive)
to 4 (relatively active). Cells with highly ramified, long processes with a scattered,
irregularly shaped cell body were ranked in state 1. Cells with an asymmetrical cell body
and many long, defined processes were ranked in state 2. Cell bodies that were more
rounded with several shorter, thicker processes were ranked 3, and large, round
amoeboid-like cell bodies with few to no processes were ranked in state 4 [34]. To assess
microglia, two analyses were performed. First, the percentage of cells in each activation
state was calculated for each micrograph and averaged per group. Second, total number
of Iba1+ cells were counted per mm2 and averaged for each group. A group of shamoperated rats were assessed for microglial activation to confirm the surgery alone did not
activate microglia. Two evaluators that were blinded to group performed all
morphological assessments.

Measurement of cerebral blood flow autoregulation and brain water content
Separate groups of Preg (n = 6) and RUPP+HC (n = 10) rats were anesthetized initially
with isoflurane (1 - 3 % in oxygen) for intubation and instrumentation, after which
anesthesia was maintained with a bolus intravenous injection of chloral hydrate (200
mg/kg into femoral vein). Animals were mechanically ventilated to maintain blood gases
and pH within normal physiological ranges. Body temperature was monitored with a
rectal thermometer and maintained with a heating pad at 37 oC throughout the
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experiment. Relative cerebral blood flow (rCBF) was measured transcranially in the
posterior cerebral cortex using laser Doppler flowmetry. The left side of the
medioposterior skull was exposed and the bone thinned. A laser Doppler probe (Perimed,
Ardmore, PA, USA) was affixed 2 mm lateral to the sagittal suture and 1 mm anterior to
the lambdoid suture to measure rCBF in the posterior cerebral artery territory. Femoral
arteries were cannulated to obtain blood samples for blood gas measurements and
measurement of arterial blood pressure via a pressure transducer (Living Systems
Instrumentation, Inc., Burlington, VT, USA). Femoral veins were cannulated for
administration of chloral hydrate and acute infusion of phenylephrine. To measure CBF
autoregulation, phenylephrine was infused intravenously at an increasing rate of 4 - 48
µg/min, and blood pressure and rCBF measured simultaneously, as previously described
[35]. After experimentation, while under anesthesia, rats were euthanized by decapitation,
brains immediately removed and percent water content measured by wet:dry weights.
One RUPP+HC rat was excluded because of technical issues with placement of the laser
Doppler probe. The percent increase in CBF of one RUPP+HC rat was greater than two
standard deviations from the mean, and therefore excluded as a statistical outlier.
Animals were not randomized due to the use of timed-pregnant rats.

Drugs and solutions
MgSO4, phenylephrine, chloral hydrate, PTZ, sodium fluorescein and TCA were
purchased from Sigma Aldrich (St Louis, MO, USA) and all were made daily in sterile
lactated Ringer’s solution except MgSO4, which was ready-to-use. Texas red dextran was
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purchased from Invitrogen (Life Technologies, Grand Island, NY, USA) and made daily
in sterile lactated Ringer’s solution.

Statistical analyses
Data are presented as mean ± standard error of mean. Physiological parameters were
compared between Late-Preg and RUPP+HC rats using analysis of variance (ANOVA).
Pup and placental weights were compared using ANOVA with the n-value being total
pups and placentas in each group. Differences in circulating levels of ET-1 and free 8isoprostane were also compared using ANOVA. Percent change in rCBF was compared
between Late-Preg and RUPP+HC rats at pressures between 100 and 180 mmHg using
ANOVA. Comparisons of physiological parameters, seizure threshold, susceptibility,
severity, BBB permeability, % water content and microglial activation between LatePreg, RUPP+HC and RUPP+HC+MgSO4 rats were done using a one-way ANOVA with
a Bonferroni’s post-hoc test to correct for multiple comparisons. Differences were
considered significant at p < 0.05.

Results
Severe PE caused hypertension, oxidative stress, endothelial dysfunction, and fetal and
placental growth restriction
Table 1 shows physiological parameters of Late-Preg and RUPP+HC rats. RUPP+HC
rats weighed significantly less on day 20 of gestation compared to Late-Preg rats. This
decrease in maternal body weight was not due to significant pup loss or fetal
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reabsorptions, as the number of pups and reabsorbed fetuses were not statistically
different between groups. However, RUPP+HC caused both fetal and placental growth
restriction, as shown by significant reductions in pup and placental weights. Further, rats
with severe PE had increased systolic blood pressure compared to Late-Preg rats. When
serum markers of oxidative stress and endothelial dysfunction were compared, severe PE
was associated with significantly higher levels of circulating free 8-isoprostane compared
to control rats: 369 ± 25 pg/mL for RUPP+HC vs. 281 ± 8 pg/mL for Late-Preg; p <
0.01 and ET-1: 0.99 ± 0.25 pg/mL for RUPP+HC vs. 0.46 ± 0.06 pg/mL for Late-Preg; p
< 0.05.

Severe PE was associated with decreased seizure threshold and increased seizure
susceptibility
To determine if severe PE was a state associated with increased neuronal excitability,
seizure threshold was measured in vivo in RUPP+HC and Late-Preg rats by timed
infusion of PTZ and simultaneous EEG recording. Figure 1A shows a representative EEG
tracing in a Late-Preg rat during PTZ infusion that had spike wave discharges indicative
of seizure onset after 2.4 min of infusion. Seizure threshold was significantly lower in
RUPP+HC rats, requiring less PTZ to elicit electrical seizure than in Late-Preg controls
(Figure 1B). Further, severe PE was associated with a higher seizure susceptibility score
than in Late-Preg controls, suggesting that RUPP+HC rats are in a state of increased
neuronal excitability (Figure 1C). Comparison of recurring seizures and percentage of
time spent seizing revealed no differences between RUPP+HC and Late-Preg rats (Table
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2), indicating that although rats with severe PE were more susceptible to seizure than
controls, seizure severity was similar between these groups.

MgSO4 treatment reversed seizure susceptibility in rats with severe PE
Treatment of RUPP+HC rats with MgSO4 raised serum Mg2+ levels into the target
therapeutic range that was significantly higher than RUPP+HC rats that did not receive
treatment (5.2 ± 0.5 mg/dL for treated vs. 1.2 ± 0.1 mg/dL for untreated; p < 0.01).
MgSO4 treatment did not affect physiological parameters or pregnancy outcome, as
maternal body weight (389.2 ± 8.9 grams; p > 0.05 vs. untreated), number of pups (11.5
± 1.2; p > 0.05) and fetal reabsorptions (1.8 ± 0.9; p > 0.05) were similar to RUPP+HC
rats (see Table 1). Severe PE rats that received MgSO4 had significantly higher seizure
threshold compared to rats with severe PE that did not receive treatment (Figure 1B).
Further, MgSO4 reversed the increase in seizure susceptibility, lowering susceptibility
scores back to control levels (Figure 1C). Despite these apparent protective effects,
MgSO4 did not affect seizure severity, as there were no changes in either number of
recurrent seizures or percent of time spent seizing with MgSO4 treatment (Table 2). There
were no differences in any physiological parameters under anesthesia during seizure
threshold measurements between groups (Table 3).

Severe PE rats with and without MgSO4 had decreased seizure-induced cerebral
vasogenic edema formation
Cerebral vasogenic edema is present in ~ 90 % of women with eclampsia [36]. Further,
the maternal brain has been shown to be more susceptible to vasogenic edema formation
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than the nonpregnant state under pathologic conditions including acute hypertension and
in response to seizure [37,38]. However, whether the brain during severe PE is more
susceptible to seizure-induced vasogenic edema has yet to be investigated, and the effect
of MgSO4 treatment under such conditions remains unknown. In the current study,
seizure-induced vasogenic edema formation was significantly lower in RUPP+HC rats
compared to Late-Preg controls, and remained unaffected by MgSO4 treatment (Figure
2).

Severe PE increased BBB permeability in vivo that was unaffected by MgSO4 treatment
BBB permeability to sodium fluorescein, the small ~ 470 Da solute, was increased in
RUPP+HC rats compared to Late-Preg rats, with significantly more tracer passing from
the cerebral circulation into the brain parenchyma in rats with severe PE (Figure 3A).
There was no difference in permeability of the BBB to Texas red dextran, a larger 70 kDa
tracer, between Late-Preg and RUPP+HC rats (Figure 3B). MgSO4 treatment
administered to rats with severe PE did not affect BBB permeability, as permeability to
sodium fluorescein remained higher in RUPP+HC+MgSO4 rats than Late-Preg controls
(Figure 3A), with no change in permeability to Texas red (Figure 3B).

Severe PE increased neuroinflammation that was reversed by MgSO4 treatment
Figure 4A illustrates the dynamic morphological changes that occur as quiescent
microglia transition to an activated state and was used as a graded scale to assess
microglial activation. Figure 4B shows representative photomicrographs of Iba1+
microglia from the posterior cerebral cortex of Late-Preg, RUPP+HC and
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RUPP+HC+MgSO4 rats. The total number of microglia was modestly increased in rats
with severe PE regardless of MgSO4 treatment, but was not statistically different than
Late-Preg controls (Figure 4C). There was a significantly higher percent of cells in fully
activated state 4 in rats with severe PE compared to controls, that was coupled by a
reduction in the percent of cells in activation state 2 (Figure 4D). These findings indicate
the presence of neuroinflammation in rats with severe PE. Treatment of RUPP+HC rats
with MgSO4 decreased the percent of activated microglia, shifting back to a relatively
quiescent and inactive pattern similar to Late-Preg controls, with the majority of
microglial cells residing in a relatively inactive state. Sham operated rats had similar
microglial activation as Late-Preg control rats (data not shown).

CBF autoregulation and brain water content in Severe PE
An underlying feature of neurological complications during severe PE is thought to be
impairment of CBF autoregulation [39]. To compare CBF autoregulation between LatePreg and RUPP+HC rats, rCBF vs. pressure curves were generated. Figure 5A shows that
as arterial blood pressure increased, the change in rCBF was similar between Late-Preg
rats and rats with severe PE and stayed below 20 % until 150 mmHg (Figure 5A). To
investigate if RUPP+HC rats were more susceptible than Late-Preg rats to hypertensioninduced cerebral edema, percent water content of the brain was measured after
measurement of CBF autoregulation. There was no difference in brain water content after
phenylephrine-induced hypertension between Late-Preg and RUPP+HC rats (Figure 5B).
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Discussion
When eclamptic seizure occurs in women with early-onset severe PE there is
approximately a 50 % maternal mortality rate [3]. This suggests that the maternal brain is
adversely affected in severe PE and at a greater risk of damage. The mechanism(s) by
which eclampsia occurs is not clearly understood, but may involve a pathologic process
involving BBB dysfunction, neuroinflammation and hyperexcitability of the brain. Here,
we modeled severe PE by introducing placental ischemia in a setting of maternal
endothelial dysfunction due to hyperlipidemia. RUPP+HC rats had increased blood
pressure and were in a state of oxidative stress and endothelial dysfunction, as indicated
by elevated circulating levels of free 8-isoprostane and ET-1. Further, rats with severe PE
had fetal and placental growth restriction that was not associated with a change in number
of pups or fetal reabsorptions. This is similar to women with early-onset severe PE that
have intrauterine growth restriction and placental disease [40]. Importantly, rats with
severe PE were in a state of increased seizure susceptibility, with seizure threshold being
significantly lower than normal pregnant controls. Seizure susceptibility in rats with
severe PE was associated with increased BBB permeability to small solutes and
microglial activation. However, there was no change in seizure severity between LatePreg and RUPP+HC rats, indicating that regulatory mechanisms limiting prolonged
seizure activity were similar to the control state, despite neuroinflammation in rats with
severe PE. Thus, the brain seems to be at a greater risk of seizure due to breakdown of the
BBB and associated neuroinflammation in this rat model of severe PE.
Neuroinflammation, demonstrated in the current study by activated microglia, can
increase neuronal excitability through microglial secretion of pro-inflammatory cytokines
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such as tumor necrosis factor alpha (TNFα) [8,13]. TNFα causes trafficking of excitatory
receptors to the neuronal cell surface and simultaneous internalization of inhibitory
receptors, resulting in a net increase in neuronal excitability [8,41,42]. Thus, it is possible
that in this model of severe PE, lower seizure threshold and increased seizure
susceptibility were a consequence of neuroinflammation because they also had marked
microglial activation. In the current study, severe PE rats treated with MgSO4 had
significantly less microglial activation that correlated with increased seizure threshold. In
fact, MgSO4 treatment returned neuroinflammation and seizure susceptibility to the level
of normal pregnant controls. However, the effect of MgSO4 appeared to be a direct effect
on microglial activation, as opposed to limiting BBB permeability. MgSO4 has been
shown to limit LPS-induced microglial secretion of pro-inflammatory cytokines in cell
culture through inhibition of L-type calcium channels and subsequent reduction in
downstream signaling of nuclear factor kappa B (NF-κB), a transcription factor involved
in inflammatory pathways [43-45]. However, to our knowledge, this is the first study
showing that MgSO4 treatment increases seizure threshold in severe PE via a quiescent
effect on activated microglia in vivo. This is in agreement with a recent study showing
MgSO4 treatment increased seizure threshold in a LPS model of PE, however, the
mechanism by which this occurred was not investigated [5].
Overall the effect of MgSO4 treatment on seizure threshold appeared to be due to
reducing neuroinflammation, and not a protective effect at the BBB. In the present study,
rats with severe PE had selectively increased BBB permeability to small, but not large
solutes. Increased permeability to sodium fluorescein but not 70 kDa Texas red dextran
suggests size-selectivity of the increased permeability and indicates modest tight junction
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disruption [46,47]. However, as MgSO4 is thought to decrease BBB permeability through
a calcium-antagonistic action on tight junction permeability [16,21,22,48], it was
surprising that there was no effect of MgSO4 on BBB permeability in rats with severe PE.
Instead, the increase in BBB permeability to sodium fluorescein may indicate an increase
in transcellular permeability that may be calcium-independent, which could further
explain the lack of effect of MgSO4 treatment on severe PE-associated BBB
permeability.
The lack of increase in permeability to large solutes is in contrast to two recent
studies using the RUPP model without high cholesterol treatment. Both studies report
increased BBB permeability to Evan’s Blue in RUPP compared to pregnant control rats
[49,50]. One explanation of these contrasting results is the different methodology used.
Evan’s Blue binds to albumin that changes during pregnancy and PE [51-54]. Thus, the
use of 70 kDa Texas red dextran that does not bind to albumin likely provides more
reliable results. Further, the two studies reporting increased BBB permeability to Evan’s
Blue in RUPP rats allowed the tracer to circulate for a longer duration of time: 3 – 24
hours versus 10 minutes in the current study [49,50]. These longer time frames likely
provide more variable results due to differences in clearance by cerebrospinal fluid or
other tissues, including placenta [55-57]. Regardless, in the present study, RUPP+HC rats
had selectively increased BBB permeability that may contribute to lowering seizure
threshold by allowing passage of serum constituents into the brain that activated
microglia and created a neuroinflammatory state.
Cerebral edema formation is considered a leading cause of the neurological
symptoms that occur in severe PE, including eclamptic seizure [58-60]. In fact,
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approximately 90 % of women with eclampsia have vasogenic cerebral edema formation
as indicated by diffusion-weighted MRI [36]. Seizure itself leads to BBB disruption,
making it difficult to determine if edema is the cause of or a consequence of eclamptic
seizure [10,61]. A recent study using PTZ to induce seizure in normal pregnant rats found
that the maternal brain was more susceptible to seizure-induced vasogenic edema
formation than the nonpregnant state [38]. This may be an effect of increased plasma
volume during pregnancy that, under conditions of BBB disruption such as seizure, may
drive water into the brain. In the current study, however, brain water content after seizure
was significantly lower in RUPP+HC rats compared to Late-Preg rats, with no effect of
MgSO4 treatment. Plasma volume contraction is known to occur in women with PE that
may underlie the decreased vasogenic edema formation in severe PE rats [62]. This
would also support the concept that increased plasma volume contributes to increased
seizure-induced edema. Further, plasma volume contraction could also explain the
significant reduction in maternal body weight that occurred in rats with severe PE.
Although the brain does not seem to be more susceptible to seizure-induced vasogenic
edema formation in severe PE, the cerebral circulation appears to be compromised,
indicated by increased BBB permeability and neuroinflammation that could increase the
risk of brain injury during eclampsia.
The cerebral circulation is thought to have a central role in neurologic
complications associated with PE [3]. In fact, cerebrovascular events such as edema and
hemorrhage account for ~ 40 % of maternal deaths [3]. Development of neurologic
symptoms in women with PE is thought to involve the impairment of CBF autoregulation
that is associated with decreased cerebrovascular resistance, hyperperfusion of the brain
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and vasogenic edema formation [32,39]. Studies that have assessed dynamic CBF
autoregulation in women with PE using transcranial Doppler (TCD) to measure changes
in CBF velocity in the middle cerebral artery in response to hemodynamic fluctuations
have found that CBF autoregulation appears to be intact in PE [39,63,64]. The findings in
the current study showing intact CBF autoregulation in rats with severe PE supports these
previous findings in humans. Further, as autoregulation remained intact in RUPP+HC
rats, it was not surprising that there was no difference in brain water content after
autoregulation measurements between groups. However, a recent study investigating
CBF autoregulation in rats with RUPP without a high cholesterol diet report that
autoregulation was impaired [50]. While it is unlikely that the addition of a high
cholesterol diet in the current study restored autoregulation, it is more likely that
methodological differences account for this discrepancy. Specifically, the current study
assessed CBF autoregulation in the posterior cerebral cortex where as Warrington et al.
investigated autoregulation in the anterior brain region [50]. Thus, it is possible that
regional differences exist due to the primary blood supply differing between regions that
may explain the conflicting findings between these two studies. Further, in the current
study all catheters for continuous arterial blood pressure measurement and drug delivery
were placed in distal systemic arteries such as the femoral arteries/veins to avoid
disrupting blood flow to the brain. Warrington et al. used a carotid catheter to
continuously monitor blood pressure while simultaneously recording CBF and cannulated
one jugular vein for drug infusion [50]. As the carotid arteries and jugular veins are
important for hemodynamics and CBF, their cannulation may account for the
discrepancies in the effectiveness of CBF autoregulation between these studies.
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Regardless, the current study suggests that CBF autoregulation in the posterior cerebral
cortex in rats with severe PE is similar to Late-Preg control rats. Thus it is not likely that
impaired CBF autoregulation contributes to decreased seizure threshold in rats with
severe PE.
In summary, PE is a heterogeneous disorder that seems to manifest along a
spectrum of severity and symptoms [1,65]. It remains unclear why some women with PE
develop neurologic symptoms such as seizure, and others do not. That eclamptic seizure
is more often fatal in women with severe PE stresses the importance of gaining a clear
understanding of the disease processes leading to seizure onset. This study provides
insight into the etiology of eclamptic seizure in severe PE, as it seems to involve a
pathologic process of compromised BBB function and subsequent neuroinflammation,
resulting in increased seizure susceptibility. By reducing neuroinflammation, MgSO4
effectively increased seizure threshold, without affecting BBB permeability. Overall,
preventing eclampsia, particularly during severe PE, is important in preventing maternal
and fetal morbidity and mortality worldwide. Further, understanding the mechanism by
which MgSO4 functions as a seizure prophylactic in PE may lead to more targeted
therapies and avoid unnecessary risks associated with MgSO4 treatment.
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Table 1. Physiological parameters in models of normal pregnancy (Late-Preg) and
severe preeclampsia (RUPP+HC).
Late-Preg (n)

RUPP+HC (n)

460.0 ± 10.0 (3)

371.0 ± 21.2 (5) *

# Pups

14.7 ± 1.2 (3)

11.2 ± 3.4 (5)

# Reabsorptions

1.7 ± 0.9 (3)

3.0 ± 2.5 (5)

Pup Weight (grams)

2.5 ± 0.03 (44)

2.2 ± 0.02 (56) **

Placental Weight (grams)

0.46 ± 0.01 (44)

0.42 ± 0.01 (56) **

Blood Pressure (mmHg)

114 ± 1 (6)

138 ± 3 (4) **

Body Weight (grams)

* p < 0.05; ** p < 0.01 vs. Late-Preg by ANOVA
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Table 2. Assessment of seizure severity in late-pregnant (Late-Preg) rats, rats with
severe preeclampsia (RUPP+HC), and severe preeclamptic rats treated with
magnesium sulfate (RUPP+HC+MgSO4).
# Recurrent Seizures

% of Time in Seizure

Late-Preg (n = 6)

12 ± 3

85 ± 7

RUPP+HC (n = 6)

13 ± 4

86 ± 5

6±1

88 ± 5

RUPP+HC+MgSO4 (n = 6)
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Table 3. Physiological parameters of late-pregnant (Late-Preg) rats, rats with severe
preeclampsia (RUPP+HC), and severe preeclamptic rats treated with magnesium
sulfate (RUPP+HC+MgSO4) under chloral hydrate anesthesia for seizure threshold
measurements.

Body Temp (o C)
Arterial PO2 (mmHg)
Arterial PCO2

Late-Preg

RUPP+HC

RUPP+HC+MgSO4

(n = 6)

(n = 6)

(n = 6)

36.8 ± 0.2

36.4 ± 0.1

36.5 ± 0.1

111 ± 7

121 ± 6

116 ± 10

42.8 ± 1.7

41.5 ± 1.5

44.8 ± 3.2

(mmHg)
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Figure 1. Effect of severe preeclampsia and magnesium sulfate (MgSO4) treatment
on seizure threshold and susceptibility. (A) Representative EEG tracing during timedinfusion of pentylenetetrazole (PTZ). Black arrows indicate when PTZ infusion begun
and the onset of spike-wave discharges, or seizure onset. (B) Seizure threshold was
significantly lower in rats with severe preeclampsia (RUPP+HC), and treatment with
MgSO4 (RUPP+HC+MgSO4) significantly increased seizure threshold back to latepregnant (Late-Preg) control levels. (C) Rats with severe PE had significantly higher
seizure susceptibility scores compared to Late-Preg controls that were reversed in
RUPP+HC+MgSO4 rats. * p < 0.05 vs. Late-Preg; ^ p < 0.01 vs. RUPP+HC+MgSO4; **
p < 0.01 vs. all groups by one-way ANOVA with post-hoc Bonferroni test.
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Figure 2. Effect of severe preeclampsia and magnesium sulfate (MgSO4) on seizureinduced vasogenic edema formation. Percent water content of the posterior cerebral
cortex was significantly lower after seizure in rats with severe preeclampsia (RUPP+HC)
compared to late-pregnant (Late-Preg) control rats. Treatment of severe preeclamptic rats
with MgSO4 (RUPP+HC+MgSO4) did not affect brain water content after seizure. * p <
0.05; ** p < 0.01 vs. Late-Preg by one-way ANOVA with post-hoc Bonferroni test.
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Figure 3. Effect of severe preeclampsia and magnesium sulfate (MgSO4) on in vivo
blood-brain barrier (BBB) permeability to different sized solutes. (A) BBB
permeability to sodium fluorescein was increased in rats with severe preeclampsia
(RUPP+HC) in the posterior cerebral cortex compared to late-pregnant (Late-Preg)
control rats. MgSO4 treatment in rats with severe preeclampsia (RUPP+HC+MgSO4) had
no effect on BBB permeability to sodium fluorescein. (B) Permeability of the BBB to 70
kDa Texas red dextran was similar between Late-Preg and RUPP+HC rats with and
without MgSO4 treatment. * p < 0.05 vs. Late-Preg by one-way ANOVA with post-hoc
Bonferroni test.
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Figure 4. Effect of severe preeclampsia and magnesium sulfate (MgSO4) treatment
on microglial activation. (A) Illustration of morphological changes occurring as
microglia progress from their inactive state 1, marked by long ramified processes to their
active state 4, indicated by a large, amoeboid-like shape. (B) Representative
photomicrographs of microglial cells stained for ionized calcium-binding adapter
molecule 1 (Iba1) in the posterior cerebral cortices of late-pregnant (Late-Preg) rats, rats
with severe preeclampsia (RUPP+HC) and rats with severe preeclampsia treated with
MgSO4 (RUPP+HC+MgSO4). (C) The number of Iba1+ microglia was similar between
groups. (D) The percentage of microglia in active state 4 was significantly higher in
RUPP+HC rats compared to Late-Preg controls. Treatment of RUPP+HC rats with
MgSO4 decreased the percentage of cells that were active and was similar to Late-Preg
controls. ** p < 0.01 vs. Late-Preg and RUPP+HC+MgSO4 by one-way ANOVA and
post-hoc Bonferroni test.
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Figure 5. Effect of severe preeclampsia on cerebral blood flow (CBF) autoregulation
and vasogenic edema formation. (A) Relative CBF (rCBF) increased similarly between
late-pregnant (Late-Preg) and rats with severe preeclampsia (RUPP+HC) as arterial blood
pressure was increased between 100 mmHg to 180 mmHg demonstrating intact
autoregulation of CBF that was not different between groups. (B) Percent water content
of the posterior cerebral cortex after CBF autoregulation measurements was similar
between Late-Preg and RUPP+HC rats.
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CHAPTER 5: CONCLUSIONS AND FUTURE DIRECTIONS
Eclampsia is considered a form of hypertensive encephalopathy during which an
acute hypertensive episode leads to loss of vascular resistance of cerebral arteries,
autoregulatory breakthrough, and increased hydrostatic pressure on the microcirculation,
BBB disruption, and vasogenic edema formation (Lassen and Agnoli, 1972; Easton,
1998). However, women have eclamptic seizure during seemingly uncomplicated
pregnancies at normal blood pressures and in the absence of preeclampsia (Douglas and
Redman, 1994; Katz et al., 2000). Further, preeclamptic and eclamptic women are, by
definition, normotensive prior to pregnancy. This may suggest that the pressure at which
autoregulatory breakthrough occurs is shifted to lower pressure during pregnancy.
However, previous studies in pregnant rats and findings in this dissertation suggest that
the CBF autoregulatory curve is actually extended in the pregnant state, making the
maternal brain better prepared to maintain CBF in the face of both acute hypotensive and
hypertensive episodes (Cipolla et al., 2012a). Further, CBF autoregulation appears to be
similar during preeclampsia and normal pregnancy. The findings that edema is present in
over 90% of eclamptic women has supported that eclampsia is a form of hypertensive
encephalopathy (Zeeman et al., 2004; Brewer et al., 2013); however, the maternal brain is
more susceptible to vasogenic edema formation in response to acute hypertension with
and without autoregulatory breakthrough (Euser and Cipolla, 2007; Cipolla et al., 2012a).
Further, the brain appears to be hyperexcitable during normal pregnancy, and to a greater
degree in preeclampsia. Thus, eclamptic seizure may occur due to vasogenic edema
formation in the hyperexcitable maternal brain, potentially due to mechanisms involving
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disrupted BBB function and increased permeability, rather than impairment of CBF
autoregulation. In some women, eclampsia most likely occurs due to autoregulatory
breakthrough similarly to hypertensive encephalopathy, however, the onset of eclamptic
seizure seems to be more convoluted, and perhaps should not be considered a form for
hypertensive encephalopathy.
The role of vasogenic edema formation in eclamptic seizure onset remains
difficult to determine, as seizure itself leads to BBB disruption and edema formation
(Oztas et al., 2003; Oby and Janigro, 2006). It is further complicated by the finding that
the maternal brain is more susceptible to seizure-induced vasogenic edema, suggesting
that vasogenic edema during eclampsia may be a result of the convulsions, rather than a
cause, or, perhaps, a combination of both. However, this increase in seizure-induced
edema was only present in normal pregnant rats. Vasogenic edema formation was
significantly reduced in response to seizure in rats with preeclampsia compared to normal
pregnancy, suggesting that preeclampsia may either prevent or reverse the increase in
capillary density or plasma volume that appear to contribute to the susceptibility of the
brain to vasogenic edema during pregnancy under conditions that promote BBB
disruption. Regardless, the role of vasogenic edema formation in seizure onset during
pregnancy needs to be further investigated. Further, the effect of preeclampsia on
cerebrovascular adaptations to normal pregnancy needs to be investigated, as that may
further elucidate roles of the cerebral circulation in eclamptic seizure onset.
The protective extension of the CBF autoregulatory curve during pregnancy
appears to involve changes in nitric oxide synthase (NOS). The nitric oxide (NO)dependent enhancement of vasodilation of cerebral pial arteries reported in this
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dissertation and the pregnancy-induced outward remodeling of penetrating arterioles
likely contribute to the leftward shift by increasing dilation of cerebral arteries in
response to decreased intravascular pressure, thereby maintaining CBF at lower pressures
(Cipolla et al., 2011). However, the systemic administration of a NOS inhibitor did not
affect the lower limit, suggesting that perhaps there are compensatory mechanisms to
maintain CBF, such as neuronal sources of NOS. Although in this study there was no
change in mRNA expression of endothelial NOS in the cerebral arteries investigated,
another study reported that endothelial NOS mRNA expression was decreased in the
posterior cerebral cortex compared to the nonpregnant state (Cipolla et al., 2012a). The
leftward shift of the lower limit may be due to increased activity of endothelial NOS in
response to decreased intraluminal pressure, despite the decrease in expression. Further,
NO production has been shown to contribute to the loss of vascular resistance that occurs
in response to extreme increases in pressure, leading to forced dilatation of cerebral
arteries and autoregulatory breakthrough (Talman and Nitschke Dragon, 2007). In fact,
NOS inhibition shifts the upper limit of the CBF autoregulatory curve to higher pressures
(Euser and Cipolla, 2007). Thus, the decrease in endothelial NOS expression in the
posterior cerebral cortex during pregnancy could contribute to the rightward shift of the
upper limit measured in pregnancy (Cipolla et al., 2012a). Overall, it appears that
fluctuations in arterial pressure may have a differential effect on NOS and NO production
in order to have protective effects at both the upper and lower limits of the CBF
autoregulatory curve during pregnancy; however, whether the same mechanism exists in
preeclampsia needs to be further investigated.
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CBF autoregulation being similar between rats with preeclampsia and normal
pregnant rats is particularly interesting, given the prominent role of NOS that has
emerged in the extension of the autoregulatory curve, and that preeclampsia is a state
marked by decreased bioavailability of NO. Systemically, oxidative stress and increased
reactive oxygen species decrease the bioavailability of NO during preeclampsia (Lowe,
2000). However, what may be occurring in the brain during preeclampsia regarding
changes in endothelial, neuronal or inducible NOS expression and NO production, or
cerebrovascular function in general, remains relatively unknown. That NOS inhibition
shifts the upper limit of the autoregulatory curve to higher pressure would suggest that if
preeclampsia were a state of decreased NOS expression and NO bioavailability, than the
limit may be shifted even further. However, this does not appear to be the case.
Importantly, pregnancy prevents and reverses the protective cerebrovascular remodeling
that occurs in response to chronic hypertension that has been shown to shift the upper
limit of CBF autoregulation to higher pressure (Paulson et al., 1990; Cipolla et al., 2006;
Aukes et al., 2007; Cipolla et al., 2008). Thus, that autoregulation was similar between
pregnant and chronically hypertensive preeclamptic rats may actually indicate less
effective autoregulation in rats with preeclampsia. Further investigation into the function
of cerebral arteries during experimental preeclampsia would be useful to gain a better
understanding of the role the cerebrovasculature may play in the potential for brain injury
and eclampsia.
Preeclampsia appears to be a state of greater seizure susceptibility than normal
pregnancy, which makes sense in the context that the majority of women with eclampsia
are preeclamptic (Douglas and Redman, 1994). Regardless, normal pregnancy contributes
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to the potential for eclampsia, not only by increasing the excitability of the brain, but also
by the seizure-provoking factors that circulate late in gestation (Cipolla et al., 2012b).
Under pathologic states when the BBB may be compromised due to infection, failure of
efflux transporters, or acute hypertension, such hyperexcitable factors would likely gain
access to the hyperexcitable maternal brain, and lead to seizure onset. Similarly, during
preeclampsia where a level of basal BBB disruption appears to be present, the secondary
insult necessary to initiate seizure onset is likely minor compared to the normal pregnant
state. Thus, a therapeutic medication that acts as a neuroprotectant through targeting
either the compromised BBB, hyperexcitable neurons, or activated microglia would
likely be necessary and sufficient for seizure prevention during preeclampsia.
There is in vivo evidence that MgSO4 exerts protective effects at the BBB (Kaya
et al., 2001; Esen et al., 2003; Kaya et al., 2004; Esen et al., 2005; Euser et al., 2008) and
an anticonvulsant effect on NMDA receptor-containing cortical neurons (Hallak et al.,
1992; Hallak et al., 1994). Further, findings from this dissertation provide evidence that
MgSO4 acts as a seizure prophylactic through quiescent effects on activated microglia,
thereby reducing neuroinflammation and raising seizure threshold. This is likely due to
the calcium-antagonistic effects of MgSO4, preventing the secretion of pro-inflammatory
cytokines through inhibition of L-type calcium channels and subsequent activation of the
NF-κB signaling cascade (Gao et al., 2013). By inhibiting the secretion of proinflammatory cytokines that have been shown to increase neuronal excitability
(Stellwagen et al., 2005; Riazi et al., 2008), MgSO4 restores seizure threshold to the level
of normal pregnancy. Whether there are further effects of MgSO4 on the excitability of
NMDA receptor-containing neurons that also contributes to the restoration of seizure
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threshold is unclear at this time. However, through the use of a GABAAR-specific
chemoconvulsant, there does not appear to be an effect at NMDA receptors. If there was
an effect at NMDA receptors, one might expect seizure threshold to be even higher with
MgSO4 treatment than pregnant controls. That seizure threshold is similar to pregnant
control levels suggests that it is mainly changes in the GABAAR system that is affecting
seizure threshold during pregnancy and preeclampsia. Current literature on the effects of
microglial-secreted pro-inflammatory cytokines such as TNFα indicate increased
excitability is due to the simultaneous increase in trafficking of AMPA receptors to
neuronal cell membranes coupled with increased endocytosis of GABAAR away from the
cell membrane (Stellwagen et al., 2005). This mechanism of increased excitability does
not seem to involve a role for NMDA receptors. However, direct investigation of seizure
threshold using a specific NMDA receptor antagonist in preeclamptic rats with and
without MgSO4 treatment could lead to a better understanding of potential central
anticonvulsant effects of MgSO4 treatment in seizure prevention during preeclampsia.
Normal pregnancy and preeclampsia appear to be the setting of a perfect storm,
with hyperexcitable factors circulating and the brain in a hyperexcitable state. There is
evidence that actions of MgSO4 have protective effects at several sites that may be
involved in the pathogenesis of eclampsia, including a “tightening” effect at the BBB, a
quiescent effect on microglial, and an anticonvulsant effect at NMDA receptors. This
multifaceted action likely contributes to the effectiveness of MgSO4 as a seizure
prophylactic, especially given the heterogeneity of disease processes involved in the
pathogenesis preeclampsia and eclampsia. It is unlikely that every woman with
preeclampsia that develops eclampsia has the same insult that results in seizure onset.
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Thus, by targeting several areas of potential disruption through which seizure may be
initiated, MgSO4 effectively prevents seizure in women all along the spectrum of disease.
This may be the reason why MgSO4 is more effective in seizure prevention during
preeclampsia than any anticonvulsant medication that only manipulates neuronal activity.
This dissertation had several limitations that should be taken into account.
Specifically, seizure threshold was determined as the amount of PTZ required to induce
generalized seizure. Generalized seizure can accurately be monitored via subcutaneous
EEG electrodes and, as eclampsia is generalized tonic-clonic seizure, is an appropriate
measure to begin to understand the excitability of the maternal brain that may contribute
to eclampsia. However, it may have also been useful to measure focal seizure using more
sensitive electrode placement such as cortical or implanted hippocampal electrodes.
Further, PTZ was used as the chemoconvulsant in this study due to its antagonistic
actions at GABAARs that allowed direct investigation of pregnancy-induced changes in
the inhibitory system within the brain; however, the use of a chemoconvulsant that targets
excitatory glutamatergic receptors, such as AMPA or kainic acid, may provide insight
into pregnancy-induced plasticity of the excitatory system. It is possible that the apparent
decrease in tonic inhibition due to downregulation of the GABAAR-δ is compensated for
by a decrease in excitatory receptor expression that would only be unmasked by the use
of a convulsant specific to the excitatory system. In a similar regard, only cortical protein
expression of one subunit, GABAAR-δ, was investigated via Western blot in this project.
It is possible that pregnancy-induced plasticity of the γ-subunit (GABAAR-γ) that is
synaptically located and involved in phasic inhibition may compensate for the decrease in
expression of GABAAR-δ. However, studies report that GABAAR-γ expression also
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decreases over the course of gestation (Maguire and Mody, 2009), making it more likely
that this pregnancy-induced decrease in GABAAR-γ augments hyperexcitability as
opposed to compensating for the decrease in GABAAR-δ to maintain appropriate
inhibition. Finally, the seizure model used in this dissertation was not a model of
spontaneous seizure, and therefore, not a model of eclampsia. However, this dissertation
sought to understand changes in brain excitability during pregnancy and preeclampsia
that could potentiate seizure and contribute to eclampsia. Thus, seizure was induced to
detect changes in seizure threshold and susceptibility. The findings in this dissertation
shed new light on excitability changes during normal pregnancy and preeclampsia and
potential underlying mechanisms by which that hyperexcitability may be occurring;
however, we still do not have a clear understanding of eclamptic seizure onset.
This dissertation provided insight into mechanisms of seizure during pregnancy
and preeclampsia; however, it also opened the door for further investigation into the
pathogenesis of eclampsia during both seemingly healthy pregnancies and pregnancies
complicated by preeclampsia. Future studies investigating the role of the BBB in seizure
prevention during normal pregnancy would be useful in gaining a better understanding of
not only the adaptation of the BBB to normal pregnancy, but potential mechanisms of
disrupted barrier function that may become central to seizure onset. Specifically, studies
bypassing the BBB and delivering seizure-provoking serum directly to the brain and
monitoring for spontaneous seizure in late-pregnant rats would be critical proof-ofprinciple experiments that the BBB definitively contributes to seizure prevention during
pregnancy. Further, investigation into gestational regulation of both expression and
activity of efflux transporters including Pgp and Mrp1 in cerebral microvessels would
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allow a greater understanding of the adaptation of the BBB to increased circulating
factors occurring during pregnancy. In addition, in vivo studies manipulating the activity
of efflux transporters at the BBB through pharmacological inhibition of Pgp and
Mrp1with simultaneous EEG recording during normal pregnancy would provide insight
into the role of these specific transporters in seizure prevention during normal pregnancy.
The BBB during preeclampsia should also be investigated to determine the pathologic
process leading to increased BBB permeability that occurs in rats with experimental
preeclampsia. Additional size-selectivity studies would be useful to determine the extent
of BBB disruption, including further investigation into the type of BBB disruption that is
occurring (e.g. increased paracellular vs. transcellular transport) in rats with experimental
preeclampsia. Further studies investigating whether there is an effect of circulating
factors during preeclampsia on efflux transporters at the BBB that may decrease their
activity and result in decreased barrier function remains unclear, but could also be
investigated using the experimental model of preeclampsia developed in this dissertation.
These future studies could potentially lead to enhanced screening procedures to identify
women who may be at risk of de novo seizure during pregnancy and preeclampsia.
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